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Ac  acetyl 
Ac2O  acetic anhydride 
AcOH  acetic acid 
aq  aqueous 
AS  affinity separation 
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Boc  tert–butoxycarbonyl 
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yloxytris(dimethyl 
amino)phosphonium 
hexafluorophosphate 
br  broad (NMR) 
°C  degrees Celsius 
CC column 
chromatography 
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carbodiimide 
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pyridine 
DMF N,N–dimethyl 
formamide 
e.g. exempli gratia (for 
instance) 
EI  electron impact (MS) 
Et  ethyl 
et al.  et aliae (and others) 
EtOAc  ethyl acetate 
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chromatography 
IR  infrared 
J coupling constant (in 
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spectroscopy 
M  molar 
MCR multi component 
reaction 
Me  methyl 
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NMR nuclear magnetic 
resonance 
Ph  phenyl 
ppm  parts per million 
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rt  room temperature 
s  singlet (NMR) 
t  triplet (NMR) 
tBu  tert–butyl 
TFA  trifluoroacetic acid 
THF  tetrahydrofuran 
TLC thin layer 
chromatography 
TBS  tert–butyldimethylsilyl 
UPy  ureido–pyrimidinone 
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Chapter 1 
 
INTRODUCTION 
 
 
1.1 Introduction 
 
During the last decades, a great demand for small, drug–like organic 
molecules has emerged from the pharmaceutical industry. To meet this demand, over 
the years organic chemists have developed a range of synthetic tools, which 
contribute to the speed, efficiency and selectivity of synthesis routes. Recent findings 
and further improvements in the fields of catalysis,1 asymmetric synthesis,2 and 
multi–component reactions (MCRs)3 to mention some examples provide increasingly 
versatile access to biologically relevant compounds. However, not only the synthetic 
feasibility of interesting structures is important in the development of new drugs; the 
ability to separate the desired products from side–products and impurities is also a 
crucial factor. Therefore, not only new efficient chemical transformations have to be 
developed, but novel, broadly applicable purification protocols are required as well.  
 
1.1.1  Solution–phase synthesis 
 
Standard techniques in synthetic organic chemistry, generally concerning 
solution–phase chemical reactions (Figure 1), are broadly used and well understood. 
Reagents are readily available, and standard analytical tools such as NMR, TLC, GC 
and LCMS can be routinely used to monitor the conversion of the desired reaction.  
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Figure 1: Solution–phase synthesis. 
 
However, a disadvantage of solution–phase synthesis, is the fact that reactions 
are labour–intensive in terms of work up and purification of products. Since relatively 
large quantities of solvents have to be used during these processes, the syntheses of 
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large numbers of organic compounds for pharmaceutical purposes can be expensive 
using standard techniques. Another drawback of the aqueous work up and purification 
after completion of the reaction, is that these operations are not easily automated, 
rendering solution–phase synthesis in principle less suited for automated library 
synthesis. 
These drawbacks of solution–phase synthesis for pharmaceutical purposes led 
to the development of a powerful alternative.  
 
1.1.2  Solid–phase synthesis 
 
During the 1950s, Merrifield and coworkers developed a new protocol in 
organic synthesis, which involves the covalent attachment of a substrate to a solid 
polymer resin (Figure 2).4 This resin is generally insoluble in both organic and 
aqueous media, but can be treated with soluble reagents and catalysts to obtain the 
desired chemical reaction. When full conversion is reached, no laborious work up is 
needed; simple filtration and subsequent washing of the polymer beads yields the 
pure product, which is still attached to the resin.  
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ABcleavagefiltrationAB
 
 
Figure 2: Solid–phase synthesis. 
 
If more steps are required, this process can be repeated until the desired 
compound is formed. After cleavage of the covalent bond between product and resin, 
the insoluble polymer can be filtered off to give the pure product. 
This methodology has been widely used for several decades now,5 because it 
has some clear advantages over traditional solution–phase synthesis. Besides the fact 
that no work up and purification of reaction products is required, this methodology 
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can be easily automated to generate large libraries of biologically interesting 
compounds. 
Nevertheless, from a practical point of view, some disadvantages have to be 
mentioned as well. Since chemical reactions usually proceed somewhat differently 
under solid–phase conditions compared to the analogous solution–phase conditions, 
translation of well–described reaction conditions into a robust solid–phase protocol is 
not always straightforward. In many cases, significant optimisation of reaction 
procedures is needed to realise full conversion during a reaction cycle, and thus 
suppress the formation of side products after multiple cycles. In addition, due to the 
generally lower reactivity of compounds on a bead, significantly longer reaction times 
are required in solid–phase synthesis.  
A second problem in this respect is the limited number of analytical tools to 
monitor the conversion of reactions on solid–phase resins. Standard techniques 
applied in solution–phase chemistry, such as TLC and NMR, cannot be used when 
solid polymer beads are present and both starting material and product are not in 
solution. Because of these restrictions, the most commonly applied analytical tools to 
examine solid–phase reactions are IR–spectroscopy and elemental analysis, but these 
methods give only limited information.  
Finally, it has to be mentioned that heterogeneous catalysis cannot be applied 
when a solid support is used, first of all due to the limited contact between the 
insoluble resin and catalyst, and secondly because of the impossibility to separate the 
catalyst from the resin. 
 
1.1.3  Synthesis based on affinity separation (AS) 
 
For the aforementioned reasons, numerous groups set out to explore the 
possibilities to combine the benefits of both solution– and solid–phase chemistry. One 
approach involves the attachment of reactants or starting materials to a chemical label 
(affinity tag) possessing certain physical properties, which can be used to selectively 
isolate these compounds from mixtures through affinity separation (AS, Figure 3).6  
In this case, a chemical reaction is performed under solution–phase 
conditions, and the process can be monitored by standard analytical tools. When the 
reaction has been completed, an additional medium, which is immiscible with the 
reaction mixture, is added. The additional phase is either a solvent or a solid that has a 
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distinct affinity for the tagged compound, but no affinity whatsoever for the other 
reagents and products. This way, affinity binding will occur; the tagged compound 
will transfer to the added affinity medium, whereas the other reactants will remain in 
the initial phase. 
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Figure 3: Purification of products by affinity separation. 
 
When the two phases are separated, either by extraction (in case of a liquid–
liquid system) or filtration (in case of a liquid–solid system), the tagged compound 
will be isolated in the affinity medium. If the affinity medium is a liquid, only 
evaporation of this solvent is required to obtain the pure product. In the case of a solid 
affinity medium, an extra step is needed to liberate the product from the solid affinity 
binder (Figure 3). This is usally performed by a solvent switch; during affinity 
binding a suitable solvent is chosen to establish the non–covalent interaction between 
the tagged product and the affinity binding agent. When the resulting complex is 
taken up in a solvent with different properties, the interaction between the tagged 
compound and the solid particles can be reduced which will result in dissociation of 
the compound from the solid. Filtration then yields the tagged product in solution, 
and evaporation of the solvent will give the desired compound in pure form. 
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Obvious advantages of the AS method lie in the fact that chemical 
transformations can be carried under well–known conditions in solution, and that the 
progress of reactions can be monitored by standard techniques such as TLC, NMR 
and LCMS. Heterogenous catalysis can also be applied without difficulties, especially 
since a solid catalyst can be separated from the reactants in solution. Also, in analogy 
with solid–phase chemistry, reagents can be without difficulty used in excess to drive 
reactions to completion and alternatively the cycle can be repeated until the desired 
compound has been fully formed. 
After the last reaction and purification cycle, the product must be spliced from 
the tagged linker. At this point, affinity separation can be utilised in a different way, 
namely as a scavenging tool for the tagged linker (Figure 4). 
 
ABTag Linker
cleavage
Tag Linker
AB
affinity
binding
TagAB
Tag Linker
phase
separation AB
 
 
Figure 4: Cleavage and purification of the product. 
 
When the product is freed from the tagged linker, it has no affinity for the 
resin anymore. This means that when the resin is added, it only binds the linker that 
still bears the affinity tag. The product will remain in solution and when the resin is 
filtered off, and the solvent is evaporated, one should end up with product AB in pure 
form. 
Besides the aforementioned easy monitoring of reaction progress, the use of 
affinity tag–methodology has some additional advantages. Because the tag has a 
distinct affinity for a different medium than the other reagents in the reaction mixture, 
the tagged product is usually obtained in high purity. Laborious and time consuming 
purification can therefore be circumvented, which makes this method potentially 
faster and cheaper than conventional techniques. Second, phase separation of the 
reaction mixture and the affinity medium can be automated using a similar setup as in 
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solid phase chemistry, so that libraries of compounds can be generated rapidly in a 
combinatorial fashion. 
Because of these properties, affinity separation has been recognised as a 
welcome tool in organic synthesis, and has been explored by different groups in 
recent years.7 A range of suitable tags has been developed, utilising all sorts of 
affinity interactions.  
 
1.2 Tag methodology in organic synthesis 
 
1.2.1  Fluorous phase separation 
 
A widely spread affinity protocol has been developed in the groups of 
Horváth8 and Curran.9 This method involves the combined use of an organic and a 
fluorous solvent, which are separable at room temperature by a standard liquid–liquid 
extraction. Importantly, when the temperature is increased, the miscibility of the two 
phases increases and at a certain point both solvents merge into a homogenous 
solution (Figure 5). The two initial layers are reinstalled by cooling of the mixture, 
and the phases can be separated again. 
 
reaction
preparation separation
fluorous
phase
fluorous
phase
monophasic
mixture
T
progress of process
organic 
phase
organic 
phase
 
 
Figure 5: Fluorous phase separation.10 
 
By tagging a compound with a fluorous phase tag prior to this process, it will 
become soluble in a fluorous solvent, since “similia similibus solvuntur”.11 A solution 
of a fluorous tagged starting material in a fluorous solvent can be added to an organic 
solution of standard reagents. At elevated temperatures, hence when a homogeneous 
monophasic solution is formed, a conventional chemical reaction can be carried out. 
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When the desired transformation has been accomplished, the fluorous tagged product 
can be isolated by cooling of the mixture and subsequent phase separation. 
An early example of this method involved a silicon–based fluorous substrate 
tag, which was introduced to allylic alcohols which were subsequently transformed 
into isoxazolines (Scheme 1).12 
 
R1 BrSi(Rf)3
Et3N
Rf = CH2CH2C6F13
R1
1 2
R2 C N O ON
R2
R1 OSi(Rf)3
3
OH OSi(Rf)3
 
 
Scheme 1: Synthesis of fluorous phase tagged isoxazolines. 
 
The tagged isoxazolines 3 were purified by a liquid/liquid extraction using a 
fluorous solvent and an organic solvent, as described above. The products were 
isolated in good yields, and high purity (91 to >97%). After treatment of the 
isoxazolines with HF, the tag–free derivatives were obtained after a second affinity 
purification cycle, as described in Section 1.1.3. 
The same tag was later used to isolate and purify disaccharides,13 and fluorous 
silyl–tagged benzoic acid derivatives were used in Ugi and Biginelli multicomponent 
reactions.14 Perfuoroalkyl alcohols can also be used as an affinity tag after coupling to 
substrates, e.g. in the form of the corresponding esters15 and acetals.16 Finally, 
fluorinated protection groups have been developed to purify compounds by this 
elegant affinity protocol, for instance the fluorinated THP–group17 and the fluorinated 
BOC–group.18 
A second application of fluorous phase separation is the recycling of catalysts 
that are equipped with a similar tag. In this case, an organic solution of the starting 
material(s) and reagents is added to a fluorous solution of the catalyst. After the 
desired reaction has been carried out (usually at elevated temperature or under 
vigorous stirring), the mixture is cooled to room temperature and the organic layer, 
containing the product, is separated from the fluorous layer, which contains the 
catalyst. The recycled catalyst solution can then be directly reused in a next reaction 
cycle, giving rise to better atom–efficiency than under conventional conditions. A 
range of fluorous catalysts have been synthesised, including a fluorous Wilkinson 
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catalyst,19 Mn– and Co–based oxidation catalysts,20 and a fluorous metathesis 
catalyst.21 Also, fluorous reagents have been developed, e.g. fluorous organotin 
hydrides.22 
  
1.2.2  Separation by hydrophobic interaction 
 
A second example of affinity separation in synthesis, is based on the 
hydrophobic interaction between charcoal and tetrabenzo[a,c,g,i]fluorine (Tbf) 
(Figure 6).23  
 
O
OR
O
charcoal
10
O
OR
O
10
apolar solvent
polar solvent
4  
 
Figure 6: Reversible binding of tetrabenzo[a,c,g,i]fluorine to charcoal.  
 
After tagging of an organic compound with the Tbf–group, it can be 
abstracted from a polar solvent upon the addition of charcoal. The resulting solid 
complex can be filtered off, leaving reagents and impurities in the filtrate. When an 
apolar solvent is then added to the bound substrate, it will dissociate from the 
charcoal and can be isolated by filtration and evaporation.  
This purification method was used to prepare peptides24 and DNA–strands,25 
and even a total synthesis of Ciprofloxacin® was concluded using the affinity 
properties of the Tbf–group.23 
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1.2.3  Separation by ionic interaction 
 
Fukase and Kusumoto demonstrated that the affinity of crown ethers for 
ammonium groups is sufficiently strong to utilise it as a purification tool in organic 
synthesis.26 The tag in this case was 5–(hydroxymethyl)–1,3–phenylene–m–
phenylene–32–crown–10 (5), which was coupled to different substrates by 
esterification (Figure 7). 
 
O
O
O
O
O O
O
O
O O
O
R
O
NH3+
apolar solvent
polar solventO
O
O
O
O O
O
O
O O
O
R
O
5
 
Figure 7: Complexation between a crown ether and an ammonium ion. 
 
After a solution phase reaction of the substrate R, the product could be 
isolated from the mixture by forming a complex with an ammonium ion that was 
immobilised on a resin, so that the generated complex could be filtered off. To ensure 
binding between the ammonium ion and the crown ether tag, apolar solvents such as 
chloroform and dichloromethane were used in the complexation step. After all 
reagents and other components in the crude mixture had been eluted from the 
product–containing resin, the complex was cleaved by flushing the system with either 
an organic base (e.g. triethylamine) to deprotonate the ammonium groups, or with 
polar solvents like methanol and DMF. Using this affinity separation protocol, 
tripeptides and aromatic piperazines were obtained in good overall yield and high 
purity.  
Polymer–bound sulfonic acid moieties have also been applied to purify 
organic compounds tagged with a crown ether.27 
 
1.2.4  Separation by metal chelation 
 
Ley and co–workers developed another affinity separation method in 2001, 
which is based on the interaction between a metal and a chelating group.28 A resin 
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bearing diacid moieties was treated with a copper(II)sulfate solution, to immobilise 
the copper ions. These copper ions have a strong affinity for bipyridines and 
phenanthrolines (6), which can therefore be used as a tag (Figure 8). 
 
N
CO2-
CO2-
Cu2+
N
N
R
R
N
N
R
R
6  
 
Figure 8: Affinity separation by metal chelation. 
 
After filtration and washing, the formed complex can be cleaved by the 
addition of N,N,N’,N’–tetramethylethylenediamine (a strong chelating agent for 
copper(II) ions) to obtain the pure product. Using this method, urea–derivatives, 
hydantoins and benzodiazepines were isolated in excellent yield and purity. 
A second application of this purification system was also explored. In this 
case reagents, rather than substrates, were tagged with a bipyridine group and 
abstracted from the solution phase using the copper(II)–containing resins, yielding 
pure products.29 
 
1.2.5  Separation by hydrogen bonding 
 
Another elegant affinity purification protocol was developed by Fukase and 
co–workers.30 They used the host–guest interaction of bis(2,6–diamidopyridine)amide 
of isophthalic acid and barbituric acid (vid. 7); these moieties form a strong complex 
through the formation of six hydrogen bonds (Figure 9).31 
A standard polymer resin was functionalised with the bis(2,6–
diaminopyridine)amides and starting materials were equipped with the barbituric acid 
tag. 
 
                                  Introduction 
                                                                                                                                            
                                                                                                                                    11                             
H
N
O
H
N
O
O
O
NH
O
NH
N
N
NH
NH
O
O
HN
HN
O
O
O
OR
7
 
 
Figure 9: Host–guest interaction based on hydrogen bonding. 
 
When tagged compounds, dissolved in an apolar solvent (generally 
chloroform), were added to the functionalised resin, binding occurred as anticipated. 
The bound substrates could be dissociated again by the addition of a polar solvent 
(generally methanol), turning this reversible binding into a suitable affinity tool. 
Tripeptides, trisaccharides and arylpiperidines were formed in a series of steps and 
isolated in excellent yield and high purity.30 In addition, a naturally occurring 
liposacchararide was obtained using this method.32 A great advantage of this protocol 
is the fact that crude reaction mixtures can be directly exposed to the resin. 
Furthermore, the ease of washing and subsequent dissociation of the products renders 
this approach interesting for automisation. An additional plus is the possibility to 
recycle the tagged resin after a purification cycle, making it a relatively cheap tool. 
Although these features add up to a powerful purification tool, small 
improvements could make this method more versatile. Firstly, in an ideal situation, it 
would be possible to add the resin to a crude reaction mixture to isolate the desired 
product.  In this case though, the binding moiety on the resin is not inert to harsh 
reaction conditions, so the affinity groups on the polymer can be damaged or cleaved. 
This would hamper recycling of the resin, which is clearly preferred over a disposable 
system. Secondly, the binding constant of the complex is 2.8 × 104 M–1, which is too 
small to bind all types of tagged products.33  
For these reasons, we decided to explore the possibilities of improving this 
affinity purification method, since a robust hydrogen bonding array, displaying 
significantly larger binding constants, is available. 
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1.3 The ureidopyrimidinone unit as affinity tag 
 
1.3.1  The ureidopyrimidinone unit 
 
In 1998, Sijbesma and Meijer described the properties of 2–ureido–4–
pyrimidinone (UPy) moieties 8.34 These UPy–units can dimerise by the formation of 
four hydrogen bonds (Figure 10).  
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Figure 10: UPy–units in monomeric and dimeric forms. 
 
Three different tautomers of monomeric UPy–units 8 exist, all three stabilised 
by an intramolecular hydrogen bond. Since tautomers 9 and 11 both possess a self–
complementary hydrogen bonding array, both can form dimers in apolar solvents, and 
the resulting complexes are sufficiently strong to alter the physical properties of the 
structures dramatically.35  
Because monomers 9 and 11 have different donor (D) – acceptor (A) arrays, 
their dimerisation constants (Kdim and K’dim, respectively) are also different. Dimer 10 
is believed to be more stable than dimer 12, since the secondary interactions of the 
AADD–array are more favoured than those in the DADA–array of complex 12.34  
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Using fluorescence spectroscopy, Kdim was determined to be 6 × 107 in 
chloroform, and 6 × 108 in toluene.36 These values are significantly higher than the 
binding constant of the barbituric acid tag system developed by Fukase (vide supra), 
which suggests that abstraction of tagged substrates from solution using the UPy–unit 
should be more efficient.  
 
1.3.2  Synthesis of ureidopyrimidinone–tagged compounds and resins 
 
The synthesis of UPy–tagged compounds is well described37 and different 
compounds should be readily obtainable starting from isocytosines 14 (Scheme 2). 
These isocytosines can be derived from β–keto esters 13 via a condensation reaction 
with guanidinium carbonate.38 
 
N
NH
O NH2
R1
N
NH
O N
H
R1
N
H
O
R2
1) CDI
2) R2-NH2
or:  R2-NCO
14 15
R1
O
OEt
O
13
guanidinium
carbonate
 
 
Scheme 3: Synthesis of isocytosines and UPy–tagged compounds. 
 
Upon treatment of the isocytosines 14 with carbonyl diimidazole (CDI) and a 
primary amine, UPy–unit bearing compounds 15 can be obtained. 
An alternative procedure to install the urea functionality is the reaction of 
isocytosines 14 with isocyanates, which gives rise to products 15 in a single step.39 
Similar procedures can be carried out on a resin, functionalised with amino end 
groups. This should yield a UPy–functionalised resin (16), which can then be used as 
the affinity medium in a purification protocol of UPy–tagged compounds via 
hydrogen bonding (Scheme 3). In apolar solvents, the UPy–groups on the resin can 
form four hydrogen bonds with UPy–tagged compounds in solution (vid. 17). As 
described above, in case a starting material is equipped with this affinity tag, 
supposedly conventional solution phase reactions can be carried out. When the 
reaction is complete, the resin bearing UPy–units can be added to the crude mixture, 
and the tagged product will be abstracted from the solution.  
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In case the reaction has been carried out in a polar solvent, a switch to an 
apolar solvent prior to the addition of the affinity resin is required, since an apolar 
environment is necessary for hydrogen bonding. Obviously, standard extractions 
involving separation of an aqueous and an organic phase can also be used to wash out 
salts or carry out acid–base extractions. 
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Scheme 3: Reversible binding of a UPy–tagged compound and resin. 
 
After the resin has been added to the crude apolar reaction mixture, the excess 
of reagents and other side products can be washed away by rinsing the product–
bearing resin. The pure product can then be obtained upon addition of polar solvents 
such as methanol and DMF, or mixtures thereof, to the resin–substrate complex. The 
hydrogen bonds will be cleaved in these solvents, and the solid resin can then be 
filtered off. Evaporation of the filtrate should then yield the UPy–tagged product in 
pure form. 
 
1.4 Purpose and outline of this thesis 
 
In order to investigate the potential of such a hydrogen bonding based affinity 
separation method, a collaborative project with Dr. R.P. Sijbesma (Eindhoven 
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University of Technology, The Netherlands) and Dr. P.H.H. Hermkens (N.V. 
Organon, Oss, The Netherlands) was started, funded by the Technology Foundation 
STW. While the Einhoven group focussed on developing new (heterodimeric) 
hydrogen–bonding systems, it was our goal to explore and evaluate the scope and 
limitations of the UPy–unit in a novel affinity purification protocol. 
– In Chapter 2, a study of the bonding properties of UPy–functionalised resins 
will be discussed. The influence of the resin type and the amount of functional groups 
on its affinity for tagged molecules in solution are described. Also, a second hydrogen 
bonding tag with affinity towards UPy–units will be discussed. 
– The synthesis of some novel isocytosines is described in Chapter 3. The 
isocytosines are used in the synthesis of well–soluble UPy–tagged linkers, and the 
affinity binding of these compounds with a tagged resin is demonstrated. 
– In Chapter 4 second generation UPy–tagged linkers are synthesised, and a 
substrate molecule is coupled to these affinity tag–labelled compounds. An aromatic 
substitution is subsequently performed on these substrates and the products are 
purified by the newly developed affinity protocol. In a second step, the products are 
cleaved from the UPy–tagged linkers, and a second affinity purifcation is performed. 
– A benzoic acid derivative is equipped with a UPy–tag in Chapter 5. This 
compound is then used in an Ugi multicomponent reaction, and the products of this 
process are isolated using the UPy–based purification technique. 
– A different approach to utilise the properties of the self–complementary UPy–
units is described in Chapter 6, where a copper(I)–ligand is tagged with the affinity 
label. The ligand is then used to facilitate a reaction catalysed by copper, and the 
catalytic complex is isolated from the reaction mixture by a tagged resin.40 
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Chapter 2 
 
INITIAL COMPLEXATION STUDIES 
 
 
2.1 Introduction 
 
Initial studies to demonstrate the viability of non–covalently linking 
compounds to an affinity resin using ureido[1H]pyrimidinone (UPy) units were 
carried out prior to the start of this project.1  
These studies commenced with the development of an optimal affinity tag 
(AT) equipped resin system to actually prove the possibility of non–covalent linking. 
To start with, both a flexible Merrifield resin (2% cross–linked) and a highly cross–
linked, rigid ArgoPore resin were functionalized with different ATs and their 
complexation efficiency was evaluated (Table 1).  
 
Table 1: Studies towards an optimal resin for affinity separation. 
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N
H
N
N
H
N
H
NH2
O
O
N
HN
O
Me
N
H
N
H
O
N
HN
O
R
N
H
N
H
O
N
HN
O
O
O
OMe
Entry Resin bound affinity tag Fraction of unbound
substrate
1
2
3
4
1a
1b
2a
2b
3a
3b
4b, R = C13H27
5b, R = Me
0.9
1.0
1.0
0.8
Resin1
1.0
0.6
0.5
0.4
Conditions: 4 equiv. of binding sites on the resin (relative to the amount of 6) in 1,2-dichloropropane, 2 h,
rt.
1: a = 2% cross-linked Merrifield, b = ArgoPoreTM.
NH
NO
C13H27
H
N
H
N
O
O
O
Substrate :
6
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Using the UV–active UPy–tagged compound 6,2 complexation studies were 
performed to determine which resin would be most suited to bind tagged compounds 
from a solution. The different resins were added to a stock solution of 6 (10-6 to 10-7 
M) with 4 equiv of binding sites relative to the amount of 6. After two hours of 
shaking, the resins were filtrated, and the concentration of 6 in the filtrate was 
determined using UV measurements. The results are summarised in Table 1. 
The high amounts of unbound substrate using resins 2a and 3a led us to 
conclude that homo–dimerisation on the solid support was a significant problem: the 
relatively flexible linker allows the resin bound ATs to dimerise, so that binding of 
substrate molecules becomes more difficult. In case of the rigid ArgoPore resin, the 
substrate is bound somewhat more efficiently, with a clear difference between the 
linker bound UPy (2b) and the UPy that is directly attached to the resin (3b). This 
observation confirms the hypothesis of homodimerisation on the resin (vid. Figure 
1a). 
 
 
 
                                                                       
   1a                                                                          1b                                 
 
Figures 1a and 1b: Dimerisation of ureidopyrimidinone tags on the resin hampers 
binding of substrate molecules from solution. 
 
Finally, the best results were obtained using the rigid ArgoPore resin with a 
low degree of functionalisation (0.28 mmol of endgroups/g, schematically depicted in 
Figure 1b).3 Since the side–group on the UPy–moiety does not have a large influence 
on the complexation behaviour of the resin (compare 4b to 5b), commercially 
available isocytosine (R = Me) was used to functionalise the polymer.  
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With the latter, quantitative measurements using a UV–active UPy species in 
solution, showed that in toluene 8 equiv of binding sites on the resin were required to 
abstract 95% of substrate molecules from a solution. After this association between 
tagged substrate and tagged resin was obtained, the formed complex proved to be 
strong enough to allow filtration and washing of the resin, with no notable leaking of 
substrate. Subsequent dissociation of these non–covalently bound substrates from the 
resin was also not a problem. Various protic and/or polar solvents (e.g. MeOH, 
iPrOH, DMF, acetone) were effective in cleaving the hydrogen bonds within a short 
period of time, and simple filtration yielded the tagged substrates. 
These findings in our view strongly underline the viability of our concept and 
convincingly show that this non–covalent system indeed can be used as a fast and 
easy purification technique in organic synthesis, despite the drawback of the homo–
complementarity of the used ATs.  
In this chapter we describe our first attempts to synthesise linkers connected to 
a UPy–tag, which should both be easy to isolate from solution using a functionalised 
resin, and bear a functional group that enables us to couple a range of substrates 
(Figure 2). 
N
NH
Me
O N
H
N
H
O
O
OH
Tag
Linker
Spacer Coupling handle
 
 
Figure 2: Linker equipped with a UPy–tag. 
 
An alternative heterocomplementary hydrogen bonding array, to circumvent 
the problem of dimerisation on the resin as a limiting factor, will also be discussed. 
These alternative systems will also consist of a hydrogen bonding tag, and handle to 
couple substrates with. 
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2.2  Functionalisation of the resin 
 
As stated in the previous Section, an amine containing ArgoPore resin was 
functionalised directly with a UPy–AT (5b). Since the previous experiments had only 
been conducted on small scale, we looked somewhat more detailed into its synthesis. 
Two different methods to functionalise this resin are known,4 and we decided to 
investigate both of them (Scheme 1).  
 
N
H
N
H
O
N
HN
O
Me
NH2
NCO
7
9
5b
8
, DMAP
DMAP
NMP
120 °C, 16 h
O
OO Cl
Cl
Cl
Cl
Cl
Cl
HN
N
Me
ON
H
N
O
N
10
HN
N O
Me
H2N
11
CHCl3
30 min
DMF
90 °C, 20 h
path A:
path B:
 
 
Scheme 1: Resin functionalisation. 
 
The first route (path A, Scheme 1) is a one step conversion from the 
commercially available polymer 7 to give UPy–tagged resin 5b. Isocytosine 11 was 
treated with carbonyl diimidazole (CDI) in DMSO to give compound 8 in excellent 
isolated yield.5 Direct treatment of the ArgoPore resin 7 with 8 provided the AT–
functionalised resin 5b in one step at 90 °C in DMF.  
In the second route (path B, Scheme 1), the amino end groups are first 
transformed into isocyanates by treatment with triphosgene (9). We preferred to use 
this reagent over phosgene itself, because being a solid it is easier to handle than 
phosgene, which decreases health risks. The reactivity of triphosgene is comparable 
to phosgene and after stirring in the presence of resin 7 for 30 min at room 
temperature a full conversion was obtained, as indicated by a negative bromophenol 
blue test.6 The second step proved to be more troublesome since the commercially 
available isocytosine (11), which bears a methyl group at the 6–position, is insoluble 
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in most organic solvents. NMP could be used, but only at elevated temperatures and 
long reaction times. To obtain the highest conversion of 10, a large excess of 
isocytosine 11 had to be used at 120 °C in combination with a catalytic amount of 
DMAP. To remove the isocytosine and catalyst after the reaction, the resin had to be 
washed with hot NMP, and subsequent drying in vacuo gave compound 5b. 
Elemental analyses of 5b indicated that path A gave a lower degree of 
functionalisation than path B, which is in agreement with literature.4 For this reason, 
we decided to use path B to synthesise resin 5b throughout our project. 
 
2.3 Synthesis of a ureidopyrimidinone–tagged linker 
 
With the functionalised resin in hand, the first complexation experiments of the 
polymer and UPy–tagged substrates in solution could be carried out. To be able to 
readily connect substrates to the AT, we had the versatile linker system 12 in mind, 
consisting of two parts (Figure 3). 
 
N
H
NHBoc
N
H
ONH
NO
Me
N
H
H
N
N
H
ONH
NO
Me
O
O
OAc
O
O
OAc
HO
+
12
13 14  
 
Figure 3: Retrosynthesis of the tagged linker. 
 
One part (13) bears the AT to bind to the resin, and the other part (14) 
contains an acid labile para–alkoxybenzyl alcohol based linker. This moiety enables 
facile acid–mediated cleavage of substrates from the tag after purification by our 
method.7 Logically, a mixture of product and tag will then remain, from which the tag 
can be removed using the same functionalised resin so that the pure products can be 
obtained. The synthesis of the tagged compound 13 was planned to proceed in two 
steps as shown in Scheme 2. 
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H2N
NH2
Boc2O
H2N
NHBoc
HN
N O
Me
N
H
N
O
N 8
N
H
NHBoc
N
H
ONH
NO
Me
15
13  81% over 2 steps
THF/H2O (1:1 v/v)
0 °C to rt, 12 h
DMF
95 °C, 3 h
 
 
Scheme 2: Synthesis of fragment 13. 
 
The mono–Boc–protection of hexamethylene diamine was carried out by 
using 0.1 equiv of Boc2O, relative to the diamine.8 A simple extraction was sufficient 
to separate the remaining diamine from compound 15, which was used in the second 
step without further purification. The UPy moiety was again connected by 
straightforward treatment of 15 with the activated isocytosine 8 in DMF at room 
temperature, yielding the functionalised tag 13 in 81% yield over two steps. 
To arrive at the acid–labile part 17 of the desired linker, p–hydroxybenzyl 
alcohol was treated as described in Scheme 3. 
 
AcO
O OH
O
HO
OH
HO
O OMe
O
HO
O OH
O
Br OMe
O
K2CO3, DMF
12 h, rt
2M NaOH
 40 °C, 4 h
Ac2O, Et3N
14   86%
16   96%
17   95%
CH2Cl2
0 °C to rt, 4 h
 
 
Scheme 3: Synthesis of fragment 14. 
 
Alkylation of p–hydroxybenzylalcohol with 5–bromovalerate went smoothly 
under standard conditions, using K2CO3 in DMF, to give compound 16. After 
saponification of the ester, the resulting carboxylic acid 17 was acetyl protected with 
Ac2O to give the desired linker fragment 14 in 78% yield over three steps. 
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The coupling of the two linker fragments 14 and 20 (which was derived from 
13 upon removal of the Boc–group, vid. Scheme 4) proved to be more troublesome 
than anticipated. Standard procedures using carbodiimides failed, and more reactive 
coupling agents such as benzotriazol–1–yloxytris(dimethylamino)phosphonium 
hexafluorophosphate (BOP) and benzotriazol–1–yloxytris(pyrrolidino)phosphonium 
hexafluorophosphate (PyBOP) (Figure 4) were required to obtain a conversion at all. 
 
N
N
N
O
PN N
N
PF6
18
N
N
N
O
PO O
O
PF6
NN
N
19  
 
Figure 4: Coupling agents BOP (18) and PYBOP (19). 
 
However, the yields never exceeded 50% (over two steps from compound 6, 
Scheme 4), and a number of side products were formed. 
 
N
H
NHBoc
N
H
ONH
NO
Me
13
N
H
NH2N
H
ONH
NO
Me
TFA
TFA/CH2Cl2
(1:2 v/v)
2 h
N
H
H
N
N
H
ONH
NO
Me
O
O
OAc
12   50% over 2 steps
20
PYBOP, 14
Et3N
DMF
rt, 12 h
 
 
Scheme 4: Coupling of the linker fragments. 
 
A plausible explanation for this inreactive behaviour might lie in the different 
tautomers in which the ureidopyrimidinone unit can be present (vid. Section 1.3.1), 
which contain nucleophilic moieties. It is not inconceivable that this feature, in 
combination with the high reactivity of the coupling agents, is the main reason for the 
unsatisfactory outcome. 
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 Besides these reactivity problems, the solubility of the resulting linker 10 
is rather low in CHCl3 and the compound does not dissolve at all in toluene. Despite 
this drawback, several complexation experiments could be performed, which will be 
described in Section 5 of this chapter.  
 
2.4 Synthesis of a naphthyridine–tagged linker 
 
As stated earlier, an alternative to the homo–complementary hydrogen 
bonding UPy system would be welcome to overcome problems as described in 
Section 2.1. Zimmerman showed in 1995 that a naphthyridine diamide (Napy) moiety 
can form four hydrogen bonds with a homo–complementary array similar to the 
ureido–pyrimidinone unit.9 These naphthyridine–based molecules were able to break 
up the homo–dimers of UPy–type compounds. When added to a solution of these 
dimers, the Napy–compounds force them into another tautomeric conformer, to form 
a hydrogen bonding array that is complementary to the Napy–unit. Since the 
dimerisation constant of the homo–complementary monomers that Zimmerman used 
is almost as high as the Kdim of the UPy–ATs (3 × 107 vs. 8 × 107 in CHCl3), it can be 
reasoned that these naphthyridine diamides will be able to break up dimers of UPy–
ATs as well (Figure 5), as shown by Meijer et al..10 
 
N
H
N
H
ONH
NO
R
N NN
H
N
H
H
N
H
N
O HN
N O
R
N
H
N O
R
H
NO
NH
addition of 
naphthyridines
UPy-UPy homo-dimer Napy-UPy hetero-dimer
21 22
 
 
Figure 5: Hydrogen bonding between a naphthyridine and ureidopyrimidinone unit. 
 
To investigate whether these complexation properties could be utilised, we 
decided to synthesise a symmetrical naphthyridine tagged linker (23 in Figure 6). 
This Napy–based linker is equipped with two benzylic alcohol moieties, which can be 
used to couple substrates with.  
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O
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Figure 6: Retrosynthesis of naphthyridine–based linker 23 
 
The synthesis of 2,7–dichloronaphthyridine 25 is known,11 and we envisioned 
that this compound can be used in a modified Buchwald procedure12 to give the 
desired linker. Starting from 2,6–diaminopyridine and racemic malic acid, 
naphthyridine 26 was obtained in quantitative yield upon stirring in concentrated 
sulfuric acid at 250 °C (Scheme 5). 
 
N NH2N OHNH2N NH2
HOOC
COOH
26   >99%
H2SO4
250 °C, 2 h
H2SO4
N NHO OH
27   84%
rt, 5 min
N NCl Cl
25   80%
110 °C, 4 h
PCl5, POCl3
NaNO2
HO
 
 
Scheme 5: Synthesis of 2,7–dichloronaphthyridine. 
 
Treatment of this compound with NaNO2 and subsequent quenching with 
aqueous Na2CO3 gave the dihydroxynaphthyridine 27 in a satisfying yield. The 
hydroxyl groups were then converted into the corresponding chlorides by treatment 
with a mixture of POCl3 and PCl5, leading to compound 25 in good yield as well. 
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The dichloronaphthyridine 25 was then used in an amidation reaction as 
depicted in Scheme 6. First, ester 16 was treated with aqueous ammonia to give 
amide 28, which was subsequently protected with an acetyl group.  
 
HO
O OMe
O
16
RO
O NH2
O25% NH4OH/H2O
12 h, rt
R = H
Ac2O
28   95%
R = Ac29 >99%
N NN
H
N
H
O
O
OAcO
O
AcO
23   62%
Pd2(dba)3 (5 mol%),
xantphos (15 mol%),
Cs2CO3, toluene,
150 °C, 6 min
xantphos =
30
O
PPh2 PPh2
 
 
Scheme 6: Coupling of the linker to the naphthyridine tag. 
 
Synthon 29 was directly used in a palladium–catalysed coupling with 25, 
using xantphos (30) as a ligand12,13 in combination with Cs2CO3 as a base at 150 °C 
in a sealed tube in toluene, to give the naphthyridine linker 23. Since purification of 
this product was troublesome, the procedure was optimised using microwave 
conditions. Shortening of the reaction times in the microwave seemed to limit 
decomposition of both starting material and product, and an isolated yield of over 
60% was eventually obtained. Hereby the synthesis of a second tagged linker was 
completed, so that two different hydrogen bonding arrays could now be tested in 
complexation experiments. 
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2.5 Complexation of tagged linkers with the resin 
 
 During the first complexation experiments, a UPy–tagged resin was added 
to a solution of the tagged linkers in chloroform. An excess of 10 equiv of binding 
sites on the resin relative to the number of tags on the substrates was used to ensure 
that all substrate could be abstracted from the solution. The mixture of substrate and 
resin was shaken overnight, since from former experiments1,4 was concluded that 
longer reaction times gave better results. After binding of the tagged linkers to the 
resin, the solvent was filtered off and the beads with the bound substrate were washed 
3 times with chloroform before drying. To cleave the formed hydrogen bonds and 
redissolve the substrates, a 2:1 mixture of DMF and methanol was added to the resin, 
which was then shaken for another 3 h. Upon evaporation of the solvents, the tagged 
linkers were obtained in their original state. 
 
H
N
H
N
O HN
N O
Me
N
H
H
N
N
H
ONH
NO
Me
O
O
OAc
12
N
H
H
N
N
H
ONH
NO
Me
O
O
OAc
H
N
H
N
O HN
N O
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CHCl3, 16 h, rt
DMF/MeOH (2:1 v/v),
3 h, rt
86%
 
 
Scheme 7: Reversible binding of tagged linker 12 by a functionalised resin. 
 
When linkers 12 (Scheme 7) and 23 (not depicted) were subjected to these 
conditions, relatively large quantities of chloroform were used to ensure that the 
compounds were completely dissolved. After complexation to the resin, the 
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chloroform was filtered off and evaporated to determine the amount of unbound 
linker. 
In the case of the UPy–based linker 12, the chloroform contained about 15% 
of tagged compound. When the resin was treated with the aforementioned protic 
solvent cocktail, 86% of tagged linker was obtained after shaking and evaporation. 
On the one hand this result was not unsatisfactory, since it showed that the principle 
of binding and cleavage of tagged compounds was succesfully applied. On the other 
hand, it indicates that this linker is not the ideal compound for future research, 
because a loss of about 15% of material during one bonding/cleaving cycle is 
evidently too much for eventual application of this protocol in organic synthesis. 
When the tagged resin was added to a solution of linker 23 to form the heterogeneous 
complex (Figure 3), the chloroform still contained 50% of the naphthyridine–based 
substrate 23 after shaking overnight. Again cleaving the hydrogen bonds of the 
complex went smoothly, and the other 50% of compound could be obtained after 
shaking the resin in presence of protic solvents for 3 h, followed by filtration and 
evaporation of the solvents. Using 10 equivalents of binding sites on the resin should 
suffice in abstracting all naphthyridine linker from solution according to literature,12 
but this was clearly not the case in our situation. A possible reason is that the 
influence of the side groups of the naphthyridine linkers can be of crucial importance 
for the high affinity towards UPy–moiety, and it is known that relatively small 
changes can cause a strong decrease in binding constants.14 Also, the influence of the 
concentration of the naphthyridine and UPy–groups is an important factor in the 
complexation behaviour of these hydrogen bonding arrays.12 In concentrated 
solutions (M > 10–3) the desired heterodimer is easily being formed, but we were 
forced to use diluted mixtures (M < 10–5) for reasons mentioned above. 
 
2.6 Conclusions 
 
Although it can be stated that the first complexation experiments were 
successful, there are some issues that need to be addressed in order to make this 
purification method more valuable. First, the synthesis of the tagged compounds 
proved to be troublesome at some points. The naphthyridine–based compounds were 
difficult to purify, and only 50% of the tagged linker was abstracted from solution 
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using ten equivalents of binding sites. Clearly, the loss of compound during this 
binding is too large for application of this method, so no further experiments were 
conducted to optimise this heterogeneous system. 
The UPy–functionalised linker was only poorly soluble in most organic 
solvents. This is probably due to the fact that the ATs of these linkers form dimers in 
solution, but moreover it is feasible that these groups are also involved in π–
interactions, possibly causing the formation of larger aggregates.  
For future research and validation of this technique as a purification method, 
the synthesis of new, better soluble linkers is an absolute necessity. We concluded 
that this might be reached by the introduction of more apolar and bulky side groups 
onto the ATs, which will be described in the next chapter. Furthermore, a more robust 
synthesis route for the functionalised substrate system would also be welcome. 
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2.8 Experimental section 
 
General Information: All reactions are carried out under an atmosphere of 
dry argon. Standard syringe techniques were applied to transfer of dry solvents and 
air– or moisture sensitive reagents. Rf–values are obtained using thin layer 
chromatography (TLC) on silica gel–coated plates (Merck 60 F254) with the 
indicated solvent mixture and compounds were detected with UV light, or with 
aqueous potassium permanganate. Melting points were determined with a Büchi 
melting point B–545. IR spectra were recorded on an ATI Mattson Genesis Series 
FTIR spectrometer, equipped with a Harrick Split Pea ATR–apparatus. Absorptions 
are reported in cm–1. GC was performed on a Hewlett Packard 5890, containing a 
HP1 column (25 m * 0.32 mm * 0.17 m), FID detection, and equipped with a 
HP3393A integrator. NMR spectra were recorded on a Bruker DMX 300 (300 MHz), 
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and a Varian 400 (400 MHz) spectrometer in CDCl3 solutions (unless other wise 
reported) using TMS as internal standard; chemical shifts are given in ppm. Coupling 
constants are reported as J–values in Hz. Column or flash chromatography was 
carried out using ACROS silica gel (0.035–0.070 mm, and ca 6 nm pore diameter). 
Mass spectra and accurate mass measurements were carried out using a Fisons (VG) 
Micromass 7070E or a Finnigan MAT900S instrument. Elemental analyses were 
carried using a carlo Erba Instruments CHNS–O EA 1108 element analyzer. Solvents 
were distilled from appropriate drying agents prior to use. Unless stated otherwise 
noted, all chemicals were purchased and used as such. 
 
ArgoPore–NCO (10): To a suspension of ArgoPore–NH2–LL (7) resin 
(8.65 g, 2.42 mmol NH2 groups) in CHCl3 (200 mL) was added 
triphosgene (594 mg, 2.00 mmol). The mixture was stirred for 30 min. 
Treatment of a few beads with bromophenol blue reagent showed that all primary 
amino groups had reacted. The resin was filtered off, and washed three times with 
CHCl3, DMF and MeOH to give 2 (8.71 g, >99%). FTIR (ATR): 2923, 2258, 1691, 
1600, 1443. 
 
ArgoPore–ureidopyrimidinone (5b): Method 1: To a 
suspension of ArgoPore–NCO (10) resin (1.00 g, 0.28 mmol 
NCO groups) in NMP (25 mL) were added 2–amino–4–hydroxy–
6–methylpyrimidine (313 mg, 2.50 mmol) and a catalytic amount 
of DMAP. The mixture was heated to 100 °C, and gently stirred overnight. After 
allowing the mixture to cool to room temperature, the resin was filtered off, and 
washed three times with hot NMP (~100 °C), acetone, MeOH and dichloromethane (3 
×). 
Method 2: To a suspension of compound 8 (1.00 g, 4.57 mmol) and a catalytic 
amount of DMAP in DMF (250 mL), was added ArgoPore–NH2–LL© resin (10.0 g, 
2.8 mmol NH2 groups). After heating the mixture to 90 °C for 20 h, the resin was 
filtered off, washed with DMF, acetone, methanol and dichloromethane (3 ×). 
Spectral data as reported in literature.1 FTIR (ATR): 2923, 2852, 1658, 1490, 1450, 
830, 795, 760, 700. 
 
Imidazole–1–carboxylic acid (6–methyl–4–oxo–1,4–
dihydropyrimidin–2–yl)–amide (8): To a solution of carbonyl 
diimidazole (7.50 g, 46.2 mmol) in DMSO (200 mL) was 
carefully added of 2–amino–4–hydroxy–6–methylpyrimidine 
(2.89 g, 23.1 mmol). The resulting mixture was stirred vigorously for 12 h, and the 
formed precipitate was filtered off. After washing the white solid with DMSO (50 
mL) and acetone (50 mL), it was dried to give 4 in 100% yield. Spectral data as 
reported in literature.15  
 
(6–Aminohexyl)carbamic acid tert–butyl ester (15): To a 
solution of hexamethylene diamine (5.0 g, 43 mmol) in 
THF/H2O (200 mL, 1:1 v/v) was added dropwise at 0 °C a solution of Boc2O (0.94 g, 
4.3 mmol) in THF (5 mL). The mixture was allowed to slowly warm to rt and stirred 
for 12 h. The THF was evaporated, and the aqueous phase was extracted with CH2Cl2 
(3 × 75 mL). The combined organic layers were washed with brine, dried (MgSO4) 
and evaporated to give 5 (0.93 g, 100%, relative to Boc2O) as a sticky solid. Spectral 
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data as reported in literature.8 1H NMR (CDCl3, 300 MHz): δ 4.55(br s, 1H), 3.10 (q, 
J = 6.5 Hz, 2H), 2.67 (t, J = 6.7 Hz, 2H), 1.43 (2, 9H), 1.32 (m, 8H), 1.23 (m, 2H).   
 
{6–[3–(6–Methyl–4–oxo–1,4–dihydropyrimidin–2–
yl)ureido]hexyl}carbamic acid tert–butyl ester (13): 
To a solution of 8 (250 mg, 1.14 mmol) in DMF (15 
mL), 15 (260 mg, 1.10 mmol) was added. The resulting mixture was heated to 95 °C 
for 3 h, and the solvent was then removed in vacuo. The residue was precipitated in 
acetone, the product was filtered off and dried to give 13 (341 mg, 81%) as a white 
solid. FTIR (ATR): 3342, 2975, 2933, 2856, 1682, 1628, 1570, 1521, 1366, 1253, 
1172. 1H NMR (CDCl3, 300 MHz): δ 13.12 (br s, 1H), 11.85 (br s, 1H), 10.13 (br s, 
1H), 5.84 (s, 1H), 3.24 (app. q, J = 6.5 Hz, 2H), 3.09 (app. q, J = 6.1 Hz, 2H), 2.23 (s, 
3H), 1.60 (quint , J = 7.3 Hz, 4H), 1.44 (s, 9H), 1.39–1.31 (m, 4H). 
 
5–(4–Hydroxymethylphenoxy)pentanoic acid methyl ester 
(16): To a solution of 5–bromo valerate (7.00 mL, 9.54 g, 
48.9 mmol) in acetone (200 mL) were added p–hydroxybenzyl alcohol (5.59 g, 45.0 
mmol), K2CO3 (7.60 g, 55.0 mmol), and a catalytic amount of 18–crown–6. After 
refluxing the mixture for 20 h, the solvent was removed in vacuo, and the residue was 
dissolved in H2O/EtOAc (300 mL, 1:1 v/v). The layers were separated, and the 
aqueous phase was back extracted with EtOAc (150 mL). The combined organic 
layers were washed with a saturated aqueous NaHCO3, dried (MgSO4) and 
evaporated to give 7 (11.2 g, 96%) as a colourless oil, which was used without further 
purification for the next step. 1H NMR (CDCl3, 300 MHz): δ 7.24 (d, J = 8.4Hz, 2H), 
6.84 (d, J = 8.7 Hz, 2H), 4.58 (d, J = 5.4 Hz, 2H), 3.95 (t, J = 5.7 Hz, 2H), 3.66 (s, 
3H), 2.39 (t, J = 6.9 Hz, 3H), 1.83–1.79 (m, 4H).  
 
5–(4–Hydroxymethylphenoxy)pentanoic acid (17): 
Compound 16 (11.1 g, 46.6 mmol) was dissolved in 2M 
aqueous NaOH (250 mL). The mixture was heated to 40 °C and stirred for 4 h. The 
solution was washed with heptane (150 mL), and then acidified with 10M aqueous 
HCl. The aqueous mixture was extracted with EtOAc (3 × 150 mL). The combined 
organic layers were dried and evaporated to give 17 (9.97 g, 95%) as a white solid, 
which was used without further purification for the next step. FTIR (ATR): 3429, 
2907, 2857, 2611, 1707, 1610, 1512, 1384, 1251, 1197, 1173, 1002, 932, 815. 1H 
NMR (CD3OD, 300 MHz): δ 7.28 (d, J = 8.7 Hz), 6.87 (d, J = 8.7 Hz), 4.55 (s, 2H), 
4.02 (t, 6.0 Hz), 2.42 (t, J = 6.9 Hz, 2H), 1.87–1.81 (m, 4H). 
 
5–(4–Acetoxymethylphenoxy)pentanoic acid (14): To a 
solution of 17 (9.97 g, 44.5 mmol) in CH2Cl2 (200 mL) were 
added Et3N (17.4 mL, 100 mmol) and Ac2O (9.45 mL, 100 mmol) at 0 °C. The 
mixture was slowly warmed to rt and stirred for 4 h. Ater concentrating the mixture in 
vacuo, the residue was taken up in 2M aqueous NaOH (250 mL), and the mixture was 
washed with heptane (150 mL). After acidification of the solution it was extracted 
with EtOAc (3 × 150 mL). The combined organic layers were washed (NH4Cl), dried 
(MgSO4) and evaporated to give 14 (10.2 g, 86%) as a white solid, which was used 
without further purification. 1H NMR (CHCl3, 300 MHz): δ 7.25 (d, J = 8.1 Hz, 2H), 
6.84 (d, J = 8.1 Hz, 2H), 5.01 (s, 2H), 3.96 (m, 2H), 2.56–2.40 (m, 2H), 2.06 (s, 3H), 
1.85 (m, 4H). 13C NMR (CDCl3, 75 MHz): δ 172.3, 170.5, 160.2, 131.5 (2C), 129.4, 
115.8 (2C), 68.5, 67.4, 47.2, 36.1, 29.6, 22.3. 
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2–(6–Aminohexylamino)–6–methylpyrimidin–
4(1H)–one, TFA salt (20): Compound 13 (3.00 g, 
8.16 mmol) was dissolved in a 1:1 (v/v) mixture of 
TFA and CH2Cl2. After 3 h of stirring at rt, the solvents were removed in vacuo to 
give 20 as light yellow crystals, which were used in further experiments without 
further purification. 
 
Acetic acid 4–(4–{6–[3–(6–methyl–4–
oxo–1,4–dihydropyrimidin–2–
yl)ureido]hexylcarbamoyl}butoxy)be
nzyl ester (23): To a solution 
compound 9 (47 mg, 0.17 mmol) of in DMF (5 mL) were added 20 (69 mg, 0.18 
mmol) and DIPEA (0.10 mL, 72 mg, 0.71 mmol). The solution was cooled to 0 °C, 
and BOP (88 mg, 0.20 mmol) was added carefully. The resulting mixture was slowly 
warmed to rt, and was stirred for an additional 5h. The solvent was then removed in 
vacuo, and the residue was taken up in H2O/CH2Cl2 (20 mL, 1:1 v/v). The layers were 
separated, and the aqueous phase was back extracted with CH2Cl2 (2 × 10 mL). The 
combined organic layers were washed with a saturated aqueous solution of NaHCO3, 
dried (MgSO4) and evaporated to give 102 mg as a white solid. Precipitation from 
EtOAc yielded 23 (44 mg, 50%) as the pure compound. 1H NMR (CD3OD, 300 
MHz): δ 7.25 (d, J = 8.6 Hz, 2H), 6.81 (d, J = 8.9 Hz, 2H), 5.78 (s, 1H), 4.57 (s, 2H), 
3.93 (br s, 2H), 3.21 (app q, J = 6.1 Hz, 2H), 2.61 (s, 3H), 2.20–2.18 (m, 4H), 1.79–
1.33 (m, 8H). 
 
7–Amino[1,8]naphthyridin–2–ol (26): 30.0 g of (R,S)–malic acid 
(0.224 mol) and 22.0 g of 2.6–diamino pyridine (0.200 mol) were 
ground to powder and cooled to 0 °C. 100 mL of sulfuric acid was added dropwise, 
and the mixture was slowly heated to 250 °C for 2h. The solution was then poured 
over ice, and made alkaline (pH 8) with a 25% solution of ammonia in water. The 
formed precipitate was filtered off, and washed thoroughly with water and acetone to 
give the desired compound as a dark yellow solid in quantitative yield. FTIR (ATR): 
3373, 3157, 2820, 1614, 1506, 1364, 1074, 871, 827, 780, 607, 495. 1H NMR (200 
MHz, CD3OD): δ 7.68 (d, J = 9.1 Hz, 2H), 7.08 (s, 2H), 6.37 (d, J = 8.3 Hz, 1H), 6.14 
(d, J = 9.2 Hz, 1H). 13C NMR (DMSO, 75 MHz): δ 163.1, 160.0, 149.9, 139.2, 136.8, 
114.4, 104.8, 78.9. 
 
[1,8]Naphthyridine–2,7–diol (27): Compound 26 (7.5 g, 46.5 mmol) 
was ground to a fine powder, and dissolved in 50 mL of sulfuric acid. 
The solution was cooled to 0 °C, and NaNO2 (3.6 g, 52 mmol) was added carefully. 
The mixture was stirred for 5 minutes at rt, and then poured over ice. A saturated 
solution of Na2CO3 was carefully added until a brown precipitate was formed. The 
solid was filtered off, washed with water (3 × 200 mL) and dried to give 27 (6.36 g, 
84%) as a dark yellow solid. FTIR (ATR): 2988, 2920, 2803, 1662, 1627, 1554, 1506, 
1398, 1342, 1277, 1130, 897, 824, 780, 560, 512. 1H NMR (400 MHz, DMSO): δ 
7.79 (d, 8.8 Hz, 2H), 6.31 (d, 8.8 Hz, 2H). 13C NMR (DMSO, 75 MHz): δ 163.3, 
148.3, 139.4, 112.0, 106.3. 
 
2,7–Dichloro[1,8]naphthyridine (25): To a solution of 27 (5.39 g, 
33.2 mmol) in POCl3 (10 mL) was added PCl5 (14.0 g, 70.0 mmol) 
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carefully. The mixture was heated to 110 °C for 4 h. After careful addition of ice, the 
mixture was made alkaline (pH 8), and a yellow precipitate was formed. The solid 
was filtered off, washed with water (3 × 200 mL) and acetone (2 × 100 mL), and 
dried to give 25 (5.30 g, 80%)  as a yellow solid. FTIR (ATR): 3045, 2980, 2842, 
1645, 1593, 1532, 1467, 1303, 1139, 1117, 919, 845, 789, 655. 1H NMR (400 MHz, 
DMSO): δ 8.60 (d, 8.4 Hz, 2H), 7.77 (d, 8.6 Hz, 2H). 13C NMR (DMSO, 75 MHz): δ 
153.3 (2C), 139.8 (2C), 133.6 (2C), 123.2 (2C), 120.0 (2C). 
 
5–(4–Hydroxymethylphenoxy)pentanoic acid amide (28): 
Compound 16 (5.00 g, 17.8 mmol) was dissolved in an 
aqueous ammonia (25%) and stirred for 12 h at rt. After 
acidifying the mixture with a concentrated HCl at 0 °C to pH 7, the mixture was 
extracted with EtOAc (2 × 100 mL). The combined organic layers were washed with 
aqueous NH4Cl, dried (MgSO4) and evaporated to give 28 (3.62 g, 78%) as white 
crystals. FTIR (ATR): 3330, 3162, 2924, 2863, 1671, 1610, 1511, 1468, 1415, 1251, 
1169, 1040, 806, 694, 586. 1H NMR (300 MHz, DMSO): δ 7.23 (s, 1H), 7.19 (d, J = 
8.1 Hz, 2H), 6.85 (d, J = 8.1 Hz, 2H), 6.70 (s, 1H), 5.01 (s, 1H), 4.39 (s, 2H), 3.93 (t, 
J = 5.2 Hz, 2H), 2.10 (t, J = 6.6 Hz, 2H), 1.75–1.57 (m, 4H). 13C NMR (75 MHz, 
DMSO): δ 173.5, 157.0, 134.0, 127.5 (2C), 113.6 (2C), 66.9, 62.4, 34.6, 28.3, 21.7. 
MS (EI) m/z: 223 (M+, 5), 123 (19), 107 (18), 100 (100), 95 (19), 77 (16), 57 (60), 44 
(42), 41 (21), 29 (13). HREIMS calc. for C12H17NO3 223.1208, found 223.1198. 
 
Acetic acid 4–(4–carbamoylbutoxy)benzyl ester (29): To 
a solution of 28 (2.20 g, 9.85 mmol) in CH2Cl2 (50 mL) 
were added Et3N (6.87 mL, 49.3 mmol) and Ac2O (2.80 mL, 
29.6 mmol) carefully. The mixture was refluxed for 2 h, then cooled to room 
temperature, and subsequently washed with aqueous NH4Cl and NaHCO3. After 
drying (MgSO4) the solvent was removed in vacuo to give the wanted product (2.61 
g, 100%) as white crystals. FTIR (ATR): 3395, 3200, 2946, 2863, 1727, 1653, 1606, 
1515, 1381, 1234, 1174, 1031, 802, 646, 534. 1H NMR (400 MHz, CDCl3): δ 7.27 (d, 
J = 8.8 Hz, 2H), 6.86 (d, J = 8.8 Hz, 2H), 5.84 (br s, 1H), 5.65 (br s, 1H), 5.03 (s, 
2H), 3.99–3.96 (m, 2H), 2.32–2.29 (m, 2H), 2.07 (s, 3H), 1.85–1.82 (m, 4H). 13C 
NMR (75 MHz, CDCl3): δ 175.2, 170.4, 158.4, 129.6 (2C), 127.5, 114.1 (2C), 67.3, 
65.9, 45.8, 28.6, 22.1, 21.0. MS (EI) m/z: 265 (M+, 2), 149 (2), 124 (4), 107 (11), 100 
(100), 89 (4), 77 (4), 57 (20), 44 (9), 43 (7). HREIMS calc. for C14H19NO4 265.1314, 
found 265.1316. 
 
 
Acetic acid 4–(4–{7–[5–(4–
acetoxymethylphenoxy)penta
noylamino][1,8]naphthyridin
–2–ylcarbamoyl}butoxy)benzyl ester (23): To a solution of 29 (250 mg, 0.942 
mmol) and 25 (90.0 mg, 0.450 mmol) in toluene (3 mL) were added xantphos (39 mg, 
15 mol%), Pd2(dba)3 (90.0 mg, 5 mol%), and Cs2CO3 (360 mg, 1.10 mmol). The 
mixture was heated in a sealed tube to 150 °C for 6 minutes, using microwave 
irradiation. The mixture was cooled to rt, filtered over a piece of cotton, and the 
solvent was removed under reduced pressure. The crude product was purified by 
column chromatography (EtOAc, 1% Et3N, 1% MeOH) to give 23 (182 mg, 62%) as 
a yellow solid. FTIR (ATR): 3296, 2937, 2863, 1731, 1697, 1606, 1498, 1377, 1225, 
1169, 1130, 1022, 910, 728. 1H NMR (400 MHz, CDCl3): δ 8.73 (br s, 2H), 8.41 (d, J 
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= 8.8 Hz, 2H), 8.11 (d, J = 8.8 Hz, 2H), 7.26 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.6 Hz, 
2H), 5.02 (s, 4H), 3.99 (t, J = 5.8 Hz, 4H), 2.56 t, J = 7.0 Hz, 4H), 2.07 (s, 6H), 1.96–
1.86 (m, 8H). 13C NMR (75 MHz, CDCl3): δ 172.2 (2C), 170.9 (2C), 159.0, 158.9 
(2C), 154.1 (2C), 153.5 (2C), 139.0 (2C), 130.0 (4C), 128.0 (2C), 118.1 (2C), 114.8, 
114.4 (4C), 113.7 (2C), 67.4 (2C), 66.1 (2C), 37.2 (2C), 28.5 (2C), 21.8 (2C), 21.0 
(2C). 
 
General procedure for complexation between resin and linkers 12 and 23: 
To a solution of 1 equiv of tagged linker in chloroform (approximately 5 mM) was 
added resin 5b, (10 equiv of UPy–ATs relative to the amount of linker). The resulting 
mixture was gently shaken overnight. After the solvent was filtered off, the resin was 
washed with chloroform (2 × 10 to 20 mL). The solvent was evaporated to estimate 
the amount of unbound linker, which as app. 13% for compound 12, and 50% for 
compound 23. Then, the polymer with the bound linker was transferred into a 2:1 
mixture of DMF and MeOH (20 to 30 mL), and the mixture was shaken for 3 h. After 
filtration, the resin was rinsed with DMF (2 × 10 to 20 mL), MeOH and Et2O (both 
10 to 20 mL). The solvents were removed in vacuo, and the tagged compounds were 
recovered in their original form, 86% for UPy–based linker 12, and 50% for Napy–
based linker 23. 
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Chapter 3 
 
SECOND GENERATION ISOCYTOSINES AND LINKERS 
 
 
3.1  Introduction 
 
To arrive at tagged linkers which are suitable for successful complexation and 
purification, two problems had to be overcome. Firstly, a major drawback is the 
extremely poor solubility of the UPy–system in regular organic solvents, and 
secondly the low–yielding coupling reaction in the synthesis described in Chapter 2. 
The latter was anticipated to be easily solved via an alternative synthetic strategy to 
build up the linker system. The former problem, however, requires a more deliberate 
evaluation, since the reason for the low solubility can be twofold.  
One explanation is that the UPy–part of the linkers is simply too hydrophilic 
to dissolve in common organic solvents, except for (mixtures of) DMF, methanol and 
NMP. Unfortunately, the necessary hydrogen bond formation between substrates and 
resin for purification purposes cannot be achieved in these solvents. Another reason 
relates to the aromatic nature of the tag, so that π,π–interactions may play an 
important role as well. Formation of supramolecular aggregates as a result of π–
stacking will hamper complexation of substrates to the tagged resin.  
 
NH2
NH
NO
Me
N
H
H
N
N
H
ONH
NO
Me
O
O
OAc
21  
 
Figure 1: Initial linker from commercially available isocytosine 1. 
 
During our first attempts, described in the preceding chapter, we used 
commercially available isocytosine (1) as the main building block for the UPy–based 
ATs. This isocytosine contains a relatively small methyl group at the 6–position. 
From literature we learned that other isocytosines, with both large and apolar moieties 
at the 6–position, were synthesised before.1 We reasoned that these modified 
isocytosines (3 in Figure 2) could be useful to overcome the two aforementioned 
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problems; a larger aliphatic moiety will decrease the hydrophilicity of the 
compounds, whereas bulky side groups will prevent the tags from aggregation 
formation caused by π–stacking.  
 
NH2
NH
NO
R
O
N
H
N
H
O
N
NH
R
O
4
OH
3  
 
Figure 2: Alternative linkers from modified isocytosines 3. 
 
The para–hydroxybenzylalcohol unit that was present in the original linker 2 
is maintained, because it not only offers a useful handle to couple substrates to, but 
also cleavage of substrates from these linkers is easily obtained under mild 
conditions, as will be demonstrated throughout this chapter. 
 
3.2  Synthesis of modified isocytosines 
 
The most convenient route towards new isocytosines with side groups on the 
6–position consists of condensation of the corresponding β–ketoester with a 
guanidine salt. This method was already reported in 1938, and has been widely used 
since.2,3 Starting from commercially available acid chlorides, we used a facile two–
step procedure developed by Wemple and coworkers to obtain the required β–keto 
esters 5a and 5b.4  
 
O
O
OEt
O
K
1. MgCl2, Et3N, EtOAc,
40 °C, 6h
2. R-COCl, rt, 16h R
O
OEt
O
NH2
H2N NH2
2
CO3 2
NaOtBu, EtOH,
reflux, 18h
N
NH
O NH2
R
R= ,
99%
97%
> 99%
> 99%
a b
5a
5b
3a
3b
 
 
Scheme 1: Synthesis of modified isocytosines. 
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The two acid chlorides to which these conditions were applied, contain 
branched aliphatic groups such as (2–ethyl)pentyl (a) and 1–adamantyl (b) (Scheme 
1). Treatment of potassium ethyl malonate with MgCl2 and base caused the formation 
of CO2 so that this reaction could be easily monitored. Subsequent addition of the 
acid chlorides to this mixture gave the desired oxo–esters 5a and 5b in excellent yield 
and high purity, on both small and larger scale (up to 30 g).  
The condensation of guanidinium carbonate and β–ketoester 5a was known, 
and upon refluxing overnight in ethanol the desired isocytosine 3a was isolated in 
high yield. Surprisingly, the same conditions were not suitable for the synthesis of the 
adamantyl derivative. However, upon addition of a stoichiometric amount of a strong 
base (NaOtBu) and refluxing for 18 h, isocytosine 3b was isolated in excellent yield 
as well. When NaOtBu was added in the synthesis of isocytosine 3a, a small 
shortening in reaction time was observed.  
With these new building blocks for UPy–containing ATs in hand, we focused 
on the development of alternative linkers for our purification system. 
 
3.3  Synthesis of new linkers 
 
The first approach to attach the new isocytosines 3a and 3b to a suitable 
linker, involved a one–pot procedure to react them directly with acid 6. In the 
previous chapter the synthesis of compound 6 was described, which could be carried 
out on large scale without any difficulties and facile purification after each step. To 
arrive at the tagged linkers from this synthon a Curtius5 rearrangement has to be 
carried out to give the corresponding isocyanate 7, which can be quenched in situ 
with a range of different nucleophiles.6 In the past, this method has been successfully 
applied to generate urea derivatives by addition of amines to the crude isocyanate.7 
We anticipated that using isocytosines 3a and 3b in a similar procedure would yield 
the desired ureido–pyrimidinone moieties 8a and 8b (Scheme 2). 
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rt to reflux, 12 h
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reflux, 12 h64%
47%
 
 
Scheme 2: Introduction of ureido–pyrimidinone ATs via a one–pot procedure. 
 
Diphenylphosphoryl azide, a frequently used reagent in Curtius 
rearrangements,8 was used to generate an intermediate acyl azide under mild 
conditions. Upon refluxing the resulting mixture overnight in toluene, isocyanate 7 
was formed as expected, and quenched with isocytosines 3a and 3b to indeed give the 
UPy–tagged compounds 8a and 8b. It has to be mentioned that this one–pot three–
step transformation was not a straight forward procedure; reproducible yields up to 
80% were obtained on milligram scale scale, but when larger quantities of 6 
underwent the same procedure, yields dropped significantly. Compounds 8a and 8b 
were soluble in organic solvents such as chloroform, DMF, a variety of alcohols and 
mixtures thereof, so that the desired change in physical properties was achieved.  
To ensure that these tagged linkers were suitable for future synthetic purposes, 
we conducted complexation experiments using the functionalised ArgoPore resin 
described in the previous chapter. To our delight, we were able to abstract these 
compounds from a solution in chloroform in quantitative amounts, using 10 equiv of 
binding sites on the resin with respect to the amount of linker. No leaching of 
substrate from the resin was observed during rinsing with chloroform, and after 
treatment with a mixture of DMF/MeOH (2:1 v/v) the compounds were fully 
dissociated from the polymer. After filtration and subsequent evaporation the linkers 
were recovered in yields over 98%. 
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With these encouraging results in hand, studies towards application of the new 
purification protocol could commence. The tagged compounds 8a and 8b are, as 
stated earlier, both equipped with a cleavable linker. To use these compounds in 
synthesis, the benzylic alcohol must be deprotected and coupled to a substrate 
molecule. Then, as a proof of principle, this substrate can undergo a reaction in 
solution, after which the product can be isolated from the reaction mixture using the 
resin as described in this section. 
 
3.4  Coupling of substrates 
 
To deprotect AT–equipped linkers 8a and 8b, standard conditions were 
applied (Scheme 3). 
 
O
N
H
N
H
O
N
NH
R
O
8a,b
O
N
H
N
H
O
N
NH
R
O
4a
4bOAc OH
K2CO3
MeOH
rt, 16h
>84%
>80%  
 
Scheme 3: Deprotection of tagged linkers 8a and 8b. 
 
Treatment of these compounds with K2CO3 in methanol at ambient 
temperature proceeded smoothly and the resulting alcohols 4a and 4b were isolated 
by precipitation from water, diethyl ether or acetone in good yield.  
At this point, a suitable substrate had to be chosen in order to give easy access 
to the desired proof of principle. We decided to couple benzoic acid derivative 7 to 
the linkers, which should lead to compounds 10a and 10b (Scheme 4).  
 
O
N
H
N
H
O
N
NH
R
O
10a,b
O
O
F
NO2
HO
O
F
NO24a,b
9
coupling agent
 
 
Scheme 4: Coupling of benzoic acid derivative 9 with tagged linkers. 
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Next, facile nucleophilic aromatic substitution of the fluoro substituent of 8 
using different amines would be a suitable reaction to validate our new purification 
procedure. When standard conditions were applied on compounds 4 and 9, using 
carbodiimides in combination with DMAP, no conversion was observed. Other 
procedures involving Mitsonobu reagents, acid chlorides or mixed anhydrides were 
not successful either (Table 1). The desired product was only observed after treatment 
of compound 4a with BOP (see Section 2.3), albeit in very small amounts. 
Purification was troublesome because of the presence of many side products and 
degradation compounds, and 10a was isolated in approximately 10% yield after 
numerous experiments. This unexpected drawback showed that solubility of the UPy–
tagged compounds was not the only issue that had to be further addressed, as stated in 
Section 3.1. Reactions failed both in polar and in apolar solvents, so whether 
monomers or dimers were present in solution had no significant influence. 
 
Table 1: Conditions for coupling acid 9 to linker 4. 
 
Entry SolventConditions YieldR
EDC, DMAP, Et3N
EDC, DMAP, Et3N
DCC, DMAP, Et3N
DCC, DMAP, Et3N
PPh3, DEAD
TsCl, Et3N
isobutyl chloroformate, then 9
SOCl2, Et3N, then 9
9, isobutyl chloroformate, then 4
9, SOCl2, Et3N, then 4
PyBOP, Et3N
BOP, Et3N
-
-
-
-
-
-
-
-
-
-
-
~10%
1 A/EP
A/EP
A/EP
A/EP
A
A
A
A
A
A
A/EP
A/EP
2
3
4
5
6
7
8
9
10
11
12
CHCl3
MeCN
DMF
DMF
DMF
DMF
DMF
DMF
CH2Cl2
CH2Cl2
CH2Cl2
CHCl3
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To utilise these linkers nonetheless and reach a proof of principle in an 
alternative matter, we decided to oxidise the alcohol functionality and perform a 
reductive amination on the resulting aldehyde (Scheme 5). 
 
O
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A
O
4b OH
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N
H
N
H
O
N
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O
11 O
TPAP, NMO
acetone, rt, 16 h
74%
O
N
H
N
H
O
N
NH
A
O
NR1R2
HNR1R2
NaCNBH3
H
12
 
 
Scheme 5: Oxidation and reductive amination of linker 4a. 
 
Oxidation under reaction conditions developed by Ley9 using TPAP and 
NMO in acetone gave aldehyde 11 in good yield. Reductive amination to 12, 
however, did not work under standard conditions. Different amines were screened, 
but no conversion was obtained in any case. Treatment with ammonium acetate to 
give the primary amine (12, R1 = R2 = H) was not successful either. From further 
experiments we concluded that the imine was not formed, and to test this hypothesis 
we treated aldehyde 10 with a hydroxylamine, which is a stronger nucleophile than a 
regular primary amine due to the α–effect10 (Scheme 6).  
As we anticipated, compound 13 was formed in high yield, indicating that 
aldehyde 11 is insufficiently electrophilic to react with standard amines. When 
compound 13 could be reduced to the benzylamine derivative 14, the coupling 
reaction with acid 9 would yield an amide instead of an ester as cleavable linkage 
(15). Since the benzylic amine 14 is considerably more nucleophilic than the benzylic 
alcohol 4, the outcome of such a coupling reaction may differ from the results in 
Table 1. 
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Scheme 6: Formation of oxime 13 and subsequent reduction. 
 
Oxime 13 could not be reduced to benzylamine 14 though and, alternatively, 
direct alkylation of the oxime functionality was also not successful, thereby reducing 
the usefulness of this compound for our synthesis routes to zero. 
A different approach was based on work of Jung et al., who reported a method 
to synthesise iodides directly from an acetyl protected alcohol in a one–pot procedure 
using TMSI.11 This reagent is also used in deprotections of both alcohols and acids.12 
Treatment of 8b with TMSI should give the benzyl iodide derivative in situ and 
reaction of this iodide with NaN3 should then provide azide 16 (Scheme 7).  
 
O
N
H
N
H
O
N
NH
A
O
8b
O
N
H
N
H
O
N
NH
A
O
OAc N3
TMSI, then NaN3
16  
 
Scheme 7: One–pot conversion of 8b into azide 16. 
 
Again, the desired conversion was never observed so that azide 14 could not 
be isolated. 
The failure of these straightforward procedures to transform the AT–bearing 
linkers under a large variety of conditions raised the question whether easy 
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functionalisation of UPy–tagged compounds was at all feasible. This hypothesis was 
inspired by the fact that there seemed to be no correlation between the experiments 
that did not work, nor between the successful transformations. The only conclusion 
we could draw from our data, was that in many cases the UPy–tagged compounds 
exhibited an entirely different reactivity than the non–tagged counterparts. We 
envisioned that this change in reactivity may be assigned to their complexation and 
aggregation behaviour in solution that has also been demonstrated in literature.13 
Apparently, the use of bulky isocytosines did not entirely prevent aggregation of the 
linkers. Furthermore, it is not inconceivable that the aromatic and polar groups on the 
right hand side of linkers 4, 8, and 11 are involved in stacking interactions as well, 
causing a decreased reactivity. 
We decided to further investigate this theory, and synthesised the acetylene–
equipped UPy 17 to do so (Scheme 8).  
 
NH
NO N
H
N
H
O3a
CDI, CHCl3, 5 h, rt
then propargylamine,
16 h, rt
>99%
17
NH
NO N
H
N
H
O
N N
N
Azide (1 equiv),
20 mol % Cu(OAc)2
40 mol % Na-ascorbate
H2O/tBuOH 1:1
72 h, rt
R
Entry       Azide        Product  Yield
N3
OH
O
OAc
OAc
OAc
AcO
N3
O
OAc
OAc
OAc
AcO
N3
N3
COOMe
NHBoc
COOMe
NHBoc
N3
1 18 >99%
2 19 >99%
3 20 >99%
4 21 >99%
5 22 >99%
18-22  
 
Scheme 8: Huisgen cyclisation on UPy–tagged acetylene 17. 
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A spacer between the acetylene and AT was left out to minimise possible 
interactions between these compounds in solution, and to limit the rotational freedom 
of the part of the molecule that will undergo a coupling reaction. 
We tried to couple substrates to this UPy–tagged compound via the copper(I)–
mediated Huisgen cyclisation (click–reaction), which was independently developed 
by Meldal14 and Sharpless15 in 2002 and has been widely used since.16  
Conversion of isocytosine 2a using carbonyl diimidazole (CDI) and 
propargylamine went smoothly to give UPy–derivative 15 in quantitative yield. 
Compound 15 was treated under conditions described by Sharpless with Cu(OAc)2 
and sodium ascorbate15 in presence of an azide to give compound 16 in excellent 
yield. This procedure was also carried out with azide–bearing amino acids to give 17 
and 18, and similar treatment with fully protected, azide–equipped sugars provided 
triazoles 19 and 20, all in quantitative yield. 
These results show that coupling reactions between UPy–tagged compounds 
and substrates can be performed successfully. The products of these Huisgen 
cyclisations are not suitable for follow up chemistry because neither the introduced 
triazole nor the ureum moiety can be cleaved under mild conditions. For meaningful 
application of our purification method, however, we need a cleavable linker as stated 
in Section 3.1. These last results led us to conclude that when a more rigid, cleavable 
linker will be used, the outcome of the coupling reactions may turn out to be better 
than so far. 
 
3.5  Conclusions 
 
The synthesis of new isocytosines with bulky side groups was accomplished 
in two high yielding steps. When these compounds were used to form ATs, the 
solubility of the derived UPy–tagged compounds was indeed increased in most 
organic solvents. The derived linkers could be isolated from solution quantitatively 
using the resin, which is a significant improvement in comparison to former 
experiments (Chapter 2). 
Although we envisioned that these features would facilitate further 
transformations of the linker molecules, most reactions to functionalise the AT–
bearing linkers failed. The main conclusion that can be drawn from these results is 
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that when compounds contain a UPy–based AT, their behaviour in synthesis is 
strongly altered in comparison to the parent compounds. Since some experiments 
failed when both polar and apolar solvents were used, we conclude that possible 
aggregation of the starting material is not the key issue.  
What seems to have a bigger influence on their reactivity is the rigidity of the 
AT–bearing compounds. Relatively flexible linkers were only transformed when 
harsh conditions were applied, but a short inflexible linker could be coupled to a 
range of azides under very mild conditions in excellent yields. This implies that when 
a more rigid linker is used, the coupling of substrates can be accomplished. 
The successful Huigen–cycloadditions on the latter rigid linker system 
prompted us to synthesise alternative linker systems, which are significantly more 
rigid than the linkers in this system. This will be discussed in Chapter 4. 
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3.7  Experimental section 
 
4–Ethyl–3–oxooctanoic acid ethyl ester (5a): To a solution of 
potassium ethyl malonate (2.50 g, 14.7 mmol) in EtOAc (60 mL) at 
0 °C, were added Et3N (6.41 mL, 36.7 mmol) and MgCl2 (1.90 g, 
20.0 mmol). The mixture was heated to 35 °C for 5 hours. After cooling the solution 
to 0 °C, 2–ethylhexanoyl chloride (1.71 g, 10.5 mmol) was added dropwise, and the 
resulting mixture was stirred overnight at rt. After the addition of an aqueous solution 
of HCl (5.0 M), the mixture was stirred for 30 minutes, and the layers were separated. 
The aqueous phase was back extracted with toluene (2 × 50 mL), and the combined 
organic layers were washed with a 5.0 M HCl solution, and with brine. After drying 
(MgSO4) and removal of the solvent in vacuo the resulting yellow oil was purified by 
column chromatography (15% EtOAc/heptane), to give β–keto ester 5a (2.24 g, 
>99%) as a colourless oil. FTIR (ATR): 2960, 2932, 2873, 1746, 1713, 1646, 1624, 
1457, 1421, 1367, 1305, 1226, 1151, 1095, 1033, 841, 802. 1H–NMR (CDCl3, 300 
MHz): δ 12.04 (s, 1H, enol), 4.94 (s, 1H, enol), 4.18 (q, J = 7.2 Hz, 2H), 3.42 (s, 1H), 
δ 2.49 (m, 1H) 1.27 (t, J = 7.2Hz, 3H), 1.72–1.17 (m, 8H), 0.88 (m, 6H). 13C NMR 
(CHCl3, 75 MHz): keto–enol mixture δ 205.7, 180.9, 172.3, 166.7, 89.2, 60.7, 59.4, 
53.5, 48.1, 47.2, 31.6, 30.1, 29.2, 29.0, 25.4, 23.8, 22.4, 22.3, 13.8, 13.7, 13.5, 13.4, 
11.4, 11.1. 
 
 
O O
OEt
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Adamantan–1–yloxoacetic acid ethyl ester (5b): 1–Adamantoyl 
chloride (2.00 g, 7.99 mmol) was treated as described above for 
compound 5a, to give compound 5b as colourless crystals in 97% yield. 
mp: 139 °C. FTIR (ATR): 2976, 2900, 2847, 1744, 1694, 1641, 1618, 
1451, 1409, 1230, 1181. 1H NMR (CDCl3, 300 MHz): δ 12.29 (s, 1H enol), 4.96 (s, 
1H, enol), 4.24–4.13 (q, J = 7.1 Hz, 2H), 3.52 (s, 2H, keto), 2.06–1.65 (m, 15H), 1.27 
(t, J = 7.1 Hz, 3H). 13C NMR (CHCl3, 75 MHz): keto–enol mixture δ 207.6, 184.2, 
167.9, 85.1, 61.0, 59.7, 46.7, 43.3, 40.3, 38.9, 38.4, 37.7, 36.4, 36.2 (2C), 27.9, 27.7, 
27.6, 14.1, 13.9. HRMS (EI) calcd for C15H22O3 (M+) 250.1569, found 250.1558. 
 
2–Amino–6–(1–ethylpentyl)–1H–pyrimidin–4–one (3a): To a solution 
of 5a (2.35 g, 11.0 mmol) in EtOH (25 mL) were added guanidine 
carbonate (2.25 g, 12.5 mmol) and sodium tert–butoxide (1.93 g, 20.0 
mmol). The mixture was refluxed for 48 h, and after cooling the solution 
to rt the solvent was removed in vacuo. The residue was taken up in 
CHCl3 (50 mL), and this solution was washed with aqueous NaHCO3, dried (MgSO4) 
and evaporated to give isocytosine 3a (2.30 g, >99%) as a white solid. 1H NMR 
(CDCl3, 300 MHz) : δ 7.03 (br s, 2H), 5.56 (s, 1H), 2.18 (dt, J = 7.1, 7.0 Hz, 1H), 
1.60–1.48 (m, 4H), 1.29–1.15 (m, 4H), 0.83 (t, J = 6.9 Hz, 3H), 0.81 (t, J = 7.2 Hz, 
3H). 13C NMR (DMSO, 75 MHz): δ 170.4, 163.2, 155.5, 100.2, 48.0, 33.0, 29.2, 
26.5, 22.2, 13.9, 11.9. 
 
6–Adamantan–1–yl–2–amino–1H–pyrimidin–4–one (3b): To a 
solution of of 3b (2.00 g, 7.99 mmol) in EtOH (50 mL) were added 
guanidine carbonate (1.59 g, 8.80 mmol) and NaOtBu (1.49 g, 15.5 
mmol). The resulting suspension was refluxed for 18 hours, and 
subsequently cooled rt. After filtering, the filtrate was concentrated in 
vacuo and the residue was precipitated in CHCl3 to give 3b (1.96 g, 100%) as a white 
solid. mp: 252 °C. FTIR (ATR): 3338, 1340, 2897, 2847, 1652, 1565, 1508, 1470, 
1390. 1H NMR (CD3OD, 300 MHz): δ 5.68 (s, 1H), 2.08–1.78 (m, 15H). (DMSO, 75 
MHz): δ 182.5, 175.0, 169.2, 79.2, 37.6, 36.8 (3C), 28.2 (3C), 28.0 (3C). HRMS (EI) 
calcd for C14H19N3O (M+) 245.1528, found 245.1523. 
 
Acetic acid 4–(4–{3–[6–(1–ethylpentyl)–4–oxo–1,4–
dihydropyrimidin–2–yl]ureido}butoxy)benzyl 
ester (8a): To a solution of 6 (1.0 g, 3.3 mmol) in 
toluene (100 mL) was added Et3N (0.95 mL, 6.7 
mmol) and diphenylphosphoryl azide (0.85 mL, 3.8 mmol). The mixture was stirred 
at rt for 2 h and then heated to reflux overnight. After the solution was cooled to rt, 3a 
(1.2 g, 5.5 mmol) was added together with a catalytic amount of DMAP, and the 
mixture was refluxed overnight. After cooling the mixture to rt, the solvent was 
evaporated and the residue was taken up in CH2Cl2/H2O (100 mL). After separation, 
the aquaeous layer was extracted with CH2Cl2 (3 × 50 mL). The combined layers 
were washed with brine, dried (MgSO4) and evaporated. Flash colum chromatograpy 
(methanol/chloroform 1:49) yielded 8a (1.1 g, 64%) as a white solid. FTIR (ATR): 
3209, 2958, 2928, 1735, 1692, 1640, 1576, 1511, 1437, 1377, 1225, 1174, 1126, 
1022, 819. 1H NMR (CHCl3, 400 MHz): δ 13.23 (s, 1H), 11.93 (s, 1H), 10.29 (s, 1H), 
7.26 (d, J = 8.8 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 5.82 (d, J = 1.4 Hz, 1H), 5.02 (s, 2 
H), 3.99 (t, J = 6.3 Hz, 2H), 3.34 (dt, J = 7.1, 6.2 Hz, 2H), 2.34–2.27 (m, 1H), 2.07 (s, 
3H), 1.91–1.77 (m, 4H), 1.72–1.53 (m, 4H), 1.43–1.42 (m, 4H), 0.90 (t, J = 7.4 Hz, 
O OEt
O
HN
NH2N O
HN
NH2N O
AcO
O
N
H
N
H
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HN
O
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3H), 0.87 (t, J = 7.1 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 173.1, 170.9, 159.1, 
156.7, 155.5, 154.8, 130.0 (2C), 127.8, 114.5 (2C), 106.2, 67.5, 66.1, 45.3, 39.7, 32.8, 
29.3, 26.7, 26.6, 26.0, 22.4, 21.0, 13.8, 11.7. 
 
Acetic acid 4–(4–[3–(6–adamantan–1–yl–4–oxo–
1,4–dihydropyrimidin–2–yl)ureido]butoxy) benzyl 
ester (8b): Acid 6 was treated as described above to 
yield 8b (3.62 g, 47%) as a white solid. mp: 212 °C. 
FTIR (ATR): 3209, 3019, 2902, 2846, 1735, 1692, 
1636, 1576, 1511, 1238. 1H NMR (CHCl3, 300 MHz): δ 13.32 (s, 1H), 11.92 (s, 1H), 
10.25 (s, 1H), 7.23 (d, J = 8.4 Hz, 2H), 6.84 (d, J = 8.4 Hz, 2H), 5.84 (d, J = 1.5 Hz, 
1H), 5.01 (s, 2 H), 3.98 (t, J = 5,7 Hz, 2H), 3.98 (t, J = 5.7 Hz, 2H) 3.34 (dt, J = 5.4 
Hz, J = 6,5 Hz, 2H) 2.12–1.77 (m, 19H), 2.06 (s, 3H). 13C NMR (CDCl3, 75 MHz): δ 
173.8, 170.9, 160.2, 159.1, 156.8, 154.7, 130.0 (2C), 127.8, 114.5 (2C), 102.9, 67.5, 
67.3, 66.1, 40.1 (3C), 39.6, 36.1 (3C), 27.9 (3C), 26.7, 25.9, 21.0. 
 
1–(6–(Heptan–3–yl)–4–oxo–1,4–dihydropyrimidin–
2–yl)–3–(4–(4–(hydroxymethyl)phenoxy)butyl)urea 
(4a): To a suspension of 8a (150 mg, 0.317 mmol) in 
MeOH (10 mL), K2CO3 (109 mg, 0.794 mmol) was 
added. The mixture was heated to reflux for 4 h, and cooled to rt. After addition of 
NH4Cl (107 mg, 2.00 mmol), the solvent was removed under reduced pressure. The 
residue was taken up in CH2Cl2/H2O (50 mL, 1:1 v/v) and the layers were separated. 
The aqueous phase was back extracted with CH2Cl2 (25 mL), and the combined 
organic layers were dried (MgSO4) and evaporated to give 4a as a sticky, colourless 
oil (115 mg, 84%). FTIR (ATR): 3373, 3213, 3023, 2954, 2924, 2868, 1692, 1640, 
1576, 1511, 1467, 1243, 1169, 1009, 814. 1H NMR (400 MHz, CDCl3): δ 13.24 (s, 
1H), 11.86 (s, 1H), 10.22 (s, 1H), 7.23 (d, J = 8.7 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 
5.81 (d, J = 1.4 Hz, 1H), 4.58 (br s, 2H), 3.97 (t, J = 6.2 Hz, 2H), 3.32 (dt, J = 6.8, 6.1 
Hz, 2H), 2.33–2.26 (m, 1H), 1.88–1.74 (m, 4H), 1.71–1.48 (m, 4H), 1.33–1.21 (m, 
4H), 0.89 (t, J = 7.4 Hz, 3H), 0.87 (t, J = 7.1 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 
173.2, 158.5, 156.7, 155.6, 154.7, 133.0, 128.4 (2C), 114.4 (2C), 106.1, 67.4, 64.9, 
45.3, 39.7, 32.9, 29.3, 26.8, 26.6, 25.9, 22.4, 13.8, 11.7.  
 
1–(6–Adamantan–1–yl–4–oxo–1,4–
dihydropyrimidin–2–yl)–3–[4–
(hydroxymethylphenoxy)butyl]urea (4b): To a 
suspension of 8b (4.90 g, 9.60 mmol) in MeOH (100 
mL) was added K2CO3 (3.40 g, 24.6 mmol). The 
mixture was heated to reflux for 4 h, and subsequently 
cooled to rt slowly. After slow addition of NH4Cl (2.63 g, 49.2 mmol) the solvent was 
evaporated. The residue was precipitated in water (75 mL), filtered off and washed 
with water (50 mL) and acetone (2 × 10 mL) to give 4b ( 3.60 g, 80%) as a white 
solid. mp: 177 °C. FTIR (ATR): 3330, 3200, 3019, 2920, 2846, 1684, 1640, 1563, 
1511, 1234, 1165, 1005, 811. 1H NMR (CHCl3, 300 MHz): δ 13.36 (s, 1H), 11.89 (s, 
1H),  10.25 (s, 1H), 7.23 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 5.86 (s, 1H), 
4.59 (br s, 2H), 4.00 (t, J = 6.0 Hz, 2H), 3.35 (dt, J = 6.3, 6.1 Hz, 2H), 2.15–2.10 (m, 
4H), 1.86–1.70 (m, 15 H). 
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1–(6–Adamantan–1–yl–4–oxo–1,4–
dihydropyrimidin–2–yl)–3–[4–(4–
formylphenoxy)butyl]urea (11): To a suspension of 
4b (100 mg, 0.214 mmol) in acetone (4 mL) were 
added NMO (53 mg, .045 mmol) and a catalytic 
amount of TPAP. The mixture was stirred at rt for 16 h 
and concentrated under reduced pressure. The residue 
was taken up in CHCl3 (10 mL), filtered over Hyflo® and evaporated to give a yellow 
oil, which was purified by flash chromatography (2% MeOH in CHCl3) to give 11 (80 
mg, 80%) as a colourless oil. FTIR (ATR): 3204, 3028, 2902, 2846, 1688, 1632, 
1571, 1528, 1506, 1247, 1156, 828, 728, 651. 1H NMR (CHCl3, 300 MHz): δ 13.36 
(s, 1H), 11.94 (s, 1H),  10.31 (s, 1H), 9.86 (s, 1H), 7.80 (d, J = 8.8 Hz, 2H), 6.98 (d, J 
= 8.7 Hz, 2H), 5.86 (d, J = 1.4 Hz, 1H), 4.09 (t, J = 6.3 Hz, 2H), 3.36 (dt, J = 6.8, 6.2 
Hz, 2H), 2.13 (br s, 4H) 1.91–1.73 (m, 15H). 13C NMR (CDCl3, 75 MHz): δ 190.7, 
173.8, 164.1, 160.3, 156.8, 154.7, 131.9 (2C), 129.8, 114.8 (2C), 102.9, 77.2, 67.9, 
40.1 (3C), 39.6, 36.1 (3C), 27.9 (3C), 26.5, 25.8. 
 
1–(6–Adamantan–1–yl–4–oxo–1,4–
dihydropyrimidin–2–yl)–3–[4–
((hydroxyiminomethyl)phenoxy)butyl]urea (13)   
To a solution of 11 (20 mg, 0.043 mmol) in pyridine 
(4 mL) was added hydroxylamine hydrochloride (6.0 
mg, 0.086 mmol). The mixture was stirred at rt for 
72 h, and concentrated in vacuo. The residue was precipitated in water (2 mL), 
washed (water, 2 × 1 mL) and dried to give 13 (21 mg, >99%) as a white solid. mp: 
213 °C. FTIR (ATR): 3209, 3023, 2898, 2850, 1688, 1632, 1571, 1506, 1303, 1243, 
1169, 970, 823. 
 
1–[6–(1–Ethylpentyl)–4–oxo–1,4–dihydropyrimidin–2–yl]–3–
prop–2–ynylurea (17) : To a solution of 3a (1.70 g, 8.10 mmol) in 
CHCl3 (50 mL) was added carbonyl diimidazole (1.82 g, 11.3 
mmol) carefully. After 5 h of stirring at rt, propargylamine (1.65 g, 
30.0 mmol) was added dropwise. The mixture was stirred for an additional 36 h at 
ambient temperature, and diluted with water. The layers were separated, and the 
aqueous phase was back extracted with CHCl3 (2 × 40 mL). The combined organic 
layers were washed with aqueous NH4Cl, dried (MgSO4) and evaporated to give a 
yellow oil. This oil was purified using column chromatography (2% MeOH in CHCl3) 
to 17 (2.35 g, 100%) as a light yellow solid. FTIR (ATR): 3205, 2954, 2924, 2855, 
1697, 1653, 1575, 1519, 1247, 845, 772, 590. 1H NMR (400 MHz, CDCl3): δ 12.95 
(s, 1H), 12.04 (s, 1H), 10.75 (s, 1H), 5.78 (s, 1H), 3.99 (dd, J = 5.2, 2.4 Hz, 2H), 2.24 
(m, 1H), 2.20 (t, J = 2.4 Hz, 1H), 1.54 (m, 4H), 1.19 (m, 4H), 0.82 (t, J = 7.2 Hz, 3H), 
0.78 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 172.5, 156.1, 155.1, 154.1, 
106.1, 79.5, 70.8, 45.3, 32.8, 29.3, 29.2, 26.6, 22.5, 13.9, 11.7. 
 
General procedure for Huisgen–cyclisation of compound 17 and azides: 
Compound 1 (58 mg, 0.20 mmol, 1 equiv) and the azide (1 equiv) were dissolved in 2 
mL of tBuOH. To this solution, a mixture of Cu(OAc)2 (20 mol%) and sodium 
ascorbate (40 mol%) in 2 mL of H2O was added. The dispersion was stirred at rt for 
72 h, and then diluted with 4 mL of CHCl3. The layers were separated, and the 
aqueous phase was back–extracted with CHCl3. The combined organic layers were 
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washed with aqueous NaHCO3, dried (MgSO4) and evaporated to the crude triazole. 
The product was purified with column chromatography (2.5% MeOH in CHCl3) to 
give triazole 18 to 22. 
 
1–(6–(Heptan–3–yl)–4–oxo–1,4–dihydropyrimidin–2–
yl)–3–((1–((1R,2R)–2–hydroxycyclohexyl)–1H–1,2,3–
triazol–4–yl)methyl)urea (18): Treatment of compound 17 
with 1–azidocyclohexan–1–ol as described above, gave 18 
as a white solid (>99%). mp: 76 °C. FTIR (ATR): 3250, 2928, 2859, 1692, 1649, 
1576, 1519, 1446, 1251, 1074, 958, 849, 802, 772. 1H NMR (400 MHz, CDCl3): δ 
13.15 (s, 1H), 11.85 (s, 1H), 10.07 (s, 1H), 7.68 (s, 1H), 5.74 (d, J = 1.0 Hz, 1H), 4.61 
(dd, J = 14.7, 4.7 Hz, 1H), 4.51 (dd, J = 14.7, 4.0 Hz, 1H), 4.14–4.08 (m, 2H), 3.83–
3.77 (m, 1H), 2.31–2.19 (m, 2H), 2.15–2.11 (m, 1H), 2.06–1.97 (m, 1H), 1.88–1.83 
(m, 2H), 1.68–1.33 (m, 7H), 1.31–1.14 (m, 4H), 0.86 (t, J = 7.2 Hz, 3H), 0.85 (t, J = 
7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 173.4, 156.3, 155.7, 154.6, 143.2, 122.7, 
106.1, 73.0, 67.2, 45.2, 35.9, 33.4, 32.7, 30.9, 29.2, 26.5, 24.8, 24.1, 22.4, 13.8, 11.6. 
 
2–tert–Butoxycarbonylamino–3–(4–{3–[6–(1–
ethylpentyl)–4–oxo–1,4–dihydropyrimidin–2–yl]–
ureidomethyl}–[1,2,3]–triazol–1–yl)propionic acid 
methyl ester (19) : Treatment of compound 17 with 
protected azidoalanine gave 19 as a colourless oil 
(>99%). FTIR (ATR): 3369, 2976, 1748, 1714, 1502, 1364, 1247, 1161, 1044, 603. 
1H NMR (400 MHz, CDCl3): δ 13.07 (s, 1H), 12.04 (s, 3H), 10.61 (s, 1H), 7.57 (s, 
1H), 5.82 (s, 1H), 5.71 (d, J = 7.0 Hz, 1H), 4.85 (dd, J = 14.9, 5.3 Hz, 1H), 4.71–4.67 
(m, 2H), 4.57 (d, J = 5.0 Hz, 2H), 3.73 (s, 3H), 2.31–2.24 (m, 1H), 1.67–1.50 (m, 
4H), 1.39 (s, 9H), 1.31–1.18 (m, 4H), 0.86 (t, J = 7.5 Hz, 3H), 0.85 (t, J = 7.5 Hz, 
3H). 13C NMR (75 MHz, CDCl3): δ 172.6, 169.0, 156.3, 155.1, 154.3, 123.1, 106.2, 
106.0, 80.3, 53.7, 53.0, 51.0, 45.4, 45.4, 35.7, 33.0, 32.9, 29.4, 29.4, 28.3 (3C), 26.7, 
26.7, 22.6, 22.6, 14.0, 11.9. 
 
2–tert–Butoxycarbonylamino–5–(4–{3–[6–(1–
ethylpentyl)–4–oxo–1,4–dihydropyrimidin–2–yl]–
ureidomethyl}–[1,2,3]–triazol–1–yl)pentanoic acid 
methyl ester (20): Treatment of compound 17 with 
protected azidopropylglycine gave 20 as a white solid 
(>99%). mp: 110 °C. FTIR (ATR): 2954, 2928, 2863, 1692, 1653, 1580, 1519, 1446, 
1359, 1247, 1165, 1048, 849, 793. 1H NMR (400 MHz, CDCl3): δ 13.10 (s, 1H), 
12.09 (s, 1H), 10.77 (t, J = 4.4 Hz, 1H), 7.60 (s, 1H), 5.82 (d, J = 1.1 Hz, 1H), 5.10 
(d, J = 7.5 Hz, 1H), 4.61 (d, J = 5.5 Hz, 2H), 4.35 (t, J = 7.0 Hz, 2H), 3.72 (s, 3H), 
2.32–2.29 (m, 1H), 2.01–1.94 (m, 2H), 1.91–1.82 (m, 1H), 1.70–1.53 (m, 6H), 1.43 
(s, 9H), 1.34–1.21 (m, 4H), 0.89 (t, J = 7.4 Hz, 3H), 0.87 (t, J = 7.3 Hz, 3H). 13C 
NMR (75 MHz, CDCl3): δ 173.0, 172.6, 156.8, 155.6, 155.4, 154.7, 145.4, 121.9, 
106.3, 80.1, 52.7, 52.5, 49.5, 45.3, 35.5, 32.8, 29.8, 29.3, 28.3, 26.6, 26.3, 22.4, 13.9, 
11.7. 
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Acetic acid 3,5–diacetoxy–2–acetoxymethyl–6–(4–
{3–[6–(1–ethylpentyl)–4–oxo–1,4–
dihydropyrimidin–2–yl]–ureidomethyl}–
[1,2,3]triazol–1–yl)tetrahydropyran–4–yl ester (21): 
Treatment of compound 17 with Ac–protected azidoglucose gave 21 as a white solid 
(>99%). FTIR (ATR): 2958, 2928, 2868, 1573, 1653, 1576, 1368, 1212, 1040, 919. 
1H NMR (400 MHz, CDCl3): δ 13.03 (s, 1H), 12.08 (s, 3H), 10.85 (s, 1H), 7.78 (s, 
1H), 5.84 (d, J = 9.3 Hz, 1H), 5.79 (d, J = 1.1 Hz, 1H), 5.44 (t, J = 9.4 Hz, 1H), 5.36 
(t, J = 9.4 Hz, 1H), 5.19 (dd, J = 10.0, 9.4 Hz, 1H), 4.57 (t, J = 4.8 Hz, 2H), 4.25 (dd, 
J = 12.6, 5.1 Hz, 1H), 4.10 (dd, J = 12.6, 2.1 Hz, 1H), 3.96 (ddd, J = 10.0, 5.1, 2.1 
Hz, 1H), 2.31–2.25 (m, 1H), 2.04 (s, 3H), 2.03 (s, 3H), 1.98 (s, 3H), 1.82 (s, 3H), 
1.68–1.49 (m, 4H), 1.30–1.18 (m, 4H), 0.86 (t, J = 7.6 Hz, 3H), 0.84 (t, J = 7.3 Hz, 
3H). 13C NMR (75 MHz, CDCl3): δ 173.0, 170.4, 169.9, 169.3, 168.7, 156.9, 155.6, 
154.6, 146.2, 120.4, 106.3, 85.6, 77.2, 75.1, 72.9, 70.1, 67.7, 61.6, 45.3, 35.3, 32.9, 
29.3, 26.6, 22.5, 20.7, 20.5, 20.2, 13.9, 11.7. 
 
Acetic acid 4,5–diacetoxy–6–acetoxymethyl–2–(4–
{3–[6–(1–ethylpentyl)–4–oxo–1,4–
dihydropyrimidin–2–yl]–ureidomethyl}–[1,2,3]–
triazol–1–yl)tetrahydropyran–3–yl ester (22): 
Treatment of compound 17 with Ac–protected azidogalactose gave 22 as a white 
solid (>99%). FTIR (ATR): 2954, 2928, 2868, 1748, 1653, 1580, 1524, 1364, 1212, 
1040. 1H NMR (400 MHz, CDCl3): δ 13.05 (s, 1H), 12.07 (s, 1H), 10.84 (s, 1H), 7.84 
(s, 1H), 5.82–5.80 (m, 2H), 5.57 (t, J = 9.8 Hz, 1H), 5.51 (d, J = 3.3 Hz, 1H), 5.21 
(dd, J = 10.3, 3.3 Hz, 1H), 4.63–4.52 (m, 2H), 4.21–4.14 (m, 2H), 4.12–4.07 (m, 1H), 
2.34–2.25 (m, 1H), 2.18 (s, 3H), 2.01 (s, 3H), 1.97 (s, 3H), 1.84 (s, 3H), 1.68–1.51 
(m, 4H), 1.31–1.18 (m, 4H), 0.86 (t, J = 7.8 Hz, 3H), 0.84 (t, J = 7.3 Hz, 3H). 13C 
NMR (75 MHz, CDCl3): δ 173.0, 170.3, 169.9, 169.8, 168.9, 156.9, 155.6, 154.7, 
146.0, 120.5, 106.3, 86.2, 77.2, 73.9, 71.0, 67.7, 66.9, 61.1, 45.3, 35.3, 32.9, 29.3, 
28.6, 26.6, 22.5, 20.6, 20.5, 20.3, 13.9, 11.7. 
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Chapter 4 
 
INITIAL PURIFICATIONS USING UPY–TAGS 
 
 
4.1  Introduction 
 
After numerous unfruitful attempts of coupling substrates to flexible UPy–
equipped linkers (Figure 1), some of which are described in the proceeding chapter, 
we concluded that not only homodimerisation of the ATs of these compounds is 
causing problems.  
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Figure 1: Unsuccessful coupling experiments. 
 
As hypothesised in Section 3.5, it is feasible that π,π–interactions and other 
supramolecular aspects play a role as well. From the successful Huisgen–cyclisations 
described in Section 3.4, it can be reasoned that when more rigid linkers are used, 
coupling reactions can be successful. To arrive at more rigid linkers, the n–butyl 
spacer in compounds 1 and 2 will be replaced by a para–substituted aromate (Figure 
2). Since the substrates must be cleaved from the linkers after modification, the acid–
labile para–alkoxybenzyl alcohol moiety is maintained. 
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Figure 2: New rigid linker 3. 
 
Coupling reactions of a simple substrate with these linkers, straightforward 
modification of these substrates, as well as subsequent cleavage of the resulting 
products will be described. 
 
4.2  Synthesis of a rigid linker 
 
To prepare rigid, cleavable linkers (4, Figure 3), we decided to start again with 
p–hydroxybenzylalcohol, since selective alkylation of the phenol had already been 
successfully realised under standard conditions in high yields (Section 2.3). 
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Figure 3: Retrosynthetic analysis of rigid linker 4. 
 
In this case, a benzylic bromide instead of an alkyl bromide will be used as 
alkylation agent to obtain the sterically restrained compound 6. Subsequent Curtius 
rearrangement should give rise to isocyanate 5, which can be treated in one pot with 
the isocytosines that were synthesised earlier. Hence, this route was designed in 
analogy with the synthesis of the more flexible linkers described in Chapter 3, and the 
desired linkers 4 were expected to be obtained without significant difficulties. 
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The first step in this synthesis was the coupling of the benzyl bromide 
derivative with the phenolic hydroxyl group (Scheme 1). As anticipated, this reaction 
went smoothly to full conversion, and compound 9 could be isolated in excellent 
yield.  
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Scheme 1: Synthesis of acid 6. 
 
The two subsequent steps were also performed in analogy with the synthesis 
reported in the previous chapter. The saponification of the methyl ester was 
performed using aqueous sodium hydroxide at slightly elevated temperatures to give 
acid 10 in quantitative yield. Protection of the resulting benzyl alcohol was carried 
out using acetic anhydride, and compound 6 was also isolated in excellent yield. In 
the next step, the introduction of the AT was accomplished (Scheme 2). 
 Treatment of acid 6 with diphenylphosphoryl azide to obtain isocyanate 5 
turned out to be not as straightforward as anticipated. When an excess of isocytosine 
was added to provide linkers 4, only on a few occasions the desired product could be 
isolated. Yields varied strongly, and the reason for this irreproducibility was never 
fully understood. When other nucleophiles than the isocytosines were used to quench 
isocyanate 5 in situ, for instance tert–butanol to give the BOC–protected amine, no 
product was obtained either. Also, treatment of the crude mixture with water to yield 
the corresponding amine was not successful. 
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R= ,
a b
(PhO)2P(O)N3, Et3N
5
toluene
rt to reflux, 12 h
isocytosines,
DMAP, Et3N
4a
4b
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AcO
O
OH
O
AcO
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N C O
N
H
N
H
O
N
NH
R
O
O
OAc
toluene,
reflux, 12 h
64%
68%
 
 
Scheme 2: Intoduction of the ureidopyrimidinone ATs via a one–pot procedure. 
 
These findings suggest that the formation of the isocyanate is troublesome, 
which can be explained by the presence of the aromatic ring directly connected to the 
nitrogen atom; when an aliphatic derivative was used (as in Chapter 3) these 
problems did not arise. Although from literature it is known that Curtius 
rearrangements can be performed on aromatic acids to give the corresponding 
anilines or ureido derivatives in a one–pot procedure, examples are not 
multitudinous.1 In addition, the isocytosines as well as the desired products are poorly 
soluble in toluene, which also can limit the efficiency of the reaction. Switching to 
chloroform as solvent did not increase yields significantly though. 
Despite the problems concerning the reproducibility of this conversion, we 
were able to obtain sufficient amounts of 4a and 4b to investigate the possibility of 
coupling substrates to these linkers, which will be discussed in the next section. 
 
4.3  Coupling of substrates 
 
As stated in Section 4.1, the first substrate to equip our new linkers with, was 
benzoic acid derivative 7, which was also used in Chapter 3. To couple this substrate 
to linkers 4a and 4b, the benzylic hydroxyl groups had to be deprotected (Scheme 3). 
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This deprotection was effected upon treatment with potassium carbonate in 
methanol, providing compounds 3a and 3b in excellent yield. Purification of these 
linkers was performed by precipitation in acetone and since the solubility of 3a and 
especially of 3b, was rather poor in a range of solvents. 
 
R= ,
a b
4a,b
N
H
N
H
O
N
NH
R
O
O
OAc
N
H
N
H
O
N
NH
R
O
O
OH
K2CO3
MeOH, rt, 5 h
3a   95%
3b   96%
N
H
N
H
O
N
NH
R
O
O
O
O
F
NO2
12a   87%
12b   75%
HO
O
F
NO211EDC, Et3N, DMAP
CHCl3, reflux, 24 h
 
 
Scheme 3: Coupling of acid 11 to rigid UPy–linkers 3a and 3b. 
 
Next, we focussed on the coupling of these new, rigid linkers with acid 11. 
Much to our delight, standard conditions using a carbodiimide and DMAP, with 
triethylamine as a base, gave the desired products 12a and 12b. After optimisation, 
yields of 85% and higher were obtained using 10 equiv of EDC and compound 11. 
Microwave heating strongly decreased reaction times, but yields dropped 
significantly (to 40–50%) because of decomposition of the product under these 
conditions. 
However, the isolation of 12a and 12b supports the hypothesis that was 
postulated in Section 3.5; the fact that UPy–tagged linkers 3a and 3b were 
successfully coupled to a substrate indicates that the rigidity of the AT–functionalised 
linkers is of major importance for their chemical behaviour. We described in Chapter 
3 that the more flexible linkers, containing a linear butylene chain, gave no 
conversion under these reaction conditions, whereas compounds 3a and 3b containing 
a rigid aromatic system instead, gave the coupling product without difficulties. 
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With AT–equipped substrates 12a and 12b in hand, the first chemical 
transformations and subsequent purification by hydrogen bonding could be explored. 
 
4.4  Proof of principle 
 
4.4.1  Modification of bound substrates and subsequent purification 
 
As stated earlier, the first compounds which we intended to purify using our 
new affinity separation (AS) method, are products from a straightforward aromatic 
substitution on compounds 12a and 12b. These substitutions are well described2 and 
proceed under mild conditions (Scheme 4). 
 
N
H
N
H
O
N
NH
R
O
O
O
O
F
NO2
12a,b
N
H
N
H
O
N
NH
R
O
O
O
O
NR1R2
NO2
10 equiv HNR1R2
10 equiv Et3N
CHCl3, rt, 24 h
R= ,
a b
13-16
 
 
Scheme 4: Aromatic substation on tagged substrates 12a and 12b. 
 
Treatment of AT–equipped substrates 12a and 12b with an excess of amine 
(see Table 1) and triethylamine as a base at room temperature, gave indeed 
substitution products 13 to 16 after 24 h. A large excess of amine was used to force 
the reactions to go to completion, which is a necessity for successful application of 
our new purification protocol. All compounds functionalised with the UPy–based AT 
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will be bound by the tagged resin, so discrimination between starting material and 
product is not possible in this case. 
According to TLC, full conversion was obtained in most cases (Table 1), 
although the sterically more hindered Ac–protected piperazine did not give rise to 
compound 15. This was not an unexpected result though; more polar solvents and 
harsh conditions are usually required to facilitate this particular conversion.3 
Purification was on one half of each batch performed by means of both column 
chromatography (CC) and on the other half via affinity separation (AS) using our AT 
methodology. The results are compared in Table 1. It has to be mentioned that when 
column chromatography was applied, an extraction was performed prior to the 
purification, whereas during affinity separation, the crude mixture was directly 
subjected to the resin without any work up. 
 
Table 1: Comparison of yields using CC and AS. 
 
NH2
NH2
AcN NH
NH2
MeO
Amine Product Yield (CC)a Yield (AS)b
13a
13b
14a
16a
15a no reaction
a = Column chromatography using chloroform/methanol eluent systems. 
b = Affinity separation using the tagged ArgoPoreTM resin in CHCl3, 10 
equiv of binding sites relative to the amount of starting material.
>95%
>95%
>95%
>95%
>95%
75%
73%
75%
 
 
As can be read from Table 1, yields after affinity separation were higher than 
after standard purification, while the purity of the products was comparable according 
to NMR. 
With these first promising results in hand, we can state that the foundation of 
a new purification method based on hydrogen bonding has been established. 
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4.4.2  Cleavage of products from the linkers and subsequent purification 
 
To substantiate the proof of principle, it was decided to cleave the substrates 
from the AT–functionalised linkers and again use the affinity protocol to purify the 
resulting products. 
We reasoned that if compounds 13 to 16 were to be treated with acid in the 
presence of water, the Wang–linker would be cleaved according to the mechanism 
depicted in Figure 4.4 After protonation of the carbonyl functionality, the phenolic 
oxygen can donate its electrons to free the desired product, and the cationic species 
17 will be subsequently quenched by water. The resulting alcohol 3 can then be 
separated from the product by treatment with the AT–bearing resin, since it will bind 
this compound from solution and leave the product unattached. 
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R
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H
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R
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O
OH
17
18
3
-H
 
 
Figure 4: Release mechanism of products from the Wang–linker. 
 
When compounds 13 to 16 (that were isolated by AS) were subjected to acidic 
conditions (TFA/H2O 95:5 v/v, Scheme 5), the desired products were formed as 
anticipated. Again, no work up was carried out after completion of the reaction.  
                                  Initial purifications using UPy–tags 
                                                                                                                                            
                                                                                                                                  61 
 
N
H
N
H
O
N
NH
R
O
O
O
O
NR'R''
NO2
13-16
HO
O
NR'R''
NO2
TFA/H2O
95:5 v/v
R= ,
a b
19-21
rt, 1.5 h
NH2
NH2
NH2
MeO
Amine Compound Product Yield (AS)a
13a
13b
14a
16a
19
19
20
21
>95%
>95%
>95%
86%b
a = Affinity separation using the tagged ArgoPoreTM resin in
CHCl3, 10 equiv of binding sites relative to the amount of
starting material. b = To obtain a pure sample of 21, treatment 
with active charcoal was necessary.  
 
Scheme 5: Purification of products 16–18 using AS. 
 
After complete removal of the protic solvents under reduced pressure was 
realised, the affinity separation was carried out as described above. As stated (vid 
Section 1.4), in this case the reaction products were not bound by the ATs on the 
resin, so after filtration of the resin, compounds 19 to 21 were isolated upon 
evaporation of the filtrate.  
 
  
 
Figure 5: Fragments of the 1H–spectra of compound 21 after purification by CC 
(left) and AS (right). 
Chapter 4 
                                                                                                                                            
 
62 
 
NMR analyses pointed out that the desired products were obtained in good 
purity (Figure 5), although additional treatment of crude 21 with activated charcoal 
was needed to yield the compound in pure form. The cleaved linker 3 was not present 
in the filtrate, and could be obtained in pure form after treatment of the resin with 
polar solvents. 
Summarizing, we can state that the affinity separation using UPy–based ATs 
was applied during two subsequent synthesis steps without any additional work up or 
purification to give compounds 19 and 20 in pure form. These results clearly show 
that our new separation protocol based on hydrogen bonding can be used as a 
purification tool during syntheses, to obtain both intermediates and final products in 
pure form. 
 
4.5  Conclusions 
 
The synthesis of rigid linkers equipped with a UPy–tag was successful, albeit 
in slightly lower yields than the corresponding flexible linker systems. Furthermore, it 
has to be mentioned that the Curtius–rearrangement was troublesome in this case, 
giving rise to a range of side products. 
The coupling of substrates to these linkers could be carried out using standard 
methods, which is in glaring contrast with the more flexible linkers described in 
Chapter 3. 
Straightforward modification of these coupled substrates proceeded without 
difficulties, and the products were purified using the tagged resin. Since no work up 
was needed prior to this purification, the obtained results using affinity separation 
were not only higher yielding, albeit on small scale, but also less time consuming than 
purification by conventional methods. 
Modification of the substrates was performed under standard conditions, and 
cleavage of reaction products from the AT–equipped linkers could be carried out 
according to a literature procedure. Using affinity separation, the products were 
isolated in good purity and excellent yields. In this case, no work up was required 
either: hence, the affinity protocol was applied in two subsequent reaction steps 
without any further purification or work up. 
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These results illustrate the power of our new purification tool, and the efforts 
made have cleared the path for application of this method in other fields of organic 
synthesis. 
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4.7  Experimental section 
 
4–(4–Hydroxymethylphenoxymethyl)benzoic acid methyl 
ester (9): To a solution of p–hydroxybenzyl alcohol (5.00 g, 
40.3 mmol) in acetone (150 mL) were added methyl 4–
(bromomethyl)benzoate (8.30 g, 36.3 mmol) and K2CO3 
(5.60 g, 40.3 mmol). The mixture was refluxed overnight, cooled to rt and 
concentrated in vacuo. The residue was taken up in a 1:1 mixture of aqueous NaOH 
(0.625 M) and EtOAc (300 mL), and the layers were separated. The aqueous phase 
was back extracted with EtOAc (2 × 100 mL), and the combined organic layers were 
washed with water, dried (MgSO4) and evaporated. The residue was precipitated in 
aqueous NaOH (0.625 M) to give the desired product (9.70 g, 98%) as a white solid. 
mp. 115–116 °C. FTIR (ATR): 3304, 2958, 2915, 2959, 1714, 1282. 1H NMR 
(CDCl3, 400 MHz): δ 8.04 (d, J = 7.8 Hz, 2H), 7.50 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 
8.2 Hz, 2H), 6.95 (d, J = 8.0 Hz, 2H), 5.13 (s, 2H), 4.62 (s, 2H), 3.92 (s, 3H). 13C 
NMR (CDCl3, 75 MHz): δ 166.1, 157.7, 141.9, 133.5, 129.7 (2C), 128.4 (2C), 126.7 
(2C), 114.7 (2C), 69.4, 65.0, 52.2. HRMS (EI) calc. for C16H16O4 (M+) 272.1049, 
measured 272.1049. 
 
4–(4–Hydroxymethylphenoxymethyl)benzoic acid (10): A 
suspension of 9 (6.45 g, 23.7 mmol) in aqueous NaOH (2.0 
M, 150 mL) was stirred at 50 °C for 12 h. After cooling the 
mixture to rt it was acidified with aqueous HCl (5.0 M, 75 
mL) and the solid was filtered off. After washing (0.01 M HCl, 50 mL) and drying in 
vacuo, compound 10 (6.12 g, >99%) was obtained as a white solid. mp. 197–198 °C. 
FTIR (ATR) : 3396, 2930, 2803, 1690, 1236. 1H NMR (DMSO, 400 MHz): δ 7.95 (d, 
J = 8.2 Hz, 2H), 7.53 (d, J = 8.2 Hz, 2H), 7.23 (d, J = 8.8 Hz, 2H), 6.96 (d, J = 8.8 
Hz, 2H), 5.17 (s, 2H), 4.41 (s, 2H). 13C NMR (DMSO, 75 MHz): δ 167.0, 156.8, 
141.8, 134.8, 129.3 (2C), 127.8 (2C), 127.1 (2C), 114.4 (2C), 68.7, 62.6. HRMS (EI) 
calc. for C15H14O4 (M+) 258.0892, found : 258.0893. 
HO
O
OMe
O
HO
O
OH
O
Chapter 4 
                                                                                                                                            
 
64 
4–(4–Acetoxymethylphenoxymethyl)benzoic acid (6): A 
solution of 10 (4.00 g, 15.5 mmol) and Et3N (10.8 mL, 77.4 
mmol) in CH2Cl2 (100 mL) was cooled to 0 °C, and Ac2O 
(4.40 mL, 46.5 mmol) was added dropwise. The mixture was 
warmed to rt and stirred for 5 h, After diluting the mixture with aqueous HCl (1.0 M, 
100 mL), the layers were separated, and the aqueous phase was back extracted with 
CHCl3 (2 × 100 mL). The combined organic layers were washed with water (250 
mL), and evaporated. The residue was precipitated from water (100 mL) to give 6 
(4.59 g, 99%) as a white solid. 1H NMR (400 MHz, DMSO): δ 12.90 (br s, 1H), 7.92 
(d, J = 8.0 Hz, 2H), 7.52 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 8.4 Hz, 2H), 6.98 (d, J = 8.4 
Hz, 2H), 5.17 (s, 2H), 4.95 (s, 2H), 1.99 (s, 3H). 13C NMR (DMSO, 75 MHz): δ 
170.5, 161.7, 158.1, 142.8, 130.3 (2C), 130.0 (2C), 128.6, 128.5, 126.8 (2C), 114.8 
(2C), 69.3, 66.1, 21.3. HRMS (EI) calc. for C17H16O5 (M+) 300.0998, found: 
300.0999. 
 
1–[6–(1–Ethylpentyl)–4–oxo–1,4–
dihydropyrimidin–2–yl]–3–[4–(4–
hydroxymethylphenoxymethyl)phenyl]urea (4a): 
To a solution of 6 (2.00 g, 6.66 mmol) and Et3N (1.90 
mL, 13.3 mmol) in CHCl3 (150 mL), (PhO)2P(O)N3 (1.70 mL, 8.00 mmol) was added 
drop wise. The mixture was stirred at rt for 6 h, then refluxed for 12 h. After cooling 
the solution to rt, the ethylpentyl isocytosine (vid. Section 3.2) (3.01 g, 14.4 mmol) 
and a catalytic amount of DMAP were added, and the mixture was refluxed for 
another 5 h. After cooling the mixture to rt, the solution was concentrated in vacuo. 
The residue was taken up in CHCl3/H2O (1:1 v/v, 200 mL). The layers were 
separated, and the aqueous phase was back extracted with CHCl3 (2 × 100 mL). The 
combined organic layers were washed with water, dried and evaporated. The residue 
was precipitated in MeOH and dried to give 4a (2.16 g, 64%) as a white solid. FTIR 
(ATR): 3022, 2956, 2925, 2866, 1737, 1648, 1605, 1581, 1508, 1321, 1219, 1173, 
1017, 822. 1H NMR (CDCl3, 400 MHz): δ 13.11 (s, 1H), 12.27 (s, 1H), 12.25 (s, 1H), 
7.71 (d, J = 8.3 Hz, 2H), 7.37 (d, J = 8.5 Hz, 2H), 7.25 (d, J = 8.6 Hz, 2H), 6.91 (d, J 
= 8.6 Hz, 2H), 5.92 (s, 1H), 5.01 (br s, 4H), 2.36–2.31 (m, 1H), 2.05 (s, 3H), 1.68–
1.55 (m, 4H), 1.33–1.25 (m, 4H), 0.94–0.84 (m, 6H). HRMS (ESI) calc. for 
C28H35N4O5 (M+H+) 507.2607, measured 507.2653. 
 
Acetic acid 4–{4–[3–(6–adamantan–1–yl–4–oxo–
1,4–dihydropyrimidin–2–
yl)ureido]benzyloxy}benzyl ester (4b): Acid 6 (2.00 
g, 6.66 mmol)was treated as described above to give  
tagged linker 4b (2.46 g, 68%). FTIR (ATR): 3019, 
2948, 2925, 1735, 1646, 1604, 1578, 1508, 1320, 1219, 1172, 1016, 820. 1H NMR 
(CDCl3, 400 MHz) : δ 13.30 (s, 1H), 12.37 (s, 1H), 12.25 (s, 1H), 7.74 (d, J = 8.4 Hz, 
2H), 7.40 (d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.6 Hz, 2H), 6.95 (d, J = 8.6 Hz, 2H), 5.05 
(s, 2H), 5.03 (s, 2H), 2.08 (s, 3H), 1.90–1.66 (m, 15H). 
 
1–[6–(1–Ethylpentyl)–4–oxo–1,4–
dihydropyrimidin–2–yl]–3–[4–(4–
hydroxymethylphenoxymethyl)phenyl]urea (3a): 
To a suspension of 4a (0.795 g, 1.57 mmol) in 
methanol (20 mL) was added K2CO3. (1.08 g, 7.85 mmol). The mixture was stirred 
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for 5 h at rt, and brought to neutral pH using aqueous NH4Cl. The methanol was 
evaporated, and the residue was precipated in water (25 mL). After filtration the 
crude product was washed with Et2O (15 mL) and dried to give 3a as a white solid 
(0.693 g, 95%). FTIR (ATR): 2956, 2925, 2862, 1640, 1605, 1508, 1445, 1406, 1227, 
1009, 818. 1H NMR (CDCl3/CD3OD, 400 MHz) : δ 7.65 (br s, 1H), 7.46 (br s, 2H), 
7.43 (d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.6 Hz, 2H), 6.96 (d, J = 8.3 Hz, 2H), 5.94 (s, 
1H), 5.06 (s, 2H), 4.57 (s, 2H), 2.44–2.35 (m, 1H), 1.69–1.58 (m, 4H), 1.36–1.22 (m, 
4H), 0.96–0.85 (m, 6H). HRMS (ESI) calcd. for C26H32N4O4Na (M+Na+) 487.2321, 
measured 487.2321. 
 
1–(6–Adamantan–1–yl–4–oxo–1,4–
dihydropyrimidin–2–yl)–3–[4–(4–
hydroxymethylphenoxymethyl)phenyl]urea (3b): 
Compound 4b (1.00 g, 1.85 mmol) was treated as 
described above to give 3b as a white solid (96% 
yield). FTIR (ATR): 2947, 2925, 1640, 1580, 1508, 1220, 1012, 819. 
 
 
4–Fluoro–3–nitro–benzoic acid 4–(4–{3–[6–
(1–ethylpentyl)–4–oxo–1,4–
dihydropyrimidin–2–
yl]ureido}benzyloxy)benzyl ester (12a): 
Method 1: To a solution of 3a (0.204 g, 0.439 mmol) and Et3N in (0.60 mL, 4.40 
mmol) in CHCl3 (25 mL), were added 4–fluoro–3–nitrobenzoic acid (11, 0.814 g, 
4.40 mmol), EDC (0.555 g, 4.40 mmol) and a catalytic amount of DMAP. The 
mixture was refluxed for 24 h, and cooled to rt. The solvent was evaporated, and the 
residue was precipitated in methanol (15 mL). After filtration, washing with methanol 
(10 mL) and drying, 12a (0.241 g, 87%) was isolated as a yellow solid.  
Method 2: To a solution of 3a (20 mg, 0.043 mmol) and Et3N (30 µL, 0.22 mmol) in 
CHCl3 (3 mL), were added 4–fluoro–3–nitro–benzoic acid (11, 40 mg, 0.22 mmol), 
EDC (27 mg, 0.21 mmol) and a cat. amount of DMAP. The mixture was heated in a 
microwave to 110°C for 10 min, using a sealed tube. After cooling the mixture to rt, it 
was diluted with aqueous NaHCO3 (5 mL). The layers were separated and the 
aqueous phase was extracted with CHCl3 (2 × 5 mL). The combined organic layers 
were dried (MgSO4) and evaporated to give a yellow solid. Precipitation of this solid 
in methanol yielded 12a (11 mg, 41%) as a yellow solid. FTIR (ATR): 3023, 2952, 
2924, 2868, 1719, 1694, 1649, 1606, 1571, 1539, 1508, 1321, 1278, 1222, 1176, 
1112, 1011, 909, 824. 1H NMR (CDCl3, 400 MHz): δ 13.11 (s, 1H), 12.32 (s, 1H), 
12.29 (s, 1H), 8.73 (dd, J = 7.2, 2.2 Hz, 1H), 8.32 (ddd, J = 8.7, 4.2, 2.2 Hz, 1H), 7.71 
(d, J = 8.6 Hz, 2H), 7.40 (d, J = 8.7 Hz, 2H), 7.37 (d, J = 8.7 Hz, 2H), 7.34 (d, J = 8.9 
Hz, 1H), 6.98 (d, J = 8.7 Hz, 2H), 5.94 (d, J = 1.5 Hz, 1H), 5.32 (s, 2H), 5.07 (s, 2H), 
2.39–2.31 (m, 1H), 1.75–1.55 (m, 4H), 1.36–1.19 (m, 4H), 0.92 (t, J = 7.6, 3H), 0.88 
(t, J = 7.6, 3H). 13C NMR (CDCl3, 75 MHz): δ 172.64, 163.16, 159.49, 158.79, 
155.91, 155.49, 154.44, 137.64, 136.41, 136.28, 132.03, 130.23, 127.98, 127.66, 
127.14, 120.70, 118.66, 188.38, 114.97, 106.45, 69.78, 67.65, 45.56, 33.08, 29.50, 
26.84, 22.68, 14.11, 11.94. HRMS (FAB): Mass calc. for C33H35N5O7F (M+H+) 
632.2521, found 632.2495. 
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4–Fluoro–3–nitrobenzoic acid 4–{4–[3–(6–
adamantan–1–yl–4–oxo–1,4–
dihydropyrimidin–2–yl)–
ureido]benzyloxy}benzyl ester (12b): 
Compound 3b (50 mg, 0.10 mmol) was treated as described above, except 
precipitation was performed in acetone to give 12b as a yellow solid (75% yield). 
FTIR (ATR): 3218, 2902, 2846, 1727, 1645, 1610, 1558, 1536, 1511, 1238, 1234, 
1109, 728. 1H NMR (CDCl3, 400 MHz): δ 13.29 (s, 1H), 12.37 (s, 1H), 12.28 (s, 1H), 
8.73 (dd, J = 7.0, 2.2 Hz, 1H), 8.32–8.30 (m, 1H), 7.73 (d, J = 8.6 Hz, 2H), 7.41–7.36 
(m, 5H), 6.98 (d, J = 8.6 Hz, 2H), 5.97 (s, 1H), 5.32 (s, 2H), 5.07 (s, 2H), 2.18–2.13 
(m, 3H), 1.91–1.76 (m, 12H). HRMS (ESI) calc. for C36H35N5O7F (M+H+) 668.2520, 
found 668.2548. 
 
General procedure for nucleophilic aromatic substitution on compounds 
12a and 12b, and subsequent purification using the tagged resin: To a solution of 
20 mg (32 µmol, 1 equiv) of compound 12a or 20 mg (30 µmol, 1 equiv) of 
compound 12b in chloroform were added 10 equiv of Et3N and 10 equiv of the 
amine. The mixture was stirred for 24 h. The tagged resin (10 equiv of binding sites 
relative to the amount of 12) was added to the crude mixture, and the flask was put in 
a shaking apparatus for 16 h. The solvent was filtered off, and the resin was washed 
with CHCl3. After transferring the resin to a flask, a 2:1 mixture of DMF:MeOH was 
added, and the mixture was shaken for 3 h. The solvent was filtered off and 
evaporated to give the desired compound with high purity and yield as indicated in 
table 1. 
 
 
4–(4–(3–(6–(heptan–3–yl)–4–oxo–1,4–
dihydropyrimidin–2–
yl)ureido)benzyloxy)benzyl 4–
(allylamino)–3–nitrobenzoate (13a): mp. 
Decomposition above 200 °C. FTIR (ATR): 3373, 2924, 1697, 1619, 1506, 1256, 
1217, 1096, 1014, 798, 759. 1H NMR (CDCl3, 400 MHz): δ 13.12 (s, 1H), 12.31 (s, 
1H), 12.25 (s, 1H) 8.89 (dd, J = 4.4, 2.0 Hz, 1H), 8.47 (br t, J = 5.3 Hz, 1H), 8.07–
8.03 (m, 1H), 7.71 (d, J = 8.5 Hz, 2H), 7.41–7.30 (m, 3H), 6.96 (dd, J = 8.8, 2.2 Hz, 
2H), 6.83 (d, J = 9.1 Hz, 2H), 5.98–5.89 (m, 2H), 5.33–5.27 (m, 4H), 5.01 (s, 2H), 
4.04–4.01 (m, 2H), 2.39–2.32 (m, 1H), 1.73–1.57 (m, 4H), 1.35–1.24 (m, 4H), 0.92 
(t, J = 7.3 Hz, 3H), 0.88 (t, J = 7.2 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 173.1, 
165.0, 158.9, 155.8, 154.8, 147.6, 136.4, 132.3, 131.5, 130.1 (2C), 129.5, 128.9, 
128.6, 128.4, 128.2 (2C), 120.9, 120.7, 117.7 (2C), 115.0 (2C), 113.8, 106.6, 77.2, 
69.8, 69.7, 66.6, 45.4, 32.9, 29.7, 29.3, 26.7, 22.5, 13.9, 11.7. 
 
4–Allylamino–3–nitrobenzoic acid 4–{4–
[3–(6–adamantan–1–yl–4–oxo–1,4–
dihydropyrimidin–2–yl)–
ureido]benzyloxy}benzyl ester (13b): mp. 
178 °C. FTIR (ATR): 3369, 2902, 2846, 
1697, 1623, 1511, 1282, 1217, 1109, 1009, 815, 759. 1H NMR (CDCl3, 400 MHz): δ 
13.29 (s, 1H), 12.37 (s, 1H), 12.26 (s, 1H), 8.90 (d, J = 2.0 Hz, 1H), 8.47 (s, 1H), 8.05 
(dd, J = 9.1, 1.9 Hz, 1H), 7.49 (d, J = 8.4 Hz, 2H), 7.40 (d, J = 8.4 Hz, 2H), 7.36 (d, J 
= 8.6 Hz, 2H), 6.97 (d, J = 8.6 Hz, 2H), 6.83 (d, 9.2 Hz, 1H), 5.97 (s, 1H), 5.97–5.89 
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(m, 1H), 5.31 (d, J = 16.0 Hz, 2H), 5.27 (s, 2H), 5.05 (s, 2H), 4.02 (t, J = 5.4 Hz), 
2.15 (br s, 3H), 1.89–1.75 (m, 12H). HRMS (FAB): Mass calc. for C39H41N6O7 
(M+H+) 705.3037, found 705.3029. 
 
3–Nitro–4–prop–2–ynylaminobenzoic 
acid 4–(4–{3–[6–(1–ethylpentyl)–4–oxo–
1,4–dihydro–pyrimidin–2–
yl]ureido}benzyloxy)benzyl ester (14a): 
FTIR (ATR): 2954, 2924, 2868, 1718, 1692, 1649, 1619, 1571, 1511, 1316, 1216, 
1113, 1009, 910, 819, 806, 741. 1H NMR (CDCl3, 400 MHz): δ 13.12 (s, 1H), 12.32 
(s, 1H), 12.27 (s, 1H), 8.91 (d, J = 1.7 Hz, 1H), 8.43 (br t, J = 5.3 Hz, 1H), 8.14 (dd, J 
= 8.9, 1.4 Hz, 1H), 7.72 (d, J = 8.3 Hz, 2H), 7.41 (d, J = 7.7 Hz, 2H), 7.37 (d, J = 8.1 
Hz, 2H), 6.98 (d, J = 8.6 Hz, 2H), 5.94 (s, 1H), 5.29 (s, 2H), 5.06 (s, 2H), 4.17 (d, J = 
5.7 Hz, 2H), 2.37–2.32 (m, 2H), 1.72–1.58 (m, 4H), 1.35–1.24 (m, 4H), 0.92 (t, J = 
7.2 Hz, 3H), 0.89 (t, J = 7.1 Hz, 3H). 13C NMR (CDCl3, 75 MHz): δ 172.66, 164.53, 
158.60, 155.49, 154.47, 146.29, 137.63, 136.32, 132.16, 130.26, 129.97, 129.17, 
128.02, 120.73, 115.01, 114.88, 113.55, 106.48, 77.98, 72.94, 69.83, 67.68, 66.74, 
45.59, 33.11, 32.94, 29.87, 29.52, 26.86, 22.70, 14.13, 11.96. HRMS (FAB): Mass 
calc. for C36H39N6O7 (M+H)+ 667.2880, found 667.2876. 
 
4–(4–Methoxybenzylamino)–3–
nitrobenzoic acid 4–(4–{3–[6–(1–
ethylpentyl)–4–oxo–1,4–
dihydropyrimidin–2–
yl]ureido}benzyloxy)benzyl ester (16a): FTIR (ATR): 3373, 3045, 2954, 2829, 
1697, 1649, 1618, 1576, 1511, 1325, 1264, 1217, 1109, 1009, 910, 798, 737. 1H 
NMR (CDCl3, 400 MHz): δ 13.12 (s, 1H), 12.31 (s, 1H), 12.27 (s, 1H), 8.91 (d, J = 
1.5 Hz, 1H), 8.70 (br t, J = 5.5 Hz, 1H), 8.00 (dd, J = 9.0, 2.0 Hz, 1H), 7.72 (d, J = 
8.4 Hz, 2H), 7.40 (d, J = 8.4 Hz, 2H), 7.35 (d, J = 8.5 Hz, 2H), 7.30–7.28 (m, 1H), 
6.96 (d, J = 8.4 Hz, 2H), 6.92–6.82 (m, 4H), 5.94 (s, 1H), 5.26 (s, 2H), 5.05 (s, 2H), 
4.55 (d, J = 5.6 Hz, 2H), 3.79 (s, 3H), 2.38–2.32 (m, 1H), 1.75–1.58 (m, 4H), 1.43–
1.24 (m, 4H), 0.92 (t, J = 7.3 Hz, 3H), 0.88 (t, J = 7.2 Hz, 3H). 13C NMR (CDCl3, 75 
MHz): δ 172.65, 164.60, 159.84, 158.57, 155.48, 154.49, 147.22, 137.80, 137.62, 
136.25, 132.15, 131.48, 130.11, 129.93, 129.28, 128.24, 128.02, 120.70, 119.02, 
117.72, 114.84, 113.78, 112.99, 112.68, 106.47, 69.82, 66.63, 55.33, 47.30, 45.57, 
33.09, 29.51, 26.85, 22.69, 14.12, 11.95. HRMS (FAB): Mass calc. for C41H45N6O8 
(M+H)+ 749.3299, found 749.3309. 
 
4–(Allylamino)–3–nitrobenzoic acid (19): Compound 13a (9.8 mg, 
14.6 µmol) or was dissolved in TFA/H2O (2 mL, 95:5 v/v) and stirred 
for 90 min. The solvent was evaporated, and the residue was taken up 
in 20 mL of CHCl3. To the resulting solution 0.50 g of the tagged 
resin was added (0.14 mmol AT–groups), and the mixture was shaken gently 
overnight. After filtering off the resin, the filtrate was evaporated to give 19 (3.2 mg, 
>99%) as a yellow solid. Compound 13b was treated in a similar fashion to give 19 in 
quantitative yield as well. FTIR (ATR): 3343, 3101, 2902, 2855, 1675, 1614, 1563, 
1537, 1437, 1364, 1277, 1230, 1152, 1083, 932, 759, 703, 543, 521. 1H NMR 
(DMSO–d6, 400 MHz): δ 8.65 (t, J = 5.9 Hz, 1H), 8.58 (d, J = 2.1 Hz, 1H), 7.91 (dd, 
J = 9.0, 1.7 Hz, 1H), 6.98 (d, J = 9.1 Hz, 1H), 5.93–5.84 (m, 1H), 5.21–5.13 (m, 2H), 
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4.08–4.05 (m, 2H). 13C NMR (DMSO–d6, 75 MHz): δ 165.8, 147.2, 135.7, 133.8, 
130.5, 128.3, 117.1, 116.2, 115.0, 44.5. 
 
3–Nitro–4–(prop–2–ynylamino)benzoic acid (20): Treatment of 
compound 14b with TFA/H2O as described above, gave acid 20 in 
quantitative yield. FTIR (ATR): 3356, 3291, 3084, 2958, 2816, 
1675, 1610, 1563, 1532, 1433, 1411, 1273, 1217, 1156, 923, 764, 
681, 646. 1H NMR (DMSO–d6, 400 MHz): δ 8.69 (t, J = 5.9 Hz, 1H), 8.62 (d, J = 2.1 
Hz, 1H), 8.04 (dd, J = 9.0, 2.0 Hz, 1H), 7.16 (d, J = 9.1 Hz, 1H), 4.28 (dd, J = 5.9, 2.4 
Hz 2H), 3.25 (t, J = 2.4 Hz, 1H). 13C NMR (DMSO–d6, 75 MHz): δ 165.8, 146.2, 
135.9, 131.2, 128.2, 117.9, 115.0, 79.9, 74.3, 32.0. 
 
4–(4–Methoxybenzylamino)–3–nitrobenzoic acid (21): 
Treatment of compound 16b with TFA/H2O as described 
above, gave acid 21 in quantitative yield. A pure sample of 21 
was obtained after filtration over a short silica plug (86% 
yield). FTIR (ATR): 3360, 2950, 2920, 2850, 1718, 1619, 1454, 1437, 1260, 1212, 
1156, 1044. 1H NMR (DMSO–d6, 400 MHz): δ 8.99 (t, J = 6.1 Hz, 1H) 8.60 (d, J = 
2.1 Hz, 1H), 7.86 (dd, J = 9.1, 2.1 Hz, 1H), 7.23 (t, J = 7.1 Hz, 1H), 6.96–6.79 (m, 
4H), 4.63 (d, J = 6.1 Hz, 2H), 3.70 (s, 3H). 13C NMR (DMSO–d6, 75 MHz): δ 165.8, 
159.5, 147.1, 139.5, 135.8, 130.8, 129.7, 128.3, 118.9, 117.4, 115.0, 112.7, 112.4, 
56.0, 54.9. 
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Chapter 5 
 
PURIFICATION OF U–4CR PRODUCTS 
 
 
5.1  Introduction 
 
With our newly established, viable method to isolate UPy–tagged compounds 
in hand, the possibilities of applying this purification technique in organic synthesis 
could be explored. Two different areas of research that have been of interest to many 
scientists during the last decades were chosen. In Chapter 6 a recycling procedure for 
catalysts, based on the AT–methodology, will be described. In this Chapter, we focus 
on multicomponent reactions (MCRs), a useful and efficient approach often used in 
library synthesis.1 
Among the MCRs, especially those involving isocyanides as reactive species 
are often used in the pharmaceutical industry in the preparation of libraries, consisting 
of lowmolecular, drug–like compounds. Since in a multicomponent approach with a 
limited number of starting materials a large variety of products can be obtained, many 
medicinally relevant compounds can in principle be obtained in a relatively short 
period of time. 
In 1959, Ugi and coworkers described a novel MCR, which has become the 
most important variant of a four–component reaction, known as the Ugi four–
component reaction (U–4CR, Figure 1).2  
 
R4 NH2
R1 OH
O
R2 H
O
R3 N C
NR1
O
R4
R2
N
H
O
R3
 
 
Figure 1: The Ugi four–component reaction (U–4CR). 
 
This versatile MCR has been studied extensively since, and applications in 
organic synthesis include the formation of peptides,3 glycopeptides,4 β–lactams,5 
iminohydantoins6 and other biologically active compounds. 
The mechanism of the U–4CR involves four equilibria, and one final acyl–
rearrangement (Figure 2). First, a condensation of the amine and the aldehyde takes 
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place (step 1). In the second stage the resulting Schiff–base is protonated by the 
carboxylic acid, after which a nucleophilic attack by the isocyanide can take place 
(step 2 and 3). Next, the carboxylic acid attacks the nitrile to establish the final 
equilibrium (step 4), and this sets the stage for the acyl transfer (step 5), which is the 
reason that all equilibria fully shift to the product side. 
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Figure 2: Mechanism of the U–4CR. 
 
In this Chapter, we will detail investigations to examine whether the UPy–
based AT – despite its previously observed incompatibility with many reagents as 
shown in previous chapters – is compatible with the U–4CRs. In addition, we aimed 
to use our affinity protocol in the purification of the derived Ugi–products and thus 
further demonstrate its viability in parallel synthesis procedures. In such an approach, 
obviously one of the four starting components needs to be connected to the AT. 
Similar to solid phase procedures,7 the other three components can be added in large 
excess to force the multicomponent reaction to go to completion, since in the 
purification process the residual starting material can be easily washed away. 
Automation of this process is feasible, so that our AT–purification methodology may 
become a valuable tool in combinatorial synthesis. 
To become acquainted with Ugi’s multicomponent procedure, a few standard 
U–4CRs were carried out, using different isocyanides. 
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5.2  Initial U–4C reactions 
 
Although isocyanides have been known for over 150 years, they have been 
studied only sporadically during the first century of this period. The fact that most 
volatile isocyanides spread a strong, strange odour probably played a role. Nowadays, 
still not many isocyanides are commercially available, but numerous publications 
have occurred on synthetic procedures to make these compounds. Most of them 
involve a dehydration of N–formamides using POCl38 or phosgene9,10 since these 
reactions are usually high–yielding. Thus, in order to obtain isocyanides by one of 
these procedures, the corresponding N–formamides had to be synthesised first 
(Scheme 1). 
Three benzylamine derivatives (1a–1c) were treated with neat ethyl formate to 
give the corresponding benzyl–substituted N–formamides 2a–2c in high yields. 
 
NH2
R
N
H
R
H
O
R
N CEthylformate
0 °C to rt, 18 h
1 2 3
a: R=F
b: R=Cl
c: R=OMe
a: 98%
b: 79%
c: 84%
POCl3, iPr2NH
a: >99%
b: >99%
c:   79%
CH2Cl2
0 °C to rt
 
 
Scheme 1: Synthesis of isocyanides 3. 
 
Since the products crashed out from solution, only filtration and washing was 
sufficient to obtain the pure compounds. Dehydration of the N–formamides was 
performed using POCl3 and diisopropylamine according to a literature procedure,8 
and the resulting isocyanides 3a–3c were isolated in good to excellent yields.  
With these isocyanides in hand, the first U–4CR could be performed. The 
commercially available starting materials 4–6 were chosen (Scheme 2). n–Butylamine 
(6) and benzaldehyde (5) were precondensed in methanol to give the Schiff base prior 
to the addition of benzoic acid (4) and isocyanides 3, which is a common modus 
operandi to improve yields and suppress side product formation.1a 
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Scheme 2: Initial Ugi four–component reactions. 
 
Methanol was our solvent of choice, because a polar solvent is needed when, 
in later experiments, a UPy–tag is attached to one of the components. Although it is 
known that the addition of mol sieves or other water–binding agents can improve 
yields as well,11 in this case reaction products 7a–7c could be isolated in satisfying to 
good yields without further tweaking of reaction conditions. These results once more 
illustrate the ease of access to libraries of biologically interesting compounds using 
the U–4CR. 
 
5.3  Affinity purification of Ugi–products 
 
To be able to use our affinity methodology in the purification of products 
derived from Ugi–reactions, one of the four starting compounds must carry the UPy–
tag. We decided to equip a benzoic acid derivative with the affinity label, via a 
straightforward two–step procedure (Scheme 3). (2–Ethyl)pentyl–substituted 
isocytosine 8 was treated with carbonyl diimidazole12 in a similar fashion as 
described in previous chapters of this thesis, followed by the addition of benzylamine 
derivative 9 to quench the activated isocytosine, yielding compound 10 in 64% yield. 
Subsequent saponification of the methyl ester provided the UPy–tagged acid 11 in 
almost quantitative yield, thereby delivering a UPy–labelled starting compound for 
the intended Ugi transformations. 
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Scheme 3: Synthesis of tagged acid 11. 
 
When acid 11 was subjected to the conditions described above, in the 
presence of an amine, an aldehyde and an isonitrile (Scheme 4), compounds 12 to 16 
were obtained in satisfying to good yields. This clearly shows that the outcome of U–
4CRs is not influenced by the presence of the UPy–AT, which is an absolute 
requirement for our purposes. However, due to the the rather poor solubility 
properties of the UPy–tagged starting compound 11, a 1:1 mixture of methanol and 
chloroform had to be used as the solvent. 
 
N
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O N
H
N
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O N
H
N
H
O
N
O
R
R1
N
H
O
R2
R NH2
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R2 NC
MeOH, CHCl3 
(1:1 v/v)
3d, rt
75%-89%
12-16  
 
Scheme 4: Ugi four–component reactions with UPy–labelled acid 11. 
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Ugi products 12 to 16 were purified by both column chromatography (CC) 
and affinity separation (AS).  
 
Table 1: Comparison between CC and AS on Ugi product purification. 
 
Compound R1 R2R
12
13
14
15
16
Yield (%)
CC AS
MeO
MeO
77 83
82 87
84 89
76 84
75 84
 
 
As can be read from Table 1, the difference in yields between the two 
purification methods proved to be small, but always in favour of the latter technique. 
 
       
 
Figure 3: 1H–spectra of compound 16 after purification by CC (left) and AS (right). 
 
The purity of the products appeared to be similar (vid. Figure 3), albeit that in 
some cases the compounds that were purified using affinity separation occurred to be 
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slightly yellow, whereas the products purified by column chromatography were 
always colourless. Simple treatment of these yellow products with activated carbon 
was sufficient to yield colourless compounds after AS as well. 
These results show that affinity purification based on the AT–methodology 
can be applied in a combinatorial fashion to obtain libraries of small, dipeptide like 
compounds.  
 
5.4  Conclusions 
 
From initial experiments on the U–4CR it can be concluded that this reaction 
provides a facile entry for the synthesis of dipeptide like libraries, under conditions 
that are suitable for the application of our new purification technique.  
Ugi–products were isolated in satisfying to good yields when one on the four starting 
compounds was equipped with a UPy tag. This indicates that the presence of an 
affinity label – at least at the benzoic acid component – does not have any influence 
on the outcome of the conducted Ugi–reactions, which confirms that the first 
requirement for the successful application of our UPy–based purification protocol on 
these types of compounds was met. 
Compounds 12 to 16 were therefore purified both by standard column 
chromatography and affinity purification. During the latter, a UPy–tagged resin was 
directly added to the crude mixture to abstract the product from solution, as described 
earlier. Yields were slightly higher than using traditional purification, and the purity 
of the derived compounds was comparable. With this outcome of the conducted 
experiments in hand, we can state that we have successfully incorporated our new 
purification technique in library synthesis, providing a new tool to obtain biologically 
interesting compounds in a fast and straightforward manner. 
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5.6  Experimental section 
 
N–(4–Fluorobenzyl)formamide (2a): To 4–fluoro–benzylamine 
(1.83 mL, 16.0 mmol) was added ethylformiate (1.58 mL, 19.5 mmol) 
at 0 °C. After 2h of stirring at 0 °C, the mixture was allowed to come 
to rt, and was stirred for an additional 16h. The product was filtered off, washed with 
cold hexane and dried to give the desired formamide 2a (2.41 g, 98%) as colourless 
needles. mp: 78 °C. FTIR (ATR): 3271, 3038, 2890, 2757, 1648, 1535, 1508, 1383, 
1157, 830, 803, 694. 1H NMR (CDCl3, 200 MHz): δ 8.22 (s, 1H), 7.25–7.21 (m, 2H), 
7.06–6.97 (m, 2H), 5.94 (br s, 1H), 4.43 (d, J = 5.8 Hz, 2H). 13C NMR (CDCl3, 75 
MHz): δ 163.7, 161.1, 133.4, 129.2 (2C), 115.3 (2C), 41.2. HRMS (EI) calcd. for 
C8H8NOF (M+) 153.0590, found 153.0597. 
 
N–(4–Chlorobenzyl)formamide (2b): 4–chloro–benzylamine (1.71 
g, 12.1 mmol) was treated as described above to give formamide 2b 
(79%) as a white solid. mp: 108 °C. FTIR (ATR): 3270, 3025, 2892, 
1646, 1530, 1487, 1382, 1226, 1090, 1012, 821, 759. 1H NMR (CDCl3, 300 MHz): δ 
8.20 (s, 1H), 7.27 (d, J = 8.1 Hz, 2H), 7.17, (d, J = 7.8 Hz, 2H), 6.18 (br s, 1H), 4.40 
(d, J = 5.8 Hz, 2H). 13C NMR (CDCl3, 75 MHz): δ 160.7, 135.9, 133.2, 128.8 (2C), 
128.6 (2C), 41.5. HRMS (EI) calcd. for C8H8NO37Cl (M+) 171.0265, found171.0272. 
 
N–(4–Methoxybenzyl)formamide (2c): 4–methoxy–benzylamine 
(4.34 mL, 33.3 mmol) was treated as described above to give 
formamide 2c (84%) as colourless needles. mp: 79 °C. FTIR (ATR): 
3278, 3005, 2884, 2830, 1642, 1510, 1378, 1241, 1214, 1179, 1031, 825. 1H NMR 
(CDCl3, 300 MHz): δ 8.16 (s, 1H), 7.17 (d, J = 8.2 Hz, 2H), 6.82, (d, J = 8.3 Hz, 2H), 
6.12 (br s, 1H), 4.35 (d, J = 5.6 Hz, 2H), 3.77 (s, 3H). 13C NMR (CDCl3, 75 MHz): δ 
160.6, 129.5, 128.9 (2C), 128.0, 113.9 (2C), 55.3, 41.7. HRMS (EI) calcd. for 
C9H11NO2 (M+) 165.0790, found 165.0798. 
 
1–Fluoro–4–(isocyanomethyl)benzene (2a): To a solution of 2a 
(1.00 g, 6.53 mmol) and diisopropylamine (1.84 mL, 13.1 mmol) in 
CH2Cl2 (20 mL) at 0 °C, was carefully added POCl3 (0.67 mL, 7.2 
mmol). The resulting mixture was stirred at 0 °C for 1 h, then warmed to rt slowly 
and stirred for 2 h. Aqueous NaHCO3 (20 mL) was added, and the mixture was stirred 
for 30 min. The layers were separated, and the aqueous phase was extracted with 
CH2Cl2 (2 × 15 mL). The combined organic layers were washed with brine, dried and 
evaporated to give isocyanide 3a (882 mg, >99%) as a light yellow oil, which was 
used in the following experiments without further purification. 1H NMR (CDCl3, 200 
MHz): δ 7.36–7.26 (m, 2H), 7.15–7.05 (m, 2H), 4.61 (br s, 2H). 
 
1–Chloro–4–(isocyanomethyl)benzene (3b): Formamide 2b (1.00 g, 
5.91 mmol) was treated as described above to give isocyanide 3b as a 
light yellow oil in quantitative yield. 1H NMR (CDCl3, 200 MHz): δ 
7.36–7.26 (m, 2H), 7.15–7.05 (m, 2H), 4.62 (br s, 2H). 
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1–(Isocyanomethyl)–4–methoxybenzene (3c): Formamide 2c (1.00 
g, 6.06 mmol) was treated as described above to give isocyanide 3c 
as a light yellow oil in 79% yield. 1H NMR (CDCl3, 200 MHz): δ 
7.28–7.23 (m, 2H), 6.94–6.87 (m, 2H), 4.55 (br s, 2H), 3.80 (s, 3H). 
 
N–Butyl–N–(2–(4–fluorobenzylamino)–2–oxo–1–
phenylethyl)benzamide (7a): To a solution of n–butylamine 
(50 mg, 0.68 mmol) in MeOH (5 mL) was added 
benzaldehyde (72 mg, 0.68 mmol), and the resulting solution 
was stirred for 2 h at rt. Then, benzoic acid (83 mg, 0.68 
mmol) and 2a (92 mg, 0.68 mmol) were added, and the mixture was stirred for 5 days 
at rt. The solvent was removed in vacuo, and the residue was dissolved in H2O/EtOAc 
(30 mL, 1:1 v/v). The layers were separated, and the aqueous phase was back 
extracted with EtOAc (15 mL). The combined organic layers were washed with a 
saturated aqueous NaHCO3, dried (MgSO4) and evaporated to give a yellow oil. This 
oil was purified by column chromatography (30% EtOAc in heptane) to give 7a (221 
mg, 78%) as a white solid. mp. 129 °C. FTIR (ATR): 3270, 3054, 2950, 2928, 2872, 
1658, 1627, 1558, 1506, 1442, 1411, 1308, 1217, 1156, 824, 724, 698, 655, 569. 1H 
NMR (CDCl3, 400 MHz): δ 7.44–7.35 (m, 10H), 7.22 (dd, J = 8.3, 5.5 Hz, 2H), 6.97 
(app. t, J = 8.7 Hz, 2H), 5.77 (br s, 1H), 4.42 (d, J = 5.4 Hz, 2H), 3.31–3.19 (m, 2H), 
1.136–1.23 (m, 1H), 0.96–0.88 (m, 3H), 0.57 (br s, 3H). 13C NMR (CDCl3, 75 MHz): 
δ 172.7, 169.7, 136.5, 135.2, 133.3 (2C), 129.5 (2C), 129.4, 129.3, 129.1 (2C), 128.8 
(2C), 128.5 (2C), 126.4 (2C), 115.5 (2C), 63.8, 48.9, 42.8, 31.3, 19.7, 13.3. HRMS 
(EI) calcd. for C26H27N2O2F (M+) 418.2057, found 418.2056. 
 
N–Butyl–N–(2–(4–chlorobenzylamino)–2–oxo–1–
phenylethyl)benzamide (7b): Compound 3b was treated as 
described above to give 7b as a white solid in 85% yield. mp. 
116 °C. FTIR (ATR): 3261, 3062, 2954, 2928, 2872, 1653, 
1632, 1553, 1489, 1441, 1407, 1312, 1091, 1014, 733, 702, 
560. 1H NMR (CDCl3, 400 MHz): δ 7.41–7.34 (m, 10 H), 7.24 (d, J = 8.4 Hz, 2H), 
7.16 (d, J = 8.2 Hz, 2H), 5.81 (br s, 1H), 4.37 (d, J = 5.8 Hz, 2H) 3.32–3.18 (m, 2H), 
1.32–1.22 (m, 1H), 0.95–0.77 (m, 3H), 0.55 (br s, 3H). 13C NMR (CDCl3, 75 MHz): δ 
172.7, 169.8, 136.7, 136.4, 135.1, 132.9, 129.5 (2C), 129.1 (2C), 128.9 (2C), 128.7 
(2C), 128.6 (2C), 128.5, 128.4, 126.4 (2C), 63.5, 48.7, 42.8, 31.3, 19.7, 13.2. HRMS 
(EI) calcd. for C26H27N2O2Cl (M+) 434.1761, found 434.1745. 
 
N–Butyl–N–(2–(4–methoxybenzylamino)–2–oxo–1–
phenylethyl)benzamide (7c): Compound 3c was treated as 
described above to give 7c as a white solid in 60% yield. 
mp. 111 °C. FTIR (ATR):3257, 3058, 2954, 2933, 2868, 
1653, 1632, 1554, 1515, 1442, 1407, 1299, 1247, 1174, 
1100, 1035, 819, 733, 703, 659, 577. 1H NMR (CDCl3, 400 MHz): δ 7.39–7.34 (m, 10 
H), 7.18 (d, J = 8.5 Hz, 2H), 6.83 (d, J = 8.6 Hz, 2H), 5.79 (br s, 1H), 4.41 (d, J = 4.6 
Hz, 2H) 3.77 (s, 3H), 3.27–3.22 (m, 2H), 1.30–1.24 (m, 1H), 0.96–0.86 (m, 3H), 0.57 
(br s, 3H). 13C NMR (CDCl3, 75 MHz): δ 172.7, 169.5, 158.9, 136.5, 135.2, 130.1, 
129.4, 129.2 (2C), 129.0, 128.7 (2C), 128.6, (2C), 128.4 (2C), 126.4 (2C), 113.9 (2C), 
63.7, 55.2, 48.8, 43.1, 31.1, 13.3. HRMS (EI) calcd. for C27H30N2O3 (M+) 430.2257, 
found 430.2247. 
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Methyl 4–(aminomethyl)benzoate (9): To a stirring solution of 4–
aminomethyl–benzoic acid (15.0 g, 99.2 mmol) in methanol (400 
mL) was added of thionyl chloride (15.3 mL, 210 mmol) dropwise at 
0 °C. The mixture was warmed to rt slowly, and was stirred for 16 h. Evaporation of 
the solvent gave the HCl salt of 9 (>99%) as a white, crystalline solid. Spectral 
properties were identical to those reported earlier.13 
 
Methyl 4–((3–(6–(heptan–3–yl)–4–oxo–1,4–
dihydropyrimidin–2–yl)ureido)methyl)benzoate (10): To 
a stirring solution of ethylpentyl–isocytosine 8 (3.00 g, 14.3 
mmol) in DMF (75 mL) were added Et3N (6.1 mL, 35 
mmol), carbonyl diimidazole (2.55 g, 15.7 mmol) and a 
catalytic amount of DMAP. The mixture was stirred for 2 h at rt, then amine 9 (HCl 
salt, 5.86 g, 29.0 mmol) and Et3N (5.2 mL, 30 mmol) were added. The mixture was 
stirred for an additional 20 h at rt, and the solvent was removed under reduced 
pressure. The residue was taken up in H2O/CH2Cl2 (250 mL, 1:1 v/v), and the layers 
were separated. The aqueous phase was back extracted with CH2Cl2 (2 × 100 mL), 
and the combined organic layers were washed with aqueous NH4Cl (150 mL), dried 
(MgSO4), and evaporated to give a light yellow solid. Precipitation in Et2O gave 
compound 10 (3.64, 64%) as a white solid. FTIR (ATR): 2951, 2931, 2853, 1720, 
1693, 1650, 1572, 1522, 1276, 1253, 1105, 848, 786. 1H NMR (CDCl3, 400 MHz): δ 
13.07 (s, 1H), 12.11 (s, 1H), 10.96 (t, J = 5.6 Hz, 1H), 8.00 (d, J = 8.1 Hz, 2H), 7.44 
(d, J = 8.1 Hz, 2H), 5.81 (s, 1H), 4.51 (d, J = 5.8 Hz, 2H), 3.89 (s, 3H), 2.31–2.27 (m, 
1H), 1.69–1.49 (m, 4H), 1.33–1.18 (m, 4H), 0.89 (t, J = 7.4, 3H), 0.52 (t, J = 7.4, 3H). 
13C NMR (CDCl3, 75 MHz): δ 172.7, 166.5, 156.6, 155.3, 154.3, 143.7, 129.6 (2C), 
128.7, 127.0 (2C), 106.1, 52.0, 45.4, 43.2, 32.9, 29.4, 26.7, 22.6, 14.0, 11.9. 
 
4–{3–[6–(1–Ethylpentyl)–4–oxo–1,4–dihydropyrimidin–
2–yl]–ureidomethyl}benzoic acid (11): Compound 10 (400 
mg, 1.00 mmol) was dissolved in aqueous NaOH (2M)/THF 
(10 mL, 1:1 v/v). The mixture was heated to 50 °C overnight, 
and then concentrated in vacuo. The resulting solution was 
then carefully acidified using concentrated HCL, upon which 
a white solid precipitated from solution. The white solid was filtered off, washed with 
water and dried in vacuo to give desired acid 11 (379 mg, 97%) in pure form. mp: 
164 °C. FTIR (ATR): 2955, 2928, 2861, 1691, 1650, 1575, 1523, 1422, 1258, 850, 
738. 1H NMR (DMSO–d6, 400 MHz): δ 8.26 (br s, 1H), 7.91 (d, J = 8.3 Hz, 2H), 7.42 
(d, J = 8.3 Hz, 2H), 5.75 (s, 1H), 4.45 (d, J = 5.8 Hz, 2H), 2.24–2.17 (m, 1H), 1.47–
1.36 (m, 4H), 1.25–1.02 (m, 4H), 0.79 (t, J = 7.1 Hz, 3H), 0.72 (t, J = 7.4 Hz, 3H). 
13C NMR (DMSO–d6, 75 MHz): δ 170.2, 167.0, 161.6, 154.7, 151.7, 144.0, 129.5, 
129.4 (2C), 127.1 (2C), 104.9, 47.6, 42.5, 32.9, 29.0, 26.4, 22.1, 13.8, 11.7. HRMS 
(ESI): Mass calculated for C20H27N4O4 (M+H)+ 387.20323, found 387.20248. 
 
 General procedure for the purification of compounds 12 to 16 by affinity 
separation: To a solution of 1 equiv of compounds 12 to 16 in chloroform were 
added 10 equiv of Et3N and 10 equiv of the amine. The mixture was stirred for 24 h. 
The tagged resin (10 equiv of binding sites relative to the amount of 12 to 16) was 
added to the crude mixture, and the flask was put in a shaking apparatus for 16 h. The 
solvent was filtered off, and the resin was washed with CHCl3. After transferring the 
resin to a flask, a 2:1 mixture of DMF:MeOH was added, and the mixture was shaken 
for 3 h. The solvent was filtered off and evaporated to give the desired compound 
with high purity and yield as indicated in table 1. 
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N–(1–tert–Butylcarbamoylpentyl)–4–{3–[6–(1–
ethylpentyl)–4–oxo–1,4–dihydropyrimidin–2–yl]–
ureidomethyl}–N–prop–2–ynylbenzamide (12): A 
mixture of 14 mg (0.25 mmol) of propargyl amine, 21 
mg (0.25 mmol) of tert–butyl isocyanide, 22 mg (0.25 
mmol) of pentanal and 39 mg (0.10 mmol) of acid 11 
in MeOH/CHCl3 (1:1 v/v) was stirred for 3 days. The solvent was evaporated, and the 
residue was purified by column chromatography (1→3% MeOH in CHCl3) to give 
the desired adduct in 77% yield as a colourless oil, or purified with the tagged resin 
(83% yield). FTIR (ATR) : 3309, 3218, 2954, 2924, 2872, 1697, 1949, 1580, 1519, 
1450, 1411, 1308, 1251, 845, 728, 603. 1H NMR (CDCl3, 400 MHz): δ 13.09 (s, 1H), 
12.11 (s, 1H), 10.93 (t, J = 4.8 Hz, 1H), 7.61–7.51 (br s, 2H), 7.45 (d, J = 8.0 Hz, 
2H), 6.51–6.37 (br s, 1H), 5.81 (s, 1H), 4.80–4.70 (br s, 1H), 4.50 (d, J = 5.8 Hz, 2H), 
4.23–4.08 (m, 1H), 4.02–3.89 (m, 1H), 2.33–2.24 (m, 1H), 2.27 (t, J = 2.4 Hz, 1H), 
2.07–1.93 (m, 2H), 1.72–1.47 (m, 6H), 1.38–1.17 (m, 6H), 1.33 (s, 9H), 0.90–0.84 
(m, 9H). 13C NMR (CDCl3, 75 MHz): δ 173.1, 169.6, 162.6, 156.8, 155.6, 154.6, 
141.4, 133.9 (2C), 127.5 (2C), 106.2, 80.1, 72.7, 59.1, 51.1, 45.3, 43.1, 37.0, 36.4, 
32.8, 29.2, 28.6, 28.5, 27.9, 26.5, 22.4, 13.9, 13.8, 11.6. HRMS (ESI): Mass 
calculated for C33H48N6O4Na (M+Na)+ 615.36347, found 615.35991. 
 
N–(1–Cyclohexylcarbamoylpentyl)–4–{3–[6–(1–
ethylpentyl)–4–oxo–1,4–dihydropyrimidin–2–yl]–
ureidomethyl}–N–prop–2–ynylbenzamide (13): A 
mixture of 39 mg (0.10 mmol) of acid 11, 14 mg 
(0.25 mmol) of propargyl amine, 27 mg (0.25 
mmol) of cyclohexyl isocyanide, and 22 mg (0.25 
mmol) of pentanal was treated as described above to give 51 mg (82% yield) of the 
wanted adduct as a colourless oil by column chromatography, and 54 mg (87%) as a 
light yellow oil by resin purification. FTIR (ATR): 3304, 3228, 3023, 2954, 2929, 
2855, 1695, 1655, 1640, 1583, 1527, 1446, 1411, 1305, 1254, 851, 806, 731, 668, 
649. 1H NMR (CDCl3, 400 MHz): δ 13.08 (s, 1H), 12.10 (s, 1H), 10.92 (s, 1H), 7.61–
7.51 (m, 2H), 7.43 (d, J = 7.9 Hz, 2H), 6.54 (br s, 1H), 5.81 (s, 1H), 4.79 (m, 1H), 
4.50 (d, J = 5.7 Hz, 2H), 4.20–4.09 (m, 1H), 3.99–3.88 (m, 1H), 3.79–3.70 (m, 1H), 
2.33–2.26 (m, 1H), 2.29 (t, J = 2.4 Hz, 1H), 2.07–1.99 (m, 2H), 1.90–1.80 (m, 2H), 
1.71–1.50 (m, 8H), 1.38–1.15 (m, 12H), 0.90–0.84 (m, 9H). 13C NMR (CDCl3, 75 
MHz): δ 173.1, 169.5, 156.9, 155.7, 154.7, 141.5, 133.9, 127.5 (2C), 127.4 (2C), 
106.3, 80.1, 72.7, 58.7, 47.9, 45.3, 43.1, 37.2, 32.8, 32.7, 29.7, 29.3, 28.5, 28.0, 26.6, 
25.5, 24.6, 22.4, 13.9, 13.8, 11.7. HRMS (ESI): Mass calculated for C35H50N6O4Na 
(M+Na)+ 641.37912, found 641.37421. 
 
N–(1–tert–Butylcarbamoyl–pent–4–enyl)–4–{3–[6–
(1–ethyl–pentyl)–4–oxo–1,4–dihydro–pyrimidin–2–
yl]–ureidomethyl}–N–prop–2–ynyl–benzamide (14): 
A mixture of 39 mg (0.10 mmol) of compound 11, 14 
mg (0.25 mmol) of 1–propargyl amine, 21 mg (0.25 
mmol) of 4–pentenal, and 21 mg (0.25 mmol) of tert–
butyl isocyanide was treated as described above, to give 
51 mg (84% yield) of the desired compound as a colourless oil by column 
chromatography, and 54 mg (89%) as a light yellow oil by resin purification. FTIR 
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(ATR): 3300, 3218, 2958, 2924, 2868, 1692, 1640, 1575, 1524, 1446, 1416, 1364, 
1308, 1247, 1143, 1022, 910, 849, 806, 728, 646. 1H NMR (CDCl3, 400 MHz): δ 
13.08 (s, 1H), 12.10 (s, 1H), 10.92 (s, 1H), 7.55 (br s, 2H), 7.45 (d, J = 8.0 Hz, 2H), 
6.42 (br s, 1H), 5.86–5.08 (m, 2H), 5.06–4.98 (m, 2H), 4.79 (m, 1H), 4.49 (d, J = 5.8 
Hz, 2H), 4.17–4.12 (m, 1H), 3.97–3.93 (m, 1H), 2.30–2.26 (m, 2H), 2.16–2.11 (m, 
4H), 1.68–1.48 (m, 4H), 1.32 (s, 9H), 1.30–1.22 (m, 4H), 0.89–0.83 (m, 6H). 13C 
NMR (CDCl3, 75 MHz): δ 172.7, 169.0, 156.6, 155.3, 154.4, 141.3, 137.1, 133.6, 
127.3 (2C), 127.2 (2C), 115.4, 106.1, 80.1, 72.9, 65.8, 58.4, 51.3, 45.4, 43.2, 37.2, 
33.0, 30.7, 29.4, 28.8 (3C), 27.6, 26.8, 22.6, 14.1, 11.9.  
 
N–(1–(tert–Butylamino)–1–oxohex–5–en–2–yl)–4–
((3–(6–(heptan–3–yl)–4–oxo–1,4–
dihydropyrimidin–2–yl)ureido)methyl)–N–(4–
methoxybenzyl)benzamide (15): A mixture of 39 mg 
(0.10 mmol) of compound 11, 34 mg (0.25 mmol) of 
4–methoxybenzyl amine, 21 mg (0.25 mmol) of 4–
pentenal, and 21 mg (0.25 mmol) of tert–butyl isocyanide was treated as described 
above, to give 51 mg (76% yield) of the desired compound as a colourless oil by 
column chromatography, and 54 mg (84%) as a light yellow oil by resin purification. 
FTIR (ATR): 3218, 3023, 2958, 2924, 2868, 1692, 1645, 1580, 1519, 1450, 1256, 
1148, 1053, 910, 845, 728. 1H NMR (400 MHz, CDCl3): δ13.07 (s, 1H), 12.07 (s, 
1H), 10.90 (s, 1H), 7.37 (br s, 4H), 7.18–7.14 (m, 1H), 6.75–6.60 (m, 4H), 5.78 (s, 
1H), 5.77–5.70 (m, 1H), 5.00–4.93 (m, 2H), 4.62–4.56 (m, 3H), 4.46–4.44 (m, 2H), 
3.74 (s, 3H), 2.31–2.24 (m, 1H), 2.14–1.83 (m, 4H), 1.69–1.48 (m, 4H), 1.33–1.13 
(m, 13H), 0.87 (t, J = 7.5 Hz, 3H), 0.85 (t, j = 7.3 Hz, 3H). 13C NMR (75 MHz, 
CDCl3): δ 173.5, 173.0, 169.3, 159.7, 156.8, 155.6, 154.6, 140.8, 137.3, 134.9, 129.6 
(2C), 127.6 (2C), 126.9 (2C), 119.6, 115.6 (2C), 113.1, 112.8, 106.2, 60.2, 55.1, 51.7, 
51.0, 45.3, 43.0, 32.8, 30.5, 29.2, 28.5 (3C), 26.5, 22.4, 13.8, 11.6. HRMS (ESI): 
Mass calculated for C38H52N6O5Na (M+Na)+ 695.38969, found 695.38388. 
 
N–(1–(Cyclohexylamino)–1–oxohex–5–en–2–yl)–
4–((3–(6–(heptan–3–yl)–4–oxo–1,4–
dihydropyrimidin–2–yl)ureido)methyl)–N–(4–
methoxybenzyl)benzamide (16): A mixture of 39 
mg (0.10 mmol) of compound 11, 34 mg (0.25 
mmol) of 4–methoxybenzyl amine, 21 mg (0.25 
mmol) of 4–pentenal and 27 mg (0.25 mmol) of cyclohexyl isocyanide was treated as 
described above, to give 51 mg (75% yield) of the desired compound as a colourless 
oil by column chromatography, and 54 mg (84%) as a light yellow oil by resin 
purification. FTIR (ATR): 3309, 3049, 2924, 2855, 1653, 1584, 1528, 1446, 1333, 
1251, 1148, 1048, 910, 728, 690. 1H NMR (400 MHz, CDCl3): δ13.06 (s, 1H), 12.06 
(s, 1H), 10.88 (s, 1H), 7.36 (br s, 4H), 7.23–7.14 (m, 1H), 6.84–6.59 (m, 4H), 5.77 (s, 
1H), 5.75–5.70 (m, 1H), 5.02–4.90 (m, 2H), 4.58–4.49 (m, 3H), 4.45–4.32 (m, 2H), 
3.73 (s, 3H), 3.62–3.58 (m, 1H), 2.31–2.23 (m, 1H), 2.15–1.49 (m, 12H), 1.32–1.00 
(m, 10 H), 0.86 (t, J = 7.5 Hz, 3H), 0.84 (t, J = 7.3 Hz, 3H). HRMS (ESI): Mass 
calculated for C40H55N6O5Na (M+H)+ 699.42339, found 699.41688. 
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Chapter 6 
 
CATALYST RECYCLING BY AFFINITY SEPARATION 
 
 
6.1  Introduction 
 
To further expand the usefulness of our affinity–based purification method, a 
second application will be discussed in this chapter. We envisioned that not only 
small organic compounds could be equipped with a hydrogen bonding affinity tag 
(AT) to allow complexation to a functionalised resin, but also transition metal–based 
catalysts could be recovered after reaction, and subsequently reused. 
The use of transition metal–based catalysts is widespread due to an 
increasingly broad applicability and generally favourable atom economy. Drawbacks, 
however, are the high prices of the metals complexes and the often laborious removal 
of these catalysts from reaction mixtures. Facile isolation of catalysts and subsequent 
reuse is therefore an attractive goal to reduce both costs and waste. As a result, the 
development of new technology for catalyst recycling has been of interest for many 
researchers in the last decades. A number of techniques to recycle metal–based 
catalysts have been developed over the years, such as covalent catalyst 
immobilisation,1 fluorous phase separation,2 nanofiltration3 and ligand 
immobilisation.4 Although significant progress has been made, there are still major 
shortcomings, including decreased activity of the catalyst, and leaching of metal ions.  
A ligand, which is used in homogeneous catalysis, is equipped with a UPy–based 
affinity tag. The ligand can be complexed to a metal, and the resulting catalyst 
(Figure 1) can be applied in a homogeneous catalytic reaction, assuming that the 
affinity tag does not affect its catalytic activity. After the catalytic reaction in an 
organic solvent, the hydrogen bonding properties of the tag allow facile isolation of 
the complex by addition of a resin bearing a complementary hydrogen bonding array. 
Similar to the procedures described in previous chapters of this thesis, a simple 
filtration separates the dissolved reaction products from the solid support that bears 
the catalyst. Upon rinsing the polymer with a protic solvent, the hydrogen bonds 
between resin and tag are cleaved and a second filtration should yield only the tagged 
metal complex, which can be directly used in the next catalytic reaction. 
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Figure 1: Concept of catalyst recycling by affinity separation. 
 
To investigate the feasibility of this catalyst recycling protocol, a generally 
used ligand was functionalised with a UPy–moiety, and standard catalysed reactions 
were performed, as will be discussed in the following sections. 
 
6.2  Synthesis of a tagged ligand 
 
The ligand of choice was 1,10–phenanthroline (phen, 1), a well–known ligand 
for Cu–mediated cross–coupling reactions.5 1,10–Phenanthroline has been 
functionalised before for immobilisation purposes, and we used the procedure 
reported by Canham et al. to obtain compound hydroxyphenanthroline 3.6 
 
N
N
1
N
N
2
N
N
HO
H2O
3
O
CHCl3/H2O (1:1 v/v)
rt, 6 h
>99%
H2SO4, 100 
oC, 1 h
NaOCl
0.5 equiv (Bu)4NHSO4
then NaOH, 5 oC
90%
 
 
Scheme 1: Functionalisation of 1,10–phenanthroline. 
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Epoxidation of 1,10–phenanthroline was achieved using aqueous sodium 
hypochlorite. During this reaction, the pH was carefully maintained between 8 and 9, 
which is necessary in order to obtain the desired epoxide 2 in high yield.7 Opening of 
this epoxide to yield hydroxyphenanthroline 3, was achieved in two steps. Firstly, the 
epoxide was opened by reacting it with sulfuric acid at 100 °C, and secondly the 
resulting diol was eliminated using sodium hydroxide and subsequent filtration to 
give the desired functionalised ligand. During the addition of aqueous sodium 
hydroxide, the temperature of the mixture was carefully monitored and kept below 5 
°C to prevent degradation of the product.6 Having equipped 1,10–phenanthroline with 
a functional group, the ligand could now be substituted with the affinity tag. It was 
decided to alkylate 3 with Boc–protected aminoethylene bromide to give compound 4 
(Scheme 2), which could be converted into tagged linker 6 in two straightforward 
steps. The alkylation procedure described by Canham proved to be low–yielding in 
this case, but switching to standard conditions using potassium carbonate as a base in 
DMF, gave the desired compound 4 in excellent yields. 
 
N
N
HO
H2O
3
N
N
O
BocHNBocHN
Br
K2CO3, DMF
rt, 16 h
94%
4
N
N
O
N
H
N
H
ONH
NO
1) TFA/CH2Cl2
     (1:2 v/v)
     rt, 10 min
2)
N
NH
O N
H
N
O
N
93% 
over 2 steps
5
6
Et3N, CHCl3
12 h
 
 
Scheme 2: Synthesis of UPy–tagged ligand 6. 
 
As anticipated, deprotection of the amino group was achieved under the 
influence of TFA, and the resulting crude amine was treated with isocytosine 
derivative 5 in a similar fashion as described in the preceding chapters of this thesis to 
give compound 6. Hence, the tagged, phenanthroline based ligand for Cu–mediated 
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coupling reactions was obtained from 4 in two well yielding steps, and studies 
towards utilisation of this ligand in catalysis could be commenced. 
 
6.3  Copper(I)–based catalyst recycling in organic synthesis 
 
6.3.1  Copper(I)–mediated tandem Sonogashira coupling/5–endo–dig cyclisation 
 
The first reaction onto which we decided to test our new concept, was the 
copper(I)–catalysed synthesis of 2–arylbenzo[b]furans developed in the group of 
Venkataraman.5a This tandem Sonogashira coupling/5–endo–dig cyclisation was 
carried out using [Cu(phen)(PPh3)2]NO3 as the catalyst, and 2 equiv of Cs2CO3 as a 
base in toluene (Figure 2). 
 
R HO
I
R' OR R'
10 mol% [Cu(phen)(PPh3)2]NO3
2 equiv Cs2CO3
toluene, 110 oC  
 
Figure 2: Synthesis of 2–aryl[b]furans by Venkataraman. 
 
After synthesising Cu(PPh3)2NO38, we performed this reaction starting from 
phenylacetylene and 2–iodophenol using the conditions described by Venkataraman 
(Scheme 3). Instead of isolating the catalyst (Cu[(phen)(PPh3)2]NO3), we prepared it 
in situ by stirring Cu(PPh3)2NO3 and 1,10–phenanthroline for 10 min prior to the 
addition of the other reactants. 
 
I
OH O
Cu[(phen)(PPh3)2]NO3
or
Cu[(uPy-Phen)(PPh3)2]NO3
7 8 9
Cs2CO3, DMF
110 oC, 24 h
isolated yield of 9
cycle 1 cycle 2 cycle 3entry catalyst
1        Cu[(phen)(PPh3)2]NO3 
2     Cu[(uPy-Phen)(PPh3)2]NO3
>99%       -            -
>99%      91%      68%
amount (mol%)
10
10  
 
Scheme 3: Comparison between standard and recycled catalysts. 
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The modified procedure did not affect the outcome of the reaction; compound 
9 was also isolated in quantitative yield. When the same procedure was used with 
tagged ligand 6 instead of 1,10–phenanthroline, compound 6 turned out to be 
insoluble in toluene, and the active complex Cu[(UPy–phen)(PPh3)2]NO3 was not 
generated. It was decided to switch to DMF as a solvent, since the UPy–equipped 
ligand 6 dissolves well in polar solvents. Again, product 9 was obtained in 
quantitative fashion using 1,10–phenanthroline, however, when in this case 
compound 6 was used as the ligand, the same excellent result was obtained. This 
shows that the AT indeed does not have any influence on the catalytic properties of 
the complex –once it is formed and dissolved– and that recycling of this tagged 
catalyst was feasible. 
To allow the affinity tag on a resin to abstract the catalyst from solution, the 
DMF was evaporated after completion of the reaction, and the residue was dissolved 
in chloroform. To this solution the tagged resin was added (10 equiv of binding sites 
on the resin, relative to the amount of catalyst), and complexation between the 
catalyst and the solid phase was again achieved upon shaking of this mixture. After 
filtering off the catalyst–bearing resin, the filtrate could be subjected to standard 
work–up and purification to give product 9, and the catalyst was recovered after 
treatment of the resin with a protic cocktail as described earlier. 
The recovered catalyst was then dissolved in DMF, and used in a second 
reaction with the same amount of starting materials. In this case, compound 9 was 
isolated in 91% yield, which indicates that the catalyst was successfully recycled. The 
small difference in isolated yield of 9 can be explained by the harsh reaction 
conditions; it is feasible that degradation of the complex occurs during the reaction. 
This assumption grew stronger when the catalyst was used in the third reaction cycle; 
a yield of 68% was obtained. 
Since these results were very promising, it was decided to apply this novel 
catalyst recycling protocol on a second reaction that is of significant value in organic 
synthesis. 
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6.3.1  Copper(I)–mediated Huisgen cyclisation 
 
To investigate the scope of our catalyst recycling procedure further, we 
decided to use AT–ligand 6 in a second copper(I)–catalysed reaction. In 2002 both 
Meldal en Sharpless independently showed that a regioselective Huisgen cyclisation 
can be performed under influence of copper(I) catalysts.9 This method of preparing 
triazoles has been widely used since then,10 and therefore forms an attractive 
application for our new procedure. For this reaction we used the copper catalyst 
Cu[(phen)(PPh3)]Br,8 which proved to be well–suited for the [3+2] cycloaddition 
reaction depicted in Scheme 4, and the desired product was isolated in quantitative 
yield using acetonitrile as the solvent. 
Analogous to the aforementioned AT–catalyst, the tagged CuBr–based 
catalyst was generated using compound 6 as a ligand, and used in the cyclisation, also 
known as ‘click–reaction’, of substrates 10 and 11. Again, compound 12 was 
obtained in quantitative yield, illustrating the absence of any possible influence of the 
tag on the outcome of the reaction. 
 
Cu[(phen)(PPh3)]Br
or
Cu[(uPy-phen)(PPh3)]Br
10 11 12
acetonitrile
rt, 16 h
isolated yield of 12
cycle 1 cycle 2 cycle 3entry catalyst
1         Cu[(phen)(PPh3)]Br
2      Cu[(uPy-Phen)(PPh3)]Br
>99%       -            -
>99%    >99%    >99%
amount (mol%)
10
10
Me
N
N N
Me
N3
 
 
Scheme 4: Second comparison between standard and recycled catalysts. 
 
When the catalyst was recycled in the same way as previously described, low 
yields were encountered in the second reaction cycle. We reasoned that this could be 
due to undesired oxidation of the copper(I) species to inactive copper(II) which is 
often observed in cyclisations of this type. This was overcome through the addition of 
2 equiv of triphenylphosphine to the mixture, so that complete conversions and 
excellent yields were obtained in the next two cycles as well. Reaction times in the 
                                  Catalyst recycling by affinity separation 
                                                                                                                                            
                                                                                                                                   89 
second and third cycle were the same as during the first reaction, which indicates that, 
when used under ambient conditions, the catalyst can be recycled for at least three 
times.  
To gain insight on the quantitative aspect of our recycling procedure, and to 
ensure that degradation of the catalyst was the reason for this downward trend in 
yields instead of leakage of the catalyst, Inductively Coupled Plasma Mass 
Spectrometry (ICP–MS) mass analyses were performed. These measurements showed 
that only 1.7% of the initial amount of copper was present in the crude product after 
abstracting the catalyst using a tagged resin. Hence, 98.3% of the catalyst was 
abstracted from the crude mixture using 10 equivalents of binding sites on the resin, 
so we can state that the actual number of reaction cycles that can be performed using 
this recycling methodology, can be significantly higher.  
From these results we can conclude that the recycling of these catalysts by 
affinity separation via hydrogen bonding can be a valuable tool in organic synthesis, 
in terms of reduction of both costs and waste. 
 
6.4  Conclusions 
 
We can state that we have realised a new concept for the recycling of 
catalysts, based on our affinity separation protocol. A common ligand for copper(I)–
mediated coupling reactions was equipped with the UPy–based tag in only three, high 
yielding steps. The use of the functionalised ligand in synthetic transformations did 
not affect the outcome of these reactions, but afforded a handle to abstract the catalyst 
from the crude mixture after completion of the coupling. The efficiency of this 
process was investigated in one of the examples with mass measurements, which 
showed that over 98% of the catalyst was indeed isolated using this novel technique. 
The viability of the recycling protocol was firmly established by applying this 
methodology on two different, copper(I)–catalysed coupling reactions. In the first 
case, a tandem Sonogashira/5–endo–dig coupling was performed three times with the 
same catalyst, but yields dropped significantly during the second and third cycle. As 
stated, this was presumably due to the rather harsh reaction conditions. This 
hypothesis was confirmed by a second application, the [2+3] Huisgen cyclisation. 
Again, three reaction cycles were carried out, and the yields of reactions performed 
with the recycled catalyst were indeed equal to the yield of the initial process.   
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These results imply that this new catalyst recycling methodology can be 
applied more widely; in principle various ligands can be equipped with the UPy–AT 
and since, on the basis of our findings, this tag is not expected to interfere with 
transformations this methodology is suitable for a range of catalysed reactions in 
organic synthesis. 
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6.6  Experimental section 
 
5,6–Epoxy–1,10–phenanthroline (2): A mixture of 900 mL of LODA© 
(commercial bleach) and 600 mL of water was brought to pH 8.0, using 
concentrated HCl. Then, a solution of 6.40 g (35.5 mmol) of 1,10–
phenanthroline in 500 mL of CHCl3 was added, and the mixture was stirred 
at rt. After NMR indicated that full conversion was obtained (app. 3.5 hours), the 
layers were separated. After washing the organic phase numerous times with water, 
the solution was dried using Na2CO3 and evaporated. The resulting yellow solid was 
recrystallised from a mixture of CHCl3/hexane (5:1) to give 4.08 g (59%) of the 
desired compound as light yellow crystals. mp: 283 °C. FTIR (ATR): 3058, 3000, 
2935, 1608, 1562, 1527, 1430, 1342, 1280, 885, 800, 746, 704. 1H NMR (CDCl3, 300 
MHz): δ 8.89 (d, J = 4.8 Hz, 2H), 7.98 (d, J = 7.5 Hz, 2H), 7.38 (dd, J = 7.5, 4.8 Hz, 
2H), 4.61 (s, 2H). 13C NMR (CDCl3, 75 MHz): δ 150.6 (2C), 149.3 (2C), 137.9 (2C), 
128.9 (2C), 123.5 (2C), 55.3 (2C). 
 
5–hydroxy–1,10–phenanthroline monohydrate (3): 1.00 g (5.10 mmol) 
of the epoxide 1 was dissolved in 3 mL of sulfuric acid in a sealed vessel. 
The solution was heated to 130 °C for 10 minutes by microwave 
irradiation. After cooling the yellow solution to rt, it was diluted with 15 
mL of water and cooled to 2 °C using an ice bath. The pH of the mixture was brought 
to 8, by careful addition of a 50% solution of NaOH, while keeping the temperature 
of the solution below 5 °C. A fine, slightly pink precipitate was filtered off, washed 
with water and dried to give 685 mg (63%) of the desired compound. FTIR (ATR): 
3027, 2888, 2799, 2718, 2602, 1616, 1592, 1446, 1415, 1307, 1222, 1144, 1071, 839, 
796, 735, 715. 1H NMR (CDCl3, 300 MHz): δ 10.88 (br s, 1H), 9.07 (d, J = 2.4 Hz, 
1H), 8.82 (d, J = 2.1 Hz, 1H), 8.62 (d, J = 7.8 Hz, 1H), 8.22 (d, J = 7.8 Hz, 1H), 7.41 
(dd, J = 7.8, 4.2 Hz, 1H),  7.59 (dd, J = 7.8, 4.2 Hz, 1H), 7.12 (s, 1H). 13C NMR 
(CDCl3, 75 MHz): δ 150.2, 149.5, 146.1, 145.9, 141.1, 133.6, 130.3, 129.1, 122.8, 
122.7, 122.3, 103.6. 
 
N
N
O
N
N
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 [2–([1,10]Phenanthrolin–5–yloxy)–ethyl]–carbamic acid tert–
butyl ester (4): 428 mg (2.00 mmol) of compound 2 and 304 mg 
(2.20 mmol) of K2CO3 were stirred in 10 mL of DMF until a clear, 
orange solution was formed (app. 15 min.). Then, 560 mg of 2–
(Boc–amino) ethylbromide (2.50 mmol) was added, and the mixture was stirred at rt 
for 16 h before removing the solvent under reduced pressure. The residue was taken 
up in CHCl3/H2O, and the layers were separated. The aqueous phase was back–
extracted, and the combined organic layers were washed (NH4Cl), dried (MgSO4) and 
evaporated to yield a yellow solid. This solid was purified with flash chromatography 
(MeOH/Et3N/CHCl3 1:1:98) to yield 640 mg (94%) of the desired product as a white 
solid. mp. : 222 °C FTIR (ATR): 3209, 3028, 2967, 2928, 1697, 1620, 1537, 1273, 
1247, 1165, 1148, 1122, 1092, 982, 849, 737, 694. 1H NMR (CDCl3, 400 MHz): δ 
9.17 (dd, J = 4.3, 1.7 Hz, 1H), 9.00 (dd, J = 4.3, 1.7 Hz, 1H), 8.64 (dd, J = 8.1, 1.7 
Hz, 1H), 8.05 (dd, J = 8.1, 1.7 Hz, 1H), 7.61 (dd, J = 8.1, 1.7 Hz, 1H), 7.52 (dd, J = 
8.1, 4.3 Hz, 1H), 6.90 (s, 1H), 5.08 (br s, 1H), 4.28 (t, J = 5.2 Hz, 2H), 3,72 (q, J = 
5.2 Hz, 2H), 1.45 (s, 9H). 13C NMR (CDCl3, 75 MHz): δ 155.3, 151.2, 150.1, 147.4, 
146.1, 142.2, 134.1, 130.2, 128.5, 122.8, 122.7, 122.1, 101.3, 79.5, 67.6, 39.8, 28.2 
(3C). HRMS (EI): M+H calcd. for C17H19N6O2 339.1570, found 339.1574. 
 
1–[6–(1–Ethyl–pentyl)–4–oxo–1,4–dihydro–pyrimidin–
2–yl]–3–[2–([1,10]phenanthrolin–5–yloxy)–ethyl]–urea 
(6): Boc–protected amine 4 (85 mg, 0.25 mmol) was 
dissolved in 2 mL of a 2:1 mixture of CHCl3 and TFA. The 
solution was stirred for 10 minutes, after which the solvents 
were removed under reduced pressure, yielding the crude amine as an off–white 
crystalline solid.  
To a solution of the ethylpentyl–isocytosine (42 mg, 0.20 mmol) in CHCl3 (5 
mL) was added carbonyl diimidazole (34 mg, 0.21 mmol) carefully. The mixture was 
stirred for 4 h at rt, after which a solution of the crude amine and Et3N (70 µL, 0.50 
mmol) in CHCl3 (5 mL) was added. The mixture was stirred overnight, and then 
diluted with water. The layers were separated, and the aqueous phase was 
backextracted with CHCl3 (2 × 5 mL). The combined organic layers were washed 
with aqueous NH4Cl, dried (MgSO4) and evaporated to give an off–white solid. 
Precipitation of this solid in Et2O yielded tagged linker 6 (88 mg, 93%) as a white 
solid. mp: 158 °C FTIR (ATR): 3217, 3053, 2955, 2928, 2866, 1659, 1614, 1550, 
1452, 1312, 1247, 1219, 1149, 1122, 1095, 842, 740. 1H NMR (CDCl3, 400 MHz) : δ 
13.14 (s, 1H), 12.06 (s, 1H), 10.81 (s, 1H), 9.13 (d, J = 4.0 Hz, 1H), 8.99 (d, J = 4.2 
Hz, 1H), 8.89 (d, J = 8.3 Hz, 1H), 8.07 (d, J = 8.1 Hz, 1H), 7.56–7.51 (m, 2H), 6.95 
(s, 1H), 5.81 (s, 1H), 4.38 (t, J = 5.3 Hz, 2H), 3.89 (dt, J = 5.2, 5.0 Hz, 2H), 2.37–2.30 
(m, 1H), 1.76–1.50 (m, 4H), 1.35–1.17 (m, 4H), 0.92–0.83 (m, 6H). 13C NMR 
(CDCl3, 75 MHz) : δ 173.0, 157.0, 155.6, 154.6, 152.2, 150.4, 147.8, 146.6, 142.8, 
134.6, 131.6, 129.2, 123.7, 123.2, 122.5, 106.3, 101.5, 67.1, 45.4, 39.2, 32.9, 29.3, 
26.6, 22.5, 13.9, 11.7. HRMS (FAB): M+H calcd. for C26H31O3N6 475.2458, found 
475.2451. 
 
General procedure for the preparation of 9 and catalyst recovery: To a 
solution of 6 (24 mg, 0.05 mmol) in DMF (4 mL) were added triphenylphosphine (13 
mg, 0.05 mmol) and [Cu(PPh3)2]NO3 (33 mg, 0.05 mmol). The mixture was stirred at 
rt until a clear, yellow solution was observed (app. 10 min). Then, 2–iodophenol (0.11 
g, 0.50 mmol), phenylacetylene (51 mg, 0.50 mmol) and K2CO3 (138 mg, 1.00 mmol) 
N
N
O
BocHN
N
N
O
N
H
N
H
ONH
NO
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were added. The resulting mixture was heated to 110  C for 24 hours, and the solvent 
was evaporated. The residue was taken up in CHCl3 (25 mL), and a tagged resin was 
added (2.5 g, app. 10 eq. of binding sites, relative to the amount of catalyst). The 
suspension was shaken for 12 hours, and the catalyst–bearing resin was filtered off. 
Compound 9 was isolated from the filtrate by flash column chromatography (1:4 
EtOAc/heptane), yields as indicated in Scheme 3. 
The catalyst was recovered by the following procedure: A mixture of 
DMF/MeOH/CHCl3 (2:1:1 v/v/v) was added to the resin, and the resulting suspension 
was shaken for 3 h. After filtering off the resin, the filtrate was evaporated to give the 
crude catalyst, which was used again in the next reaction cycle without further 
purification. 
 
General procedure for the preparation of 12 and catalyst recovery: To a 
solution of 6 (24 mg, 0.05 mmol) in acetonitrile (4 mL) were added 
triphenylphosphine (13 mg, 0.05 mmol) and [Cu(PPh3)]Br (20 mg, 0.05 mmol). The 
mixture was stirred at rt until a clear yellow solution was observed (app. 30 min). 
Then, azide 10 (74 mg, 0.50 mmol), phenylacetylene (51 mg, 0.50 mmol) and 
triphenylphosphine (26 mg, 0.10 mmol) were added, and the resulting mixture was 
stirred for 16 h at rt. Work–up, purification and catalyst recovery as described above, 
yields as indicated in Scheme 4. 
 
Procedure for the determination of catalyst leakage: Compound 16 (24 
mg, 0.05 mmol) and [Cu(PPh3)]Br (20 mg, 0.05 mmol) were dissolved in 200 mL of 
aqueous HNO3 (5%). This solution was analyzed in triplo using ICP–MS, giving an 
average ion–count of 2.16 × 107 (≡ 100%). 
Then, a Huisgen–cyclisation was carried out, and the catalyst was isolated 
using the AT–bearing resin (all as described above). The resin was filtered off, and 
the filtrate was evaporated to give the crude product as a white solid. This solid was 
then dissolved in 200 mL of aqueous HNO3 (5%), and the resulting solution was 
analyzed in triplo using ICP–MS, giving an average ion–count of 3.61 × 105 (1.72%). 
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Summary 
 
AFFINITY SEPARATION BASED ON HYDROGEN BONDING:  
SCOPE AND LIMITATIONS IN ORGANIC SYNTHESIS 
 
The purification – work up and separation from other compounds – of 
chemical reactions is a crucial step in the synthesis of organic molecules. Therefore, 
organic chemists have developed a variety of work up and purification techniques 
throughout the last centuries, and novel methods are being explored every day. 
For instance, the development of synthesis on a solid resin, which reduces 
work up to straightforward filtration steps, has made a significant contribution to the 
automation of peptidesynthesis. 
In recent years, a novel technique making use of controllable, non–covalent 
interactions was designed. In this so called affinity separation methodology (Figure 
1), a starting material (A) is equipped with a tag that has a (strong) affinity for a 
different medium than the other reagents present. After a chemical reaction, addition 
of this affinity medium and subsequent phase separation yields the pure product 
(AB), which can be obtained after cleavage from the tag. 
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Figure 1: Purification of products by affinity separation. 
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In Chapter 1 an overview of different affinity separation methods and their 
corresponding tags is given. Also, the properties of the ureido–pyrimidinone (UPy) 
unit, which is the affinity tag used in this thesis, are described. This UPy–unit is a 
self–complementary hydrogen bonding array, which exhibits a dimerisation constant 
of over 107 M–1. We hypothesised that when the end–groups of a resin are modified 
with UPy–units, this polymer should be suitable to bind UPy–unit bearing compounds 
by hydrogen bonding. If this is the case, discrimination of tagged and untagged 
products and reagents is possible, setting the stage for a new affinity separation 
method.  
Chapter 2 shows a range of complexation experiments of UPy–tagged 
substrates and resins. The goal of these experiments was to establish the most suitable 
conditions for abstraction of tagged substrates from solution by UPy–equipped resins.  
In addition, the synthesis of a first UPy–tagged linker (compound 1, Figure 2) 
is described.  
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Figure 2: UPy–tagged linker. 
 
 Besides the UPy–tag and a spacer, this linker possesses a functionality which 
can be used to couple substrates with. The synthesis of this compound was 
cumbersome, and complexation experiments were only partially successful. Since we 
reasoned that this was due to the poor solubility of these compounds, it was decided 
to abandon these linkers. 
 In Chapter 3 the synthesis of UPy–units bearing large, apolar side–chains is 
presented. Linkers containing these alternative UPy–tags are built up starting from the 
corresponding isocytosines (2, Figure 3), which are easily obtainable. As anticipated, 
the solubility of compound 3 is far better than that of linker 1 in virtually all solvents, 
and complexation experiments with these new linkers were successful. 
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Figure 3: UPy–linkers with apolar side groups. 
 
 Coupling reactions of substrates with these compounds failed though, and we 
set out to synthesise more rigid derivatives of 3. 
 These novel linkers are synthesised in a similar fashion, which is presented in 
Chapter 4. Coupling substrates to compound 4 went smoothly, and following up 
chemistry can be carried out successfully (Figure 4). Compounds 6 were purified 
using our novel affinity separation protocol, and the purity of these products was 
satisfyingly high. Cleavage of the tagged linker and subsequent affinity purification 
of desired products 7 was also performed, and again the purity of the products was 
high. These findings can be regarded as a proof of principle for our affinity separation 
method. 
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Figure 4: Aromatic substitution and subsequent cleavage of compound 7. 
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 In Chapter 5 the scope of this affinity separation technique is expanded to the 
field of multi–component reactions; a benzoic acid derivative is equipped with a 
UPy–tag, and this compound (8, Figure 5) is used in the Ugi 4–component reaction 
(U–4CR). 
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Figure 5: U–4CRs with UPy–tagged compound 8. 
 
 Products 9 were isolated from the crude reaction mixture using the hydrogen 
bonding properties of the UPy–tag. The observed yields and purities of the isolated 
compounds were comparable to those obtained using standard work up and 
purification techniques. 
 Chapter 6 shows a final application of our affinity separation method. In this 
case, not a reaction substrate is equipped with a UPy–tag, but a ligand for Cu(I) 
catalysis, (1,10)–phenanthroline (10, Figure 6) was modified (Figure 6). 
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Figure 6: Equipment of (1,10)–phenanthroline with a UPy–tag. 
 
Tagged ligand 11 was used in two Cu(I)–catalysed reactions, and the catalytic 
complex could be abstracted from the crude reaction mixture by affinity separation. 
This isolated catalyst was reused in three reaction cycles, and the yields of the 
catalytic process remained good to excellent. 
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AFFINITEITSSCHEIDING DOOR WATERSTOFBRUGVORMING: 
REIKWIJDTE EN BEPERKINGEN BINNEN ORGANISCHE SYNTHESE 
 
De zuivering – opwerken en scheiden van andere componenten – van 
chemische reactiestappen vormt een cruciale schakel in het synthetiseren van 
organische moleculen. Als gevolg hiervan hebben organisch chemici een scala aan 
opwerkings– en zuiveringsmethoden ontwikkeld gedurende de afgelopen eeuwen. 
Zo heeft bijvoorbeeld de ontwikkeling van synthese op een vast 
dragermateriaal (waarbij opwerkstappen veelal worden gereduceerd tot affiltreren) 
een belangrijke rol gespeeld bij het automatiseren van peptidesynthese.  
In de afgelopen jaren werd een zuiveringsmethode ontwikkeld die gebruikt 
maakt van gecontroleerde, niet–covalente interacties. Bij deze zogenaamde 
affiniteitsscheidingsmethode (Figuur 1) wordt de uitgangsstof (A) uitgerust met een 
tag, welke een (sterke) voorkeur heeft voor een andere fase dan de overige aanwezige 
reagentia.  
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Figuur 1: Zuivering door middel van affiniteitsscheiding. 
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Wanneer na een chemische reactie een affiniteitsmedium (geimmobiliseerde 
tag) wordt toegevoegd aan het mengsel kan het product doordat het zich niet-covalent 
hecht aan de vaste fase, worden gescheiden van de componenten in de vloeistoffase. 
Vervolgens levert het splitsen van de linker het product (AB) op. 
In Hoofdstuk 1 wordt een overzicht geschetst van affiniteitsscheidings-
methoden en de bijhorende tags die momenteel voorhanden zijn. Verder worden de 
eigenschappen van de ureido–pyrimidinon (UPy) groep, de affiniteitstag die in dit 
proefschrift wordt gebruikt, beschreven. Deze UPy–groep is een zelf–
complementaire, viervoudig waterstofbrugvormende structuur, die een homodimeer 
vormt met een bindingsconstante van ongeveer 107 M–1. We redeneerden dat wanneer 
een vaste drager gefunctionaliseerd wordt tot UPy–groepen, deze hars geschikt zal 
zijn om verbindingen die zelf ook een UPy–groep bezitten, aan zich te binden door 
middel van waterstofbrugvorming. Wanneer dit het geval is, zou dat impliceren dat 
discriminatie tussen verbindingen met en zonder een UPy–groep mogelijk is, wat een 
uitgangspunt kan zijn voor de ontwikkeling van een nieuwe 
affiniteitsscheidingsmethode. 
Hoofdstuk 2 beschrijft een reeks bindingsexperimenten tussen vaste dragers 
en substraten, beide voorzien van een UPy–groep. Het doel van deze proeven was het 
vaststellen van de optimale condities waarbij een verbinding gefunctionaliseerd met 
een UPy–groep uit een oplossing gebonden wordt door een hars met eindstandige 
UPy–groepen. 
Verder wordt de synthese van een eerste linker met UPy–functionaliteit 
beschreven (verbinding 1, Figuur 2). 
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Figuur 2: Een linker uitgerust met een UPy–groep. 
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 Naast de UPy–groep en een spacer, bezit deze linker een functionele groep 
waar substraten aan gekoppeld kunnen worden. De synthese van dit molecuul was 
echter problematisch, en bindingsexperimenten waren slechts deels succesvol. 
Aangezien dit teleurstellende resultaat waarschijnlijk samenhangt met de slechte 
oplosbaarheid van deze moleculen, werd besloten een andere benadering te kiezen. 
 In Hoofdstuk 3 wordt de synthese van UPy–verbindingen met relatief grote en 
apolaire zijgroepen beschreven. Deze linkers worden opgebouwd met nieuwe 
isocytosines (2, Figuur 3), welke gemakkelijk te verkrijgen zijn. 
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Figuur 3: UPy–linkers met apolaire zijgroepen. 
 
 Zoals verwacht is de oplosbaarheid van verbinding 3 veel hoger dan die van 
linker 1 in zo goed als ieder oplosmiddel, en de uitkomst van complexatie–
experimenten met deze nieuwe linkers was dan ook uiterst positief.  Het koppelen van 
substraten met deze linkers bleek echter niet mogelijk, waardoor we ons richtten op 
starre derivaten van verbinding 3. 
 Nieuwe linkers, gesynthetiseerd in analogie met de vorige, staan beschreven 
in Hoofdstuk 4. Het koppelen van substraatmoleculen met deze verbindingen verliep 
probleemloos, en vervolgchemie werd daarmee mogelijk. Verbindingen 6 (producten 
van een aromatische substitutie op verbindingen 5) werden gezuiverd met de nieuwe 
affiniteitsmethode, en de zuiverheid van de verkregen stoffen was zeer hoog. 
Afsplitsing van de linker en een tweede affiniteitszuivering van producten 7 leverde 
ook zeer zuivere verbindingen op. Deze bevindingen kunnen worden beschouwd als 
een validatie van de in dit proefschrift gepresenteerde zuiveringsmethode. 
Samenvatting 
                                                                                                                                            
 
102 
 
N
H
N
H
O
N
NH
R
O
O
OH
N
H
N
H
O
N
NH
R
O
O
O
O
F
NO2
4
5
koppeling
SNAr
N
H
N
H
O
N
NH
R
O
O
O
O
NR1R2
NO2
HO
O
NO2
NR1R2
splitsing
6
7
 
Figure 4: Aromatische substitutie en daaropvolgende afsplitsing van verbinding 7. 
 
 Hoofdstuk 5 laat een nieuwe toepassing van deze affiniteitsscheiding zien. 
Een benzoëzuurderivaat wordt uitgerust met een UPy–groep (8, Figuur 5) en 
vervolgens gebruikt in Ugi 4–componentreacties (U–4CRs). 
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Figuur 5: U–4CRs met verbinding 8. 
 
 Producten 9 werden uit het ruwe reactiemengsel geïsoleerd door gebruik te 
maken van waterstofbrugvorming van de UPy–groep. Zowel de opbrengsten als de 
zuiverheid van de verkregen producten waren vergelijkbaar met die van producten die 
werden onderworpen aan standaard zuiveringsmethoden. 
 Hoofdstuk 6 laat een laatste toepassing van deze nieuwe zuiveringstechniek 
zien. Hierbij wordt niet een uitgangsstof, maar een ligand voor Cu(I) katalyse, (1,10)–
phenanthroline (10, Figuur 6), voorzien van een UPy–groep. 
 
                                  Samenvatting 
                                                                                                                                            
 103 
 
 
N
N
HO
H2O
10
N
N
O
N
H
N
H
ONH
NO
11
 
 
Figuur 6: Het uitrusten van (1,10)–phenanthroline met een UPy–groep. 
 
 Het met de UPy–groep uitgeruste ligand 11 werd gebruikt in twee Cu(I)–
gekatalyseerde processen, en het katalytische complex werd uit het ruwe 
reactiemengsel geïsoleerd door middel van affiniteitsscheiding. De katalysator werd 
vervolgens hergebruikt in drie reactie–cycli, en de opbrengsten van deze reacties 
bleven goed tot uitmuntend. 
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